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The global population of immunocompromised individuals has been rising due to the 
immunosuppressive nature of advanced medical interventions such as chemotherapy for cancer 
and immunosuppressive conditions such as HIV infection. Concurrent with this is the increasing 
incidence of life threatening systemic fungal infections as well as the growing resistance towards 
existing antifungal drugs. As a result, there is an urgent need for the discovery and development 
of novel drugs of antifungal therapy. Antimicrobial peptides present as promising candidates for 
this role due to their broad-spectrum antimicrobial activity and the limited potential for the 
evolution of resistance against them.  
In this study, the potential of small AMPs to serve as therapeutic agents against fungal infections 
was investigated by characterising the antifungal activity and mode of action of natural 
cyclodecapeptides and synthetic RW-hexapeptides against a human fungal pathogen, Aspergillus 
fumigatus. In addition, biophysical characterisation of their structures was conducted to evaluate 
the role of structure in antifungal activity. 
Biophysical characterisation of the secondary structure of cyclodecapeptides confirmed their 
conserved β-sheet structure. Structural characterisation of cyclic RW-hexapeptides highlighted 
their secondary structure to be quite stable and to consist of β-sheet and β-turns. On the other hand, 
the secondary structure of the linear analogues was shown to be flexible, changing from highly 
irregular (undefined) structures to more defined structures as the polarity of the environment was 
altered.  
The cyclodecapeptides and RW-hexapeptides potently inhibited the germination and growth of A. 
fumigatus spores highlighting the potential of both peptide groups as antifungal agents. However, 
the cyclodecapeptides exhibited pronounced haemolytic activity which compromised their 
selectivity for the fungal target. In contrast, the RW-hexapeptides had little to no haemolytic 
activity which translated to a greater selectivity for the fungal pathogen.  
A partial characterisation of the mode action employed by the cyclodecapeptides and the RW-
hexapeptides was done. The cyclodecapeptide, tryptocidine C (WC), rapidly induced the uptake of 
the membrane impermeable dye, SYTOX Green (SG) in A. fumigatus hyphae. This result 
confirmed the previously described membranolytic mode of action of the cyclodecapeptides. In 
contrast, RW-hexapeptides were not as effective at inducing the uptake of SG, indicating that 
membrane lysis is not their principal mode of action. Thus, the mode of action of RW-hexapeptides 
remains unknown but ROS could potentially be involved in the antifungal mechanism of action as 
one of the cyclohexapeptides, cWWW, significantly increased the accumulation of endogenous 
ROS in A. fumigatus hyphae. Furthermore, the slightly antagonistic interactions between WC and 
the most active RW-hexapeptide analogues, especially cWWW, in the peptide combination studies 
could indicate that the two groups of peptides may share a target but act on it differently. While 
RW-hexapeptides may not be lytic, the membrane could still be their target meaning that the lytic 
activity of WC prevents them from acting on their target hence the antagonistic interactions. In 
conclusion, the demonstrated selectivity of the RW-hexapeptides renders them very attractive for 
potential development as antifungal agents for systemic use. 




Die globale bevolking van individue met 'n onderdrukte immuunstelsel het gestyg as gevolg van 
die immunonderdrukkende aard van gevorderde mediese ingrypings soos chemoterapie vir kanker 
en immunonderdrukkende toestande soos MIV-infeksie. Gepaardgaande hiermee is daar 'n 
toename in die voorkoms van lewensbedreigende sistemiese swaminfeksies asook 'n toename 
weerstand teen bestaande antifungale middels. As gevolg hiervan is daar 'n dringende behoefte aan 
die ontdekking en ontwikkeling van nuwe middels vir antifungiese behandelings. Antimikrobiese 
peptiede (AMPe) is belowende kandidate vir hierdie rol weens hul breë spektrum antimikrobiese 
aktiwiteit en die beperkte potensiaal vir die ontwikkeling van weerstand. 
In hierdie studie is die potensiaal van klein AMPe om as middels teen swaminfeksies te dien, 
ondersoek deur die antifungale aktiwiteit en werking van natuurlike siklodekapeptiede en sintetiese 
RW-heksapeptiede teen 'n menslike swampatogeen, Aspergillus fumigatus, te karakteriseer. 
Daarbenewens is die biofisiese karakterisering van hul strukture uitgevoer om die rol van struktuur 
in antifungale aktiwiteit te evalueer. 
Biofisiese karakterisering van die sekondêre struktuur van siklodekapapiede het hul bewaarde 
β-plaatstruktuur bevestig. Strukturele karakterisering van die RW-heksapeptiede het beklemtoon 
dat die sekondêre struktuur van die sikliese analoë redelik stabiel is en uit reëlmatige sekondêre 
struktuurelemente (β-plaat en β-draaie) bestaan. Daarteenoor is die sekondêre strukture van die 
lineêre analoë meer buigsaam, wat vanaf hoogs onreëlmatige (ongedefinieerde) strukture tot meer 
gedefinieerde strukture omsskakel, soos die polariteit van die omgewing verander. 
Die siklodekapeptiede en RW-heksapeptiede verhinder moontlik die ontkieming en groei van A. 
fumigatus-spore, wat die potensiaal van beide peptiedgroepe as antifungale middels beklemtoon. 
Die siklodekapeptiede het egter uitgesproke hemolitiese aktiwiteit getoon, wat hul selektiwiteit vir 
die swamteiken benadeel het. Daarteenoor het die RW-heksapeptiede min of geen hemolitiese 
aktiwiteit getoon wat 'n groter selektiwiteit vir die swampatogeen beteken.  
'n Gedeeltelike karakterisering van die meganisme van aksie wat deur die siklodekapeptiede en die 
RW-heksapeptiede gebruik word, is gedoen. Die siklodekapeptiede, triptosidien C (WC), het 'n 
vinnige opname van die membraan-deurdringbare kleurstof, SYTOX Groen (SG) in A. fumigatus 
hife veroorsaak. Die resultaat het die voorheen beskryfde litiese membraan werking van die 
siklodekapeptiede bevestig. In teenstelling hiermee het RW-heksapeptiede nie effektief die 
opname van SG veroorsaak nie, wat aandui dat membraanlise nie hul hoofmeganisme van aksie is 
nie. Die werkingsmeganisme van RW-heksapeptiede bly dus onbekend, maar ROS (reaktiwe 
suurstof spesies) kan moontlik by die antifungale aktiwiteit betrokke wees, aangesien die 
sikloheksapeptied, cWWW, die toename van endogene ROS in A. fumigatus hife aansienlik 
verhoog het. Verder kan die effense antagonistiese interaksies tussen WC en die twee aktiefste 
sikoheksapeptiede, spesifiek cWWW, in die peptiedkombinasie studies aandui dat die twee groepe 
peptiede 'n teiken kan deel, maar verskil in interaksie. Terwyl RW-heksapeptiede nie lities is nie, 
kan die membraan steeds hul teiken wees, wat beteken dat die litiese aktiwiteit van WC hulle 
verhoed om op hul teiken te reageer, wat die antagonistiese interaksies tot gevolg het. As 
afsluitende gevolgtrekking maak gedemonstreerde selektiwiteit van die RW-heksapeptiede hulle 
baie aantreklik vir die potensiële ontwikkeling vir sistemiese gebruik as antifungiese middels. 
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The increasing frequency of multi-drug resistant pathogens has become an issue of great medical 
concern worldwide, especially since the population of immunocompromised individuals continues 
to rise due to immunosuppressive infections such as HIV, post-surgery immunosuppressive 
therapies and chemotherapy of cancer patients. Immunocompromised patients are often susceptible 
to life threatening systemic fungal infections such as those caused by Aspergillus fumigatus, 
Candida albicans and Cryptococcus neoformans. Systemic fungal infections are extremely fatal 
and are associated with high mortality rates that exceed 50%, even when treatment is administered. 
The currently available antifungal agents have demonstrated inefficacy in the treatment of systemic 
fungal infections and/or toxicity towards the host. Moreover, fungal pathogens are increasingly 
acquiring resistance against these antifungal agents. As such novel therapeutic agents are urgently 
needed in order to address the global health burden of systemic fungal infections.  
Antimicrobial peptides (AMPs) are attractive candidates for potential development as alternative 
antifungal therapeutic agents. They have broad spectrum activity which compromises the efficient 
functioning of components of the microbial cell that are essential for survival such as the cell 
membrane. In addition, antimicrobial activity is swiftly elicited upon encountering a microbial 
challenge which leaves little room for the development of resistance. 
Tyrocidines and analogues are small cyclodecapeptides that are produced by the soil bacterium, 
Brevibacillus parabrevis. They have exhibited potent lytic activity against a plethora of pathogens, 
including filamentous fungi. They are also components of tyrothricin, an antibiotic that has been 
used for topical and oral applications in the management of microbial infections for the last 70 
years without resistance development. RW-hexapeptides are another group of small AMPs that 
can potentially be developed as novel antifungal therapeutic agents based on their potent 
antibacterial activity. They have shown activity against Gram-positive and Gram-negative bacteria. 
However, the antifungal of most of RW-hexapeptide analogues remains to be characterised.  
Therefore, the goal of this research was to elucidate the potential of selected AMPs (natural 
cyclodecapeptides and synthetic RW-hexapeptides) to serve as alternative antifungal agents in an 
effort to contribute to the ongoing search for novel therapeutic agents to combat fungal pathogens. 
To achieve this goal, the aims and objectives listed below had to be met. 
Stellenbosch University  https://scholar.sun.ac.za
xiv 
 
Aims and objectives  
Aim 1: Production, purification and chemical characterisation of natural cyclodecapeptides 
and RW-hexapeptides. 
1. Acquire a selection of linear and cyclic synthetic RW-hexapeptides and chemically 
characterise all peptides via electrospray mass spectrometry (ESMS) and ultra-performance 
liquid chromatography linked to ESMS (UPLC-MS). 
2. Produce selected cyclodecapeptide analogues using cultures of Brevibacillus parabrevis 
5618 supplemented with selected aromatic amino acids and purify peptides via established 
extraction and semi-preparative HPLC methodologies. Chemically characterise all peptides 
via ESMS and UPLC-MS. 
The results of these objectives are reported in Chapter 2 
Aim 2: Biophysical structural characterisation of natural cyclodecapeptides and RW-
hexapeptides 
1. Analyse secondary structures of RW-hexapeptides and cyclodecapeptides and determine 
physicochemical parameters from in silico molecular models  
2. Analyse the secondary structure of cyclodecapeptides and RW-hexapeptides using circular 
dichroism spectroscopy and determine the influence of different solvent environments on 
the secondary structures 
3. Investigate the effect of different solvent environments on the tertiary structure of 
cyclodecapeptides and RW-hexapeptides by tracking the fluorescence of Trp residues using 
fluorescence spectroscopy  
The results of these objectives are reported in Chapter 3 
Aim 3: Characterisation of the antifungal activity and mode of action of natural 
cyclodecapeptides and RW-hexapeptides against Aspergillus fumigatus 
1. Establish the growth inhibition parameters of RW-hexapeptides and natural 
cyclodecapeptides towards A. fumigatus spores and hyphae 
2. Establish the inhibition parameters of combinations of RW-hexapeptides with natural 
cyclodecapeptides to determine if peptide interactions are synergistic, additive or 
antagonistic towards A. fumigatus 
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3. Determine peptide selectivity by using established haemolytic assays 
4. Determine whether the mode of antifungal action of cyclodecapeptides and RW-
hexapeptides is lytic or  non-lytic  
5. Investigate induction of endogenous reactive oxygen species (ROS) by the most active 
cyclodecapeptides and RW-hexapeptides  
The results of these objectives are reported in Chapter 4 
Thesis Content 
This thesis consists of five chapters and was structured so that each chapter is a standalone unit 
consisting of the following sections: introduction, materials and methods, results and discussion, 
conclusion and references. This was done for the purpose of making the publication of findings 
easier.  A literature background on fungal infections and antifungal peptides is presented in Chapter 
1. This is followed by Chapter 2-4 where the details of the experimental investigations of each of 
the three aims are discussed separately. The last chapter (Chapter 5) summaries the findings from 
this entire investigation and gives recommendations for future work. Due to the structuring of the 
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Chapter 1 
Literature Review: Invasive fungal infections  
and antifungal peptides 
1.1 Introduction 
Fungi are a diverse group of eukaryotic microorganisms; roughly estimated to be around five 
million species worldwide [1]. They exist either as unicellular organisms known as yeasts or 
as multicellular filamentous organism known as moulds. The ecological niche of fungi varies, 
with several species living either as saprophytes in the soil and environment or as commensal 
organisms within humans and animals. As a result, they can influence the health of other 
organisms present in these ecological niches or the host which they infect.   
Unlike bacteria, fungi were previously regarded as predominantly phytopathogens which has 
led to a detrimental oversight of their impact on human health. Fungi infect over a billion 
people each year and millions succumb to these infections [1,2]. Approximately 600 fungal 
species have been identified as potentially pathogenic towards humans and/or animals [3], but 
only 20-25 species are frequent etiologic agents of disease [1].  
The infections caused by pathogenic fungi are split into two distinct categories namely 
superficial mycoses and invasive/systemic mycoses. Of the two types, superficial infections 
are the most common affecting approximately 1.7 billion of the global human population [2]. 
Infections of this kind normally affect the skin and nails of individuals regardless of immune 
status; often causing conditions such as athlete’s foot, ringworm of the scalp and nail infections. 
Also common are the infections of the mucosal lining of the oral cavity and female urogenital 
tract known as oral thrush and vulvovaginal thrush respectively [2]. Fortunately, despite their 
high incidence, superficial infections are easily treatable and rarely result in mortality; but the 
quality of life of the afflicted individuals is adversely affected [4]. 
In contrast, invasive fungal infections have a lower incidence but are usually life threatening 
and have an unacceptably high overall mortality rate (often exceeding 50%)[2]. Invasive fungal 
infections are characterised as a severe, life-threatening systemic infections that have 
disseminated into visceral organs of the body such as, but not limited to the lungs, liver, kidneys 
and brain. Invasive fungal infections affect mostly immunocompromised individuals. In recent 
years there has been a surge in the population of immunocompromised individuals due to 
underlying immunosuppressive conditions such as HIV infection and cancer and aggressive 
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medical interventions [5]. This has translated to an increase in the occurrence of invasive fungal 
infections. It should be noted, though, that true mortality rates remain unknown because of lack 
of good epidemiological data [3]. The estimated annual mortality rate is comparable to that of 
malaria or tuberculosis; approximately one and half million deaths occur each year due to 
invasive fungal infections[2]. This indicates that fungi have since evolved into becoming a 
major health problem and therefore the burden they impose on global health system can no 
longer be ignored. Because of this, more research must be devoted to combating fungal 
pathogens and the mycoses they cause. 
Although several fungal species are implicated in the pathogenesis of these invasive fungal 
infections, the top three causative agents are members of the Candida, Aspergillus and 
Cryptococcus species. These species account for over 90% of all invasive fungal infections 
[2][6], and by extension fungi-related deaths. The following section has been devoted to 
reviewing each of the three above-named pathogens and the invasive infections in greater 
depth. 
1.2 Human fungal pathogens causing invasive and/or systemic infections  
Aspergillus fumigatus and invasive Aspergillosis 
Aspergillus fumigatus is a ubiquitous saprophyte that commonly grows on decaying organic 
debris and produces airborne spores. Its spores enter the human body via the respiratory system 
making the lung  the primary site of infection although any organ in the body can be affected 
[7,8]. A. fumigatus causes a spectrum of disease conditions in immunocompromised hosts 
which include acute or chronic invasive aspergillosis (IA), aspergilloma and allergic 
bronchopulmonary aspergillosis [9]. Of greatest medical concern is acute IA, which is often a 
fatal infection that progresses rapidly [10]. The mortality rate associated with IA is very high, 
more than 50% even when diagnosed and treated. However, if there is a delay in diagnosis and 
or treatment, the fatality rate can be as high as 100% [2,11].  
Invasive aspergillosis affects a narrow spectrum of immunosuppressed individuals who usually 
are recipients of transplants or have underlying haematological malignancies [7,12]. According 
to a study by Patterson et al. [12], approximately 61% of the patients diagnosed with IA had 
either a haematological cancer or had received a bone marrow transplant (BMT). The estimated 
incidence of IA is 5-25% in patients with acute leukaemia, 5-10% in recipients of allogeneic 
BMT and 0.5-5% after solid organ transplantation [7]. Of those who have undergone solid 
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organ transplantation, the incidence of IA is highest amongst heart or lung transplant recipients 
(14-18%). Furthermore, an increasing frequency of IA has been observed in 
immunocompromised patients without an underlying haematological disease such as those 
diagnosed with advanced AIDS (1-12%) and those with chronic granulomatous disease (25-
40%) [7,13]. Recently, the risk of IA has also been associated with diabetes mellitus and the 
use of corticosteroid therapy [13].  
A. fumigatus is the predominant etiologic agent of invasive aspergillosis, accounting for 
approximately 90% of all human infections. However, other Aspergillus species such as A. 
flavus, A. terreus and A. niger are sometimes implicated as pathogens [7,9,14]. For the purposes 
of the research presented in this thesis, the focus is entirely on A. fumigatus since it is the most 
common agent of infection. 
Candida albicans and Candidemia 
The yeast Candida is a commensal organism that forms part of the normal flora found on 
mucosal membranes of healthy individuals. Unfortunately, in the immunocompromised host, 
Candida species have the potential to cause infections and are therefore deemed opportunistic 
pathogens [15]. According to the Centres for Disease Control and prevention (CDC), Candida 
species pose a serious threat to human health as they are increasingly becoming resistant to 
antifungal drugs [16]. 
The invasive fungal infections caused by yeast belonging to the Candida genus are termed 
invasive candidiasis and are the prevalent type of fungal infections in Western countries. The 
most common clinical presentation of invasive candidiasis is candidemia (bloodstream 
infection) [17].  It has been reported that Candida species are responsible for approximately 8-
10% of all health care related blood stream infections [13] and are the fourth most frequent 
cause of nosocomial bloodstream infection in the United States [18]. Although a multitude of 
Candida species are implicated as etiologic agents of invasive candidiasis, approximately 95- 
97% of all infections are caused by the following five species: C. albicans, C. glabrata, C. 
krusei, C. tropicalis and C. parapsilosis [13,19]. Of these, C. albicans remains the leading 
cause of human infections both in Europe and the United States, accounting for approximately 
60% of all infections. However, epidemiology trends have been changing over the years and 
the incidence of infections due non-albicans Candida is increasing [17,20,21].  
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The development of candidemia is largely associated with prolonged hospitalisation of 
vulnerable population groups with certain underlying medical conditions which include 
hematologic malignancies, severe neutropenia, gastrointestinal surgery, premature birth and 
advanced age (over 70 years).  In addition, the presence of a venous catheter, renal failure, 
extended use of broad-spectrum antibiotics and parenteral nutrition have also been identified 
as secondary risk factors within these high-risk population groups [13,22–24]. Despite 
therapeutic intervention, the mortality rate of candidemia has remained very high. Candidemia 
is associated with a crude mortality exceeding 60% and an attributable mortality between 10%- 
49% [25].  
Cryptococcus neoformans and Cryptococcosis 
Cryptococcosis is an opportunistic infection that is primarily caused by Cryptococcus 
neoformans, a ubiquitous fungal pathogen [2]. It is the second most common yeast species to 
cause opportunistic infections in immune compromised patients [21]. Infection occurs via 
inhalation and typically manifests itself as meningoencephalitis, also known as meningitis [26]. 
In regions that are highly prevalent in HIV/AIDS, C. neoformans has evolved to become the 
leading cause of meningitis [27–30]. Incidence of HIV related cryptococcal infections is about 
95% in middle and low-income countries and 80% in high income countries. This indicates 
that  HIV infection is the predominant predisposing factor to cryptococcal infections 
throughout the world [31]. Other factors that also increase one’s susceptibility to acquiring a 
cryptococcal infection include solid organ transplantation, exposure to corticosteroid or other 
immunosuppressive therapy, hematologic cancers and diabetes mellitus [26].  
According to the CDC, the global burden of cryptococcal meningitis stands at an estimated one 
million cases each year with more than 600 000 mortalities occurring in Sub-Saharan Africa. 
The disease accounts for 55-70% of AIDS related deaths in Sub-Saharan Africa and Latin 
America; thereby making it the fourth leading cause of deaths in AIDS patients [29].These 
statistics are clearly indicative of how huge the disease burden of cryptococcal meningitis is in 
Sub-Saharan Africa and how well it compares with the health burden imposed by the 
continent’s well recognised killer diseases such as tuberculosis (350,000 deaths), childhood 
diarrhoeal diseases (525,000 deaths) and malaria (405,000 deaths) [32]. What is disturbing, 
though, is that such a fatal infection has not received the same degree of attention as the other 
diseases of comparable health burden.  
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1.3 The clinical arsenal of antifungal drugs  
The high mortalities associated with invasive fungal infections are a direct result of the 
shortcomings in their clinical management. Fungal cells, being eukaryotic organisms, bear a 
strong evolutionary resemblance to human and animal cells. Because of this, the discovery of 
unique molecular targets that can be exploited for drug development without the risk of 
inducing toxicity in the host is rather difficult [4,6,33]. As a result, only a few drug classes 
(polyenes, pyrimidines, azoles and echinocandins) are currently available for clinical use to 
tackle fungal pathogens [4,6,34]. Refer to Figure 1.1 for chemical structures of selected 
antifungal drug in clinical use. In addition, toxicity and resistance issues preclude the use of 
some of the antifungal agents available in the already scant antifungal drug repository further 
constraining the choice of therapeutics. 
Polyenes 
Polyenes were the first class of antifungal agents to be approved for clinical use against 
invasive fungal infections. They are natural, macrocyclic, amphipathic molecules that were 
isolated from cultures of Streptomyces [4]. The exact mechanism of action through which 
polyenes exert their antifungal activity remains unclear despite their long history in clinical use 
[35]. For a long time,  the consensus in the scientific community was that polyenes act by 
inserting into and permeabilising ergosterol containing membranes which then leads to leakage 
of cell contents and ultimately cell death [36,37]. However, recent reports indicate that 
polyenes act as ergosterol sponges which extract ergosterol out of the lipid bilayer thereby 
disrupting the integrity of the membrane [38]. The three polyenes that are in clinical use are 
amphotericin B, nystatin and natamycin. Out of the three, only amphotericin B is used for the 
treatment of invasive and/or systemic fungal infections [4].  
Amphotericin B has the widest spectrum of fungicidal activity and is regarded as the mainstay 
of antifungal therapy due to is potent fungicidal activity. Unfortunately, its slight affinity for 
cholesterol-containing membranes often causes nephrotoxicity and infusion related side effects 
in the host [39]. These toxic side effects are observed in 50-90% of cases [34] which often 
leads to the discontinuation of treatment. Three lipid formulations of amphotericin B were 
created to circumvent the toxicity issues and they have greatly improved the toxicity profile of 
amphotericin B [1]. Nonetheless, the use of amphotericin B is limited to only those infections 
that cannot be treated with the other therapeutic options 
Stellenbosch University  https://scholar.sun.ac.za
1-6 
Pyrimidines 
Flucytosine is a fungistatic pyrimidine that is licensed for the treatment of invasive mycoses 
[34]. It is a synthetic fluorinated analogue of cytosine that is readily converted into 5-
fluororacil, a toxic antimetabolite which is a potent inhibitor of nucleic acid metabolism as well 
as protein synthesis in fungal pathogens [1,6]. Flucytosine is highly selective for fungi because 
the enzyme that catalyses its conversion into 5-fluorouracil is absent in humans [1]. The rapid 
onset of resistance, however, limits its clinical usage as primary therapy [1,6,34]. Its 
combination with amphotericin B is the gold standard for the treatment of cryptococcal 
meningitis [40] 
Azoles 
The azoles are the most widely used form of antifungal agents [4,6,41]. They are divided into 
two classes namely the imidazoles (e.g miconazole and ketoconazole) and triazoles (e.g 
fluconazole, itraconazole, voriconazole and posoconazole). The imidazoles were the first of 
the two classes to be deployed for clinical use against invasive infections but were later 
replaced by the newer triazoles due to the latter’s improved spectrum of activity, safety profile 
and pharmacokinetics [1,41]. Imidazoles are exclusively licensed for topical use [6]. 
The azoles exert their antifungal activity by interfering with the biosynthetic pathway of 
ergosterol; a lipid that is crucial to the maintenance of fungal membrane structure and function 
[42][6]. This interference leads to the accumulation of toxic sterol intermediates as well as 
depletion of ergosterol which induces severe membrane stress and ultimately, inhibition of 
fungal cell growth [43]. The mechanism of action of most azoles is fungistatic and is the reason 
for the evolution of resistance against them [44]. Voriconazole is the only drug in this family 
that is fungicidal. It is also the recommended therapeutic option for the treatment of invasive 
aspergillosis [6,34].  It is also worth noting that some Candida spp. such as C. krusei and C. 
glabrata are inherently resistant to azole therapy [6].
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Echinocandins 
This family of lipopeptide-based antifungal agents are the most recent addition to the antifungal 
arsenal even though they were first introduced into the clinical scene almost two decades ago 
[45]. They function by non-competitively inhibiting the synthesis of 1,3 β-D-glucans, an 
essential polysaccharide in the fungal cell wall. This inhibition of 1,3 β-D-glucan synthase 
compromises the structural integrity of the growing cell wall leading to osmotic instability and 
cell death [4,46,47]. The absence of 1,3 β-D-glucans in mammalian cells makes it a unique 
target in fungi which accounts for the little host toxicity that is associated with the clinical 
usage of echinocandins [1,6]. At present, three echinocandins are FDA approved and licensed 
for use in the clinical setting namely caspofungin, micafungin and anidulafungin [6,43,45]. 
Echinocandins are typically fungicidal towards Candida spp. hence are currently the prescribed 
first line treatment for invasive candidiasis and nosocomial candidemia. On the contrary, they 
exhibit a fungistatic mode of action towards filamentous fungi including Aspergillus spp. 
[48,49]. As such, they are only used as alternative or second line therapy for invasive 
aspergillosis [35]. Echinocandins are virtually ineffective against C. neoformans [35,46]. 
This brief review of the existing antifungal therapeutics has highlighted that all the drugs that 
are currently in clinical use have limitations, therefore novel classes of therapeutics with 
alternative modes of action are urgently required to alleviate the health burden imposed by 
fungal infections.  
1.4 Antimicrobial peptides 
Antimicrobial peptides (AMPs)  - Nature’s own broad-spectrum antibiotics, could potentially 
be the solution to the problematic invasive fungal infections. AMPs are natural defence 
molecules forming part the innate immune system of multicellular organisms and are widely 
produced by microorganisms as part of their competitive survival strategy [50–52]. They are 
very diverse in terms of amino acid sequence, secondary structure, origin and activity spectra. 
However, many of them share a few similarities. They are small, from seven residues up to at 
about 100 amino acid residues. Most are cationic peptides with at least one positively charged 
amino acid residue. Hydrophobic residues account for 40-60% of total amino acid composition 
thus making these compounds amphipathic. Many of them fall into one of the following 
secondary structural categories: alpha helices, beta sheet, extended helices or loops, as well 
mixtures of secondary structures [50,53–55].  
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To date, a multitude of AMPs have been identified with exceptional in vitro and in vivo 
activities against various bacterial, fungal, protozoan and viral pathogens. The most prominent 
AMPs have exhibited low MICs against pathogens (1-8µM), even against antibiotic resistant 
pathogens [53]. This potency, together with many other desirable properties, highlights the 
potential of AMPs as alternative therapeutics against microbial pathogens. AMPs kill 
pathogens much more rapidly than conventional antibiotics and in a fashion that involves 
fundamental structural components of pathogenic cells such as the cell membrane or multiple 
targets. This mechanism of action renders the development of resistance highly improbable 
[53,56]. It has been shown that AMPs are able to enhance the activities of classical antibiotics 
thus making them attractive candidates for combination therapy [53,57]. Because of their 
omnipresence and natural composition, AMPs could be an eco-friendly means to deal with the 
pathogenic challenge. Lastly, it is relatively easy to modify the structure of existing natural 
AMPs to produce synthetic analogues with improved desirable characteristics such as reduced 
toxicity and enhanced stability. 
1.5 Antifungal peptides 
Within the large family of AMPs is found a smaller group of peptides known as antifungal 
peptides (AFPs), targeting mainly fungal pathogens. These peptides are not as widely 
distributed as peptides with broad spectrum antimicrobial activity [58]. Out of the 1900 AMPs 
that are registered on the online database of AMPs, a mere 34% are antifungal peptides versus 
79% which were classified as antibacterial [59]. A summary on selected antifungal peptides is 
given in Table 1.1 
Like the rest of the AMP family, antifungal peptides have varied amino acid sequences and 
structures. However, they do seem to possess a relatively large proportion of polar and neutral 
amino acid residues [55]. In contrast to the well characterised bactericidal AMPs, little is 
known about the properties and mechanism of action of AFPs making their classification a 
daunting task [58]. For the purposes of this review, the AFPs have been classified according to 
their sources which include microorganisms, plants and animals (Table 1.1). It should be noted, 
however, that this review is not exhaustive and only a few examples of antifungal peptides are 
discussed in each category
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Mode of action Reference(s) 
Plant peptides  
DmAMP1 Dahlia merckii  S. cerevisiae Membrane permeabilisation by 
interaction with sphingolipids 
[60] 
RsAFP2 Raphanus sativus 51 amino acids C. albicans, 
P. pastoris 
Membrane permeabilisation by 
interaction with glucosylceramides, 
induction of ROS 
[61,62] 
PvD1 Phaseolus vulgaris 50 amino acids C. albicans, 
F. oxysporum 
Membrane permeabilisation by 
interaction with glucosylceramides, 
induction of ROS and NO 
[63] 
NaD1 Nicotiana alata α-helix and β-sheet F. oxysporum Interaction with cell wall, 
membrane permeabilisation and 
granulation of cytoplasm 
[64] 








Membrane permeabilisation by 
interaction with sphingolipids 
[65,66] 
Cecropin A and B Hyalopora cecropia Linear, 4 kDa, 
35-37 amino acids 
Fusarium spp. 
Aspergillus spp. 
Membrane lysis [67] 
Thanatin Posidus maculiventris β-sheet, cyclic, 





Amphimbian peptides  
Magainin 2 Xenopus laevis α-helical, 
Gly and Ser-rich, 




Membrane permeabilisation, DNA 
damage 
[68] 
Dermaseptins B and S Phyllomedusa 
sauvagii 
α-helical, Lys-rich, 




Membrane lysis by interaction with 
sterols 
[67,69] 
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Mammalian peptides  
HNP1-3 Human neutrophils β-sheet, 




Inhibition of protein and DNA 
synthesis 
[56,70] 
NP1 and NP2 Rabbit neutrophils β-sheet, 
33 amino acids 
C. albicans, 
A. fumigatus 
Interaction with chitin [71] 
      
Lactoferrin Mammalian 
secretions 
18 amino acids C. albicans, 
A. fumigatus 
Iron sequestration [72,73] 
Histatin1 and 3 Human saliva His-rich, 




Interaction with energised 
membrane 
[74] 
Bacterial peptides  
Iturin A Bacillus subtilis Cyclic lipopeptide A. flavus, 
F. moniliforme 
Membrane permeabilisation [75,76] 
Bacillomycin F Bacillus subtilis Cyclic lipopeptide A. niger, 
C. albicans, 
S. cerevisiae 
Membrane permeabilisation [77] 
Nikkomycin X and Z Streptomyces tendae Peptidyl nucleoside C. albicans Inhibition of chitin synthesis [78] 
Tyrocidines (A, B, C) Brevibacillus 
parabrevis 
Cyclodecapeptides, 







Fungal peptides  
Echinocandin B Aspergillus nidulans Cyclic lipopeptide C. albicans Inhibition of glucan synthesis 
[81] 
Aureobasidin A Aureobasidium 
pullulans 
Cyclic depsipeptide C. neoformans Interferes with actin assembly, 
delocalization of chitin, interferes 




Cys-rich A. fumigatus Membrane polarisation and 
activation of ion channels 
[84] 
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Antifungal peptides of plant origin  
Antifungal peptides sourced from plants form the majority in the antifungal peptide library. 
Nonetheless, their potential antimicrobial benefits in medical mycology have largely been 
unexplored [75,76]. This is because, until recently, fungi were considered as predominantly 
phytopathogens and as such most of the research regarding their antimicrobial activities had 
centred on phytopathogens. 
Plants produce diverse highly basic, cysteine rich peptides known as defensins whose 
antimicrobial activity is predominantly antifungal (Table 1.1) [59]. The mode of action of many 
of the plant defensins has been well characterised and is believed to involve interaction with 
specific lipid domains of the fungal plasma membrane [85]. Plant defensins are also categorised 
as either morphogenic or non-morphogenic depending on whether or not antifungal activity is 
accompanied by morphological changes such as hyphal hyper-branching [86].  
DmAMP1, a plant defensin from Dahlia merckii, was shown to interact with the sphingolipid 
mannosyldiinositolphosphorylceramide (M(IP)2C) [60] resulting in biphasic membrane 
permeabilisation in Saccharomyces cerevisiae [87]. The interaction of DmAMP1 with M(IP)2C 
was found to be enhanced in the presence of equimolar concentrations of ergosterol and 
M(IP)2C [60].  
RsAFP2 is a 50 amino acid defensin that is isolated from the seeds of the radish plant 
(Raphanus sativus) [61]. Like DmAMP1, it also induces biphasic membrane permeabilization 
but through interaction with glucosylceramides [62]. Furthermore, in C. albicans, RsAFP2 
causes morphological alterations [88] and induces the production of endogenous reactive 
oxygen species (ROS)[61].  
PvD1, a plant defensin that is found in Phaseolus vulgaris seeds [89], was shown to induce 
membrane permeabilisation in several Fusarium and Candida spp. by interacting with 
glucosylceramides as well as ergosterol [63]. Disorganisation in the cytoplasm content and 
plasma membrane of C. albicans were also observed after treatment with PvD1. In addition, 
PvD1 was able to induce the production of ROS and nitric oxide in C. albicans and F. 
oxysporum [63].  
NaD1 is a plant defensin that is isolated from the flower Nicotiana alata [90]. It has exhibited 
potent antifungal activity against numerous agronomically relevant filamentous fungi. The 
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antifungal activity was elicited by permeabilising the fungal membrane which resulted in 
granulation of the cytoplasm and cell death [64]. 
Insect-derived antifungal peptides 
Due to the absence of a specialised immune system in insects, innate immunity forms the basis of 
protection against pathogenic attack. This innate defence system heavily relies on the production 
of a cocktail of AMPs targeting various pathogens.  
Drosomycin is an inducible 5 kDa peptide consisting of eight cysteine residues and is produced 
by the fruit fly Drosophilia melanogaster [65]. It has displayed very potent fungicidal activity at 
low micromolar concentrations against filamentous fungi and yeasts [66,91,92]. Its 
membranolytic mode of action is  facilitated by the interaction with sphingolipids located in the 
fungal membrane [65,66]. Cohen et al. [93] observed that drosomycin interacts with the voltage 
gated sodium channels in D. melanogaster and hypothesised that this interaction contributes its 
antifungal activity. 
Cecropins are linear 4 kDa peptides that have been isolated from haemolymph of the giant silk 
moth, Hyalopora cecropia [94]. They have demonstrated lethal activity against Aspergillus and 
Fusarium spp., with the plasma membrane being their target [67,95]. It has also been shown that 
they are not toxic to mammalian cells at their fungicidal dosages [96,97]. 
Thanatin is a cyclic, non-haemolytic 21 residue peptide isolated from the insect Posidus 
maculiventris [98]. It is sequentially, structurally and functionally different from all the other 
insect AMPs but closely resembles the brevenins, which are frog secreted antimicrobial peptides. 
This peptide is fungicidal against B. cinerea, N. crassa and A. fumigatus but has no activity against 
yeasts such as S. cerevisiae [99]. 
Antifungal peptides of animal origin 
Amphibian-derived antifungal peptides 
Amphibians synthesise and secrete antimicrobial peptides to protect themselves against microbial 
invasion. Several families of antifungal peptides have been isolated from amphibians [67,76,100]. 
The first reported antifungal peptides from amphibians were the magainins which are produced 
by the African clawed tree frog, Xenopus laevis [75,76]. They are linear, amphipathic peptides 
enriched in glycine and serine amino acids. They have exhibited antifungal activity against C. 
neoformans, S. cerevisiae and C. albicans. [101]. They are selective for microbial membranes, but 
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their therapeutic index is too low for them to be used for the treatment of systemic infections in 
humans [58]. Magainins act by rupturing the membrane as well as interfering with DNA integrity 
[68]. 
Another frog species, Phyllomedusa sauvagii (the South American arboreal frog) secretes a group 
of antimicrobial peptides known as the dermaseptins. These peptides are linear and rich in lysine 
residues. Their fungicidal activity against filamentous fungi and yeasts has been reported. They 
employ a lytic mode of action whereby they destabilise fungal membrane architecture through 
interaction with membrane sterols [67,69]. 
Brevenins and bombinins are also amphibian produced peptides that have shown potent anti-
Candida activity. They are found in the skin secretion of the frogs belonging to the Rana and 
Bombina genera respectively. However, brevenins are highly haemolytic at low micromolar 
concentrations whereas bombinins are not [100,102]. 
Mammalian-derived antifungal peptides  
Even though mammals have a highly specialised acquired defence system, innate immunity is still 
very crucial in conferring protection against pathogenic microbes. It is through this innate immune 
system that a host of antimicrobial peptides are produced. A wide variety of antifungal peptides 
have been isolated from several mammalian species such as humans, cows, pigs, rabbits and 
chickens.  
The largest group of mammalian AMPs are the defensins which consist of six highly conserved 
cysteine residues that are stabilised by three disulphide bridges. The defensins are divided into 
three subfamilies: α, β, and θ defensins [103]. Human neutrophils constitutively express the α 
defensins HNP1-4 while HD5 and HD6 are constitutively expressed by the Paneth’s cells. HNP1 
and HNP2 have exhibited strong anti-Candida activity while HNP3 potently inhibited C. 
neoformans [104,105]. Membrane pore formation as well as inhibition of protein and nucleic acid 
synthesis have been identified to be the mechanisms employed by these peptides for antimicrobial 
activity [56,70]. In addition, rabbit produced α defensins, NP1-3 effectively killed C. albicans and 
A. fumigatus [71,106]. It was shown that NP1 and 2 interact with chitin which suggests the possible 
involvement of the fungal cell wall in their mode of action [71]. 
The β-defensin peptide family found in humans comprises six peptides namely HBD1-6. HBD1-
3 have been shown to possess excellent antifungal activity against C. albicans, C.krusei and C. 
parapsilosis [107,108]. The activity in C. albicans was shown to involve membrane 
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permeabilisation linked to inhibition of fungal cell metabolism [109]. Protegrins  and gallinacins, 
which are β-defensins produced by pigs and chickens, respectively, have inhibitory activity against 
C. albicans [110–112].  
Another class of mammalian produced antifungal peptides are the cathelicidins. LL-37, the only 
cathelicidin expressed in humans, is produced by proteolytic cleavage of the protein hCAP18 
[113]. It is a broad-spectrum antimicrobial peptide that has shown membrane mediated activity 
against C. albicans [114–116]. Cattle and pigs, on the other hand, produce several kinds of 
cathelicidins with diverse structures and antimicrobial activities. BMAP-27, BMAP-28 and 
SMAP-29 are bovine α-helical peptides that have demonstrated considerable membrane 
permeabilising activity towards C. albicans and C. neoformans, but not against  filamentous fungi 
[117]. Indolicidin, another bovine derived tryptophan rich peptide belonging to cathelicidin family 
of peptides is highly lethal against C. neoformans but moderately lethal towards Candida spp. 
[117]. It forms an extended wedge-type conformation in the presence of plasma membranes [118].  
Tritrypticin, the porcine analogue of indolicidin, was reported to have weak activity against both 
A. fumigatus and C. albicans [119].  
Humans also produce a group of cationic peptides known as histatins which possess a high content 
of histidine residues. Histatins exhibit strong candidacidal activity [120,121]. They have also 
shown great antifungal activity against C. neoformans [122] and A. fumigatus [123]. The 
mechanism by which histatins exert their antifungal activity has been postulated to involve 
interaction with an energised fungal membrane and internalisation into the cytoplasm [74].  
Antifungal peptides of microbial origin 
Bacterial-derived antifungal peptides 
Several bacterial species are sources of a variety of AFPs with excellent activities against 
pathogenic fungi. The iturins and bacillomycin peptides, which were among the first isolated 
AFPs, are products of the soil bacterium Bacillus subtilis [124]. The iturin family, which 
comprises iturin A, C, D, E, bacillomycin D, F, L, mycosubtilin and bacillopeptin, is a group of 
cyclic lipopeptides whose antimicrobial activity is primarily antifungal with little effect on 
bacteria. Iturins act by introducing ion conducting pores in the cytoplasmic membrane thereby 
increasing the leakage of K⁺ [33,58,75,76]. Iturin A was found to have potent antifungal activity 
against A. flavus and F. moniliforme [125]. Bacillomycin F effectively inhibits A. niger, C. 
albicans and S. cerevisiae [77]. Unfortunately, the downside of these peptides is that they are very 
haemolytic [126].  
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Pseudomonas syringae produces a class of cyclic lipodepsinonapeptides known as syringomycins, 
which are amongst the most potent bacterial AFPs [126]. Members of the syringomycin family 
(syringomycin E, syringotoxin B and syringstatin A) have displayed excellent in vitro activity 
against clinically relevant isolates of Candida, Aspergillus and C. neoformans species [127]. The 
mode of action of syringomycins involves the alteration of membrane potential and subsequent 
disruption of membrane function through formation of ion conducting pores in the membrane 
[128,129] 
Nikkomycins are peptidyl nucleoside inhibitors of the enzyme involved in the biosynthesis of 
chitin, which is an essential fungal cell wall component. They are produced by Streptomyces 
tendae [78,130]. Nikkomycins have shown significant growth inhibitory activity against C. 
albicans both in vitro and in vivo and are not cytotoxic to human cells [131]. Closely related to 
the nikkomycins are the polyoxins which are produced by Streptomyces cacaoi. Their mechanism 
of action is very similar to that of the nikkomycins [132].  
Brevibacillus parabrevis produces a group of small, cyclic β-sheet peptides known as tyrocidines 
[133]. These peptides have demonstrated potent growth inhibitory activity against filamentous 
phytopathogenic fungi such as F. solani and B. cinerea [79,80]. They were also shown to be active 
against the human pathogens, C. albicans and A. fumigatus [57,79]. Their antifungal activity is 
elicited via rapid membrane permeabilisation.  
Fungal-derived antifungal peptides 
By far, the most potent AFPs are those produced by fungi themselves. Examples include peptides 
such as the echinocandins produced by Aspergillus nidulans, aureobasidins, AcAFP, AFP, 
ANAFP and PAF [81,134–137].  
The echinocandins are diverse group of cyclic lipopeptides that interfere with the biosynthesis of 
the fungal cell wall by inhibiting the enzyme 1,3 β-glucan synthase [81]. Peptides that make up 
this family include the native echinochandins (A, B and C) and other closely related peptides that 
possess a modified echinocandin B core such as pneumocandins, mulundocandins, aculeacins and 
WF11899 [76]. Amongst the native echinocandins, analogues of echinocandin B have the greatest 
potency and have been used as a template for developing new drugs. Caspofungin (second 
generation pneumocandin), micafungin and anidulafungin (both echinocandins) are currently the 
only peptide-based antifungal agents approved for the treatment of invasive mycoses [58]. 
Echinochandins are currently the drugs of choice for the treatment of invasive candidiasis due to 
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their potent fungicidal activity against most of the Candida spp. including those that are resistant 
to fluconazole or amphotericin B [49,58]. However, they are fungistatic towards Aspergillus spp. 
and are only prescribed as alternative therapy for invasive aspergillosis [35,58]. Cryptococcus spp. 
are intrinsically insensitive to echinocandins [42]. 
The other Aspergillus spp. from which antifungal peptides have been isolated are A. clavatus, A. 
giganteus and A. niger which produce AcAFP, AFP and ANAFP, respectively [134–136]. These 
peptides have displayed excellent inhibitory activities against a multitude of filamentous fungi 
including A. fumigatus [138,139]. 
Aureobasidins are cyclic lipodepsipeptides that are synthesised by Aureobasidium pullulans and 
effectively inhibit Candida spp. and C. neoformans [137]. It is believed that they act by interfering 
with the synthesis of sphingolipids, altering the assembly of actin and delocalisation chitin in cell 
walls [82,83].  
Penicillium chrysogenum produces a low molecular weight cysteine-rich antifungal protein known 
as PAF [140]. PAF has been shown to inhibit A. fumigatus, amongst other opportunistic pathogens. 
Its proposed mechanism of action involves membrane polarization and activation of ion channels 
[84]. 
Based on the highlighted potencies of various antifungal peptides towards a great many fungal 
pathogens, it is safe to conclude that antifungal peptides bear the potential to become the urgently 
needed antifungal therapeutic agents. Further characterisation of their properties and mode of 
action is essential for their development into antifungal agents.  As such, the research reported in 
this thesis was conducted with the aim of enhancing the understanding of the properties of small 
aromatic peptides and elucidating their potential use as antifungal therapy.  
1.6 Antifungal potential of small aromatic peptides 
Natural cyclodecapeptides: Tyrocidines and analogues 
The tyrocidines and analogues are a group of cyclic decapeptides with broad and potent 
antimicrobial activity. They were first isolated in 1939 by Dubos [141] as constituents of 
tyrothricin, a peptide complex produced by the soil bacterium Brevibacillus parabrevis [141,142]. 
Tyrothricin is composed of approximately 40-60% tyrocidines and 10-20% linear gramicidins 
[142].Tyrothricin successfully became the first antibiotic to be approved for clinical use despite it 
Stellenbosch University  https://scholar.sun.ac.za
1-18 
being discovered a decade after penicillin [141,143]. However due to its haemolytic activity [144], 
clinical application of tyrothricin was restricted to topical and oral use [145–147].  
Structural properties 
Tyrocidines and their analogues are β-sheet cyclic peptides composed of ten amino acid residues 
[142,143]. The structural characterisation done by Tang et al.[143], indicated the existence of 
different analogues with  a conserved amino acid sequence (cyclo-[f1P2X3x4N5Q6X7V8O9L10]) 
(Table 1.2. Figure 1.2),varying only  in positions three, four, seven and nine. The variability in the 
aromatic residue in the seventh position is the basis upon which the decapeptides are named, with 
the Y-containing peptides named tyrocidines, the W-containing peptides named tryptocidines and 
the F-containing peptides named phenycidines. Variation in the aromatic dipeptide moiety in 
positions three and four  determines the letter assigned to the different analogues. The analogues 
containing the (Ff) moiety are denoted A analogues, while those containing (Wf) and (Ww) 
moieties are denoted as B and C analogues, respectively. Lastly, the amino acid residue in the 
ninth position determines whether a subscript follows the letter designated to the analogues. For 
instance, tyrocidine A (Figure 1.2) has an Orn residue while tyrocidine A1 has a Lys residue in the 
same position [143,148,149].  The tyrocidines (tyrocidine A, A1, B, B1, C and C1) are naturally 
abundant within the tyrocidine mixture whereas the phenycidines and tryptocidines are found in 
lesser quantities [143,148]. The amino acid sequence of tyrocidines and their analogues is 50% 
homologous to that of gramicidin S, an antimicrobial peptide synthesised by Bacillus brevis whose 
sequence is cyclo-(VOLfPVOLfP) [150]. It has been observed that under physiological 
conditions, tyrocidine A assumes a β-sheet conformation with two β-turns [151,152]. This 
secondary structure is also conserved in the other analogues [153]. 
Biological activity  
The natural cyclodecapeptides have displayed activity towards a broad spectrum of pathogens 
which incorporates bacteria, fungi and parasites. Following their discovery, Dubos [141] reported 
on the potent antibacterial activity of tyrocidines against the Gram-positive bacteria  Diplococcus 
pneumoniae, Streptococcus haemolyticus and Staphylococcus aureus. This activity against Gram-
positive species has been corroborated by other studies as activity against Listeria monocytogenes, 
Micrococcus luteus, S. aureus and Streptococcus pyogenes has also been reported [154,155]. 
However, it has been shown that the tyrocidines are not as effective against Gram-negative 
bacteria such as Escherichia coli, Klebsiella pneumoniae and Haemophilus influenza [141,155].   
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Figure 1.2: Cyclodecapeptide structure showing the variable positions with the possible amino 
acid substitutions for the major tyrocidines and analogues 
In addition to antibacterial activity, the cyclodecapeptides have also exhibited antifungal activity. 
Tyrocidines inhibited the germination and growth of Neurospora crassa [156]. Tyrocidine mixture 
(Trc mix) and individual tyrocidine analogues were inhibitory to the growth of a range of 
filamentous fungi and their activities were significantly greater than that of bifonazole, a 
commercial antifungal agent from the azole group [79,80]. Tyrocidines have also demonstrated 
synergism with clinical antifungal drugs, amphotericin B and caspofungin [57]. It was shown that 
combinations of these drugs with tyrocidines were highly effective at inhibiting the growth of 
planktonic C. albicans cells and formation of biofilm as well as eradicating already formed 
biofilms in vitro. Furthermore, the combination of  tyrocidine A with caspofungin displayed in 
vivo activity against C. albicans [57].  
Interestingly, the cyclodecapeptides have also exhibited noteworthy activity, with IC50 values in 
the nanomolar concentration range, against Plasmodium falciparum, one of the parasitic protozoan 
species responsible for the pathogenesis of malaria in humans [157]. Unfortunately, because of 
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systemically. Nevertheless, there is ongoing research within our group which aims to eliminate 
this unwanted toxicity via modification and formulation. 
Table 1.2: Summary of peptides identified in the tyrothricin complex 





Major Tyrocidines  
Tyrocidine C1 YC1 Cyclo-(fPWwNQYVKL) 1361.692 30 
Tyrocidine C YC Cyclo-(fPWwNQYVOL) 1347.676 100 
Tyrocidine B1 YB1 Cyclo-(fPWfNQYVKL) 1322.681 44 
Tyrocidine B1’ YB1’ Cyclo-(fPFwNQYVKL) 1322.681 5.8 
Tyrocidine B YB Cyclo-(fPWfNQYVOL) 1308.655 109 
Tyrocidine B’ YB’ Cyclo-(fPFwNQYVOL) 1308.655 14 
Tyrocidine A1 YA1 Cyclo-(fPFfNQYVKL) 1283.670 39 
Tyrocidine A YA Cyclo-(fPFfNQYVOL) 1269.653 88 
Tyrocidine Analogues  
Tryptocidine C WC Cyclo-(fPWwNQWVOL) 1370.692 23 
Tryptocidine C1 WC1 Cyclo-(fPWwNQWVKL) 1384.708 2.3 
Tryptocidine B WB Cyclo-(fPWfNQWVOL) 1331.681 26 
Tryptocidine B1 WB1 Cyclo-(fPWfNQWVKL) 1345.697 13 
Tryptocidine A WA Cyclo-(fPFfNQWVOL) 1292.647 15 
Tryptocidine A1 WA1 Cyclo-(fPFfNQWVKL) 1306.686 <1 
Phenycidine A WA Cyclo-(fPFfNQFVOL) 1253.660 3.1 
Phenycidine A1 WA1 Cyclo-(fPFfNQFVKL) 1267.675 <1 
Linear Gramicidins  
Val – Gramicidin A VGA VGALAvVvWLWLWLW 1881.078 44 
Val – Gramicidin B VGB VGALAvVvWLFLWLW 1842.067 4.1 
Val – Gramicidin C VGC VGALAvVvWLYLWLW 1858.062 24 
Gramicidin S GS Cyclo-(fPVOLfPVOL) 1140.704 - 
a The peptide sequences are as given by Tang et al. [143]. Amino acids are denoted using the standard one letter 
abbreviations with lowercase letters representing D-amino acids and uppercase letters representing L-amino acids. 
b Theoretical monoisotopic mass (Mr) was calculated as the sum of the molecular weights of the constituent amino 
acids. 
c Peptide abundance is expressed relative to the abundance of tyrocidine C [143]. 
Mode of action  
For many cationic AMPs, membrane action leading to cell lysis is regarded as the principal mode 
of action. Data from numerous studies indicates that the killing and/or inhibitory mechanisms of 
the natural cyclodecapeptides involve membranolysis [57,79,80,155,156,160]. Wenzel et al. [161] 
recently showed that tyrocidine A and tyrocidine C formed defined ion-conducting pores which 
have a major influence on phospholipid head-group orientation, yet the exact nature by which 
microbial inhibition occurs is not fully understood.  
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Interestingly, it has been argued that there is no correlation between tyrocidine activity and lysis 
and that lysis is only a secondary process that results from the activity of the target cells’ own 
autolytic enzymes [141]. Dubos et al. [154] showed that tyrocidines inhibit the metabolic reactions 
of S. aureus and S. pyogenes, substantiating the proposition that tyrocidines may employ alternate 
mechanisms of action in addition to lytic action. These mechanisms may depend upon an initial 
interaction with membrane followed by translocation into the intracellular space. Alternatively, 
the tyrocidines may remain bound to cell membrane components and interfere with their function 
without necessarily rupturing the membrane. Wenzel et al. [161] showed that the tyrocidines cause 
a loss of membrane proteins from bacterial membranes, as well as influence certain intracellular 
protein and the chromatin packing.  
It has been shown that in addition to membrane lysis, interaction with the β-glucans may play role 
in the antifungal activity of tyrocidines against F. solani.  β-glucans are essential components of 
the fungal cell wall. Treatment of hyphae with β-glucanase inhibited the activity of the tyrocidines 
against F. solani [80]. In the same study, tyrocidines induced alterations in the morphology of 
fungal hyphae which could be attributed to the interference with Ca2+ gradients, actin 
polymerisation, cell cycle or sterol rich plasma membrane domains. It was also observed that the 
presence of Ca2+ diminished antifungal activity suggesting a possible interference with the 
processes that generate and maintain Ca2+ gradients [80].  
Tyrocidines were also reported to have induced the production of ROS in C. albicans biofilms. 
However, it was observed ROS was not essential for biofilm eradication as the tyrocidines 
maintained their activity in the presence of an antioxidant [57].  
It has also been hypothesised that tyrocidines could possibly interfere with nucleic acid and protein 
metabolism. Tyrocidines are known to interact with DNA in the organism that produces them, and 
this interaction leads to the repression of RNA transcription[162,163]. Moreover, the inhibition of 
DNA, RNA and protein synthesis in N. crassa by tyrocidine substantiated this hypothesis[156].  
The antiplasmodial activity of tyrocidines was attributed to the inhibition of P. falciparum 
development and arrest of the intraerythrocytic parasite lifecycle rather than haemolysis [157]. In 
a different study, tryptocidine C distorted the lipid structures found within the food vacuole of 
malaria parasites [158]. This finding implied the possibility of a molecular target existing within 
the food vacuole.  
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There is clearly increasing evidence that suggests the utilisation of more than one mode of action 
against pathogens by the cyclodecapeptides. If this is the case,  then the likelihood of pathogens 
developing  resistance against them is greatly reduced making them attractive candidates for 
therapeutic drug development. 
Synthetic Arginine and Tryptophan rich peptides: RW-hexapeptides 
Although a vast number of natural antimicrobial peptides with excellent activities against 
pathogenic microbes have been identified, very few have successfully made it through the drug 
discovery pipeline and have been granted approval for clinical use [58]. This is mainly due to 
inherent toxicity towards eukaryotic cells and unfavourable pharmacokinetic properties. 
Moreover, many naturally occurring peptides are relatively large hence their production on a large 
scale is often difficult and costly [51,164,165]. But these limitations could be overcome by 
developing smaller AMPs with favourable toxicity and pharmacokinetic profiles. Synthetic 
combinatorial chemistry technology has enabled the identification and development of many such 
small AMPs.  
Of interest are small peptides that possess a high content of arginine and tryptophan residues in 
their primary structures as similar motifs have been identified within naturally occurring AMPs 
such as lactoferricin, indolicidin and tritrypticin and are believed to be the core of antimicrobial 
activity [166]. Through screening of different synthetic combinatorial libraries, several 
hexapeptides sequences rich in Arg and Trp residues were identified as having the highest 
antimicrobial activity [167–170]. One such hexapeptide is N-acetylated Arg-Arg-Trp-Trp-Arg-
Phe-amide (Ac-RRWWRF-NH2) whose antimicrobial activity has been illustrated [169]. Using 
this hexapeptide as a template, various sequence and structural analogues have been designed and 
investigated for antibacterial activity by our research collaborators. However, their antifungal 
activity has not been elucidated. As such, it is the goal of this study is to elucidate the antifungal 
activity as well as the mechanism of action of these analogues. These peptides will be referred to 
as RW-hexapeptides. 
Structural properties of RW-hexapeptides 
RW-hexapeptides that are the focus of the research reported in Chapter 2-4 are either linear or 
cyclic (Figure 1.3). Linear RW peptides are analogues of the Ac-RRWWRF-NH2 peptide whose 
amino acid sequences vary slightly from that of the original peptide. They are amidated at the 
carboxyl end and acetylated at the amino end. Amidation at the carboxyl end has previously been 
illustrated to be essential for high antimicrobial activity [171]. Cyclic RW-hexapeptides, on the 
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other hand, are both structural and sequential analogues of Ac-RRWWRF-NH2. The parent cyclic 
RW-hexapeptide, cyclo-RRWWRF was derived from its linear analogue through head-to-tail 
cyclisation [164].  
 
 
Figure 1.3 Structures of A) Ac-RRRWFW B) cyclo-RRRWFW. Amino acids are indicated by 
standard one letter amino acid abbreviations. Structures were drawn using ChemBioDraw Ultra 
13.0 (Cambridge Soft®, UK).  
RW-hexapeptides have a relatively simple and conserved primary structure comprising six amino 
acid residues, with Arg and Trp being the predominant residues. These residues give the 
hexapeptides their amphipathic nature and therefore, modulate antimicrobial activity. It is believed 
that the positively charged side chain of Arg attracts the peptide to negatively charged membrane 
components such as lipopolysaccharide and phospholipid head groups facilitating an initial 
interaction with target membranes. The interaction is then maintained by Trp whose bulky 
hydrophobic side chain prefers to associate with the interfacial regions of the lipid bilayers 
[164,171]. In some analogues, one or more Arg residues are replaced with Lys while Phe or Tyr 
replace Trp as the aromatic residues. Substitutions of this nature have resulted in altered 
antimicrobial and haemolytic activities, illustrating that amphipathicity alone is not enough for 
activity [164]. Rather, a fine balance between the cationic and lipophilic properties is necessary to 
achieve maximum antimicrobial activity and minimal host toxicity.  
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Linear and cyclic RW-hexapeptides have different secondary structures. The secondary structure 
of Ac-RRWWRF-NH2 has been shown to be undefined (disordered) in aqueous solution but 
becomes more ordered in a membrane-mimicking environment [172]. Conversely, cyclo-
RRWWRF has been reported to have an ordered secondary structure in either environment. In 
fact, the cyclic peptide has been proposed to have a β-sheet backbone that is stabilised by two β-
turns [173]. 
Biological activity  
The activity of synthetic RW-hexapeptides against microbes has been the subject of numerous 
investigations. Like natural AMPs, some of the RW-hexapeptides have broad spectrum 
antimicrobial activity while others are highly selective for certain target organisms.  
Blondelle et al. [169] identified a series of peptides with the sequence Ac-RRWWCX-NH2 where 
X denotes any of the 20 natural amino acids. These peptides were tested for antimicrobial activity 
against two Gram-positive species (S. aureus and Streptococcus sanguis), two Gram-negative 
species (Pseudomonas aeruginosa and E. coli) and the yeast, C. albicans. In general, they were 
inhibitory towards all microorganisms tested and did not show specificity towards any organism. 
In a different study, higher antimicrobial activity was observed against S. aureus than against P. 
aeruginosa and E. coli [171]. 
PAF26, an all D-amino acid peptide that was identified by a combinatorial approach exhibited 
strong antifungal activity against filamentous fungal phytopathogens B. cinerea, Penicillium 
italicum and Penicillium digitatum. It also inhibited E.coli and S. cerevisiae but with much lower 
efficacy highlighting its selectivity towards certain filamentous fungi [174]. It should be noted that 
PAF26 is D-amino acid analogue of Ac-RKKWFW-NH2 which is one of the peptides that will be 
investigated in this study. 
For the cyclic RW-hexapeptides, antibacterial activity has largely been the centre of focus. Their 
inhibitory activity against Bacillus subtilis, E. coli and L. monocytogenes has been reported 
[158,164,175,176]. In fact, they have demonstrated better activity than their linear counterparts. 
In  studies conducted by Dathe et al. [164,175], linear peptides were moderately active towards B. 
subtilis and inactive against E. coli. Upon cyclisation, improved antibacterial activity and 
selectivity were noted. 
Apart from their high antimicrobial activity, the absence of toxicity towards mammalian cells 
makes RW-hexapeptides very attractive leads compounds for drug development. Multiple 
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investigators have tested different RW-hexapeptides for haemolytic activity and all their results 
indicated little to no haemolysis activity [164,169,171,175].  
Mode of action 
The high content of cationic and hydrophobic residues renders the RW-hexapeptides structurally 
suited for membrane activity [177]; yet it has been illustrated several times that they do not exert 
their antimicrobial activity through membrane permeabilisation. PAF26 was shown to be 
inefficient at facilitating the uptake of SYTOX Green at sub-MIC concentrations that inhibited the 
growth and induced morphological alterations in P. digitatum hyphae. This indicated that 
membrane permeabilisation is low at concentrations that inhibit fungal growth [178]. Ac-
RRWWFR-NH2 was also quite inefficient at inducing leakage of calcein from large unilamellar 
vesicles composed of POPG/POPC (1:1); an indication of membrane disruption not being the main 
mode of action [179]. The low membrane permeabilising ability of RW-hexapeptides was further 
demonstrated when low levels of propidium iodide were detected inside E. coli after treatment 
with cyclo-RRRWFW (cWFW) at its minimum inhibitory concentration (MIC) [180]. 
While membrane lysis is not the primary mode of action of RW-hexapeptides, the exact manner 
in which they elicit antimicrobial activity has not been fully elucidated. Efforts to improve the 
understanding of how these peptides kill their targets have yielded evidence of novel mechanisms 
which appear to be target and peptide specific [176,177,181,182]. 
Peptide translocation across the bacterial membrane was ruled out as a possible mechanism of as 
cWFW against B. subtilis after fluorescence could not be detected within the cytoplasm following 
treatment of bacteria with cWFW labelled with nitrobenzoxadiazole (NBD-cWFW). This 
indicated that the fluorescent labelled cWFW had not traversed the B. subtilis membrane [177]. 
However, the peptide was observed to accumulate within the lipid bilayer; specifically, in 
cardiolipin rich domains. Based on this observation, the cytoplasmic membrane was postulated to 
be the target of the cyclic peptide [177]. Confirmation of the membrane as the target was later 
provided by Scheinpflug et al. [176] who reported that the action of cWFW against B. subtilis 
involved a rapid reduction of membrane fluidity. Changes in fluidity resulted in the formation of 
distinct membrane domains which differ in local membrane fluidity, disorganisation of membrane 
proteins and ultimately, cell autolysis.  
On the other hand, it appears that RW-hexapeptides exert their antifungal activity in a completely 
different manner. A multistep mechanism involving interaction of peptide with the fungal cell 
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envelope, internalisation of the peptide and disruption of intracellular processes has been 
suggested for PAF26 and derivatives [181]. Munoz et al. [178] was able to show the translocation 
of a FITC-labelled PAF26 into the cytoplasm of P. digitatum. They also observed that PAF26 
altered the morphology of P. digitatum hyphae as was indicated by dichotomous tip branching and 
swelling of hyphae with abnormal chitin deposition. These observations were indicative of 
changes in the structure of the cell wall and showed the that the fungal cell wall is not only the 
first line of interaction with the peptide but a target as well. Results from other investigations 
reveal that PAF26 interferes with various intracellular processes. There is evidence of interference 
with responses to DNA damage, Arg homeostasis, ribosome biogenesis and unfolded protein 
stress responses in S. cerevisiae [183]. Additionally, the effects of treating N. crassa with PAF26 
included increased production of endogenous ROS and nitric oxide as well as a dose dependent 
disruption of calcium homeostasis [184,185].  
From the above, it is possible to deduce that the antifungal and antibacterial activities of RW 
hexapeptides are elicited differently. The mechanism of action could also be dependent on the 
nature of the peptide (cyclic versus linear). This underscores the importance of both target cell and 
peptide properties on antimicrobial activity. 
1.7 Concluding remarks 
Fungal pathogens and the systemic infections they cause are a global health burden that needs to 
be addressed with urgency. To do this, new antifungal therapeutics agents with novel mechanism 
of action need to be developed. Natural cyclodecapeptides (tyrocidines and analogues) and RW-
hexapeptides are potential candidates for development as antifungal agents based on their potent 
antimicrobial activities. For this reason, it is highly essential that their antifungal activity as well 
as mode of action be characterised, as this information is pertinent to the future development of 
any drug.  
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Chapter 2 
Production, purification and chemical characterisation of natural 
and synthetic peptides 
2.1 Introduction 
Over the last couple of decades, the incidence of systemic mycoses amongst the human population 
has increased, concomitantly with an increase in the mortalities due to these mycoses. It is 
estimated that approximately one and a half million individuals succumb to systemic mycoses 
annually [1]. This is attributed to the growing population of immunocompromised individuals who 
are susceptible to infections caused by fungi and the increasing frequency of antimycotic resistant 
pathogens [2]. A major concern is that new antimycotic agents which can combat resistant 
pathogens are lacking and no new antimycotic drug has entered the market in over a decade. As 
such, the dire need for novel antimycotic agents has motivated this research study in which the 
potential of selected peptides to act as antifungal agents was determined by investigating their 
antifungal activity against A. fumigatus, a human fungal pathogen.  
The peptides that were selected for this study belong to two distinct groups, namely the 
cyclodecapeptides (tyrocidines and analogues) and the RW-hexapeptides.  Cyclodecapeptides are 
a family of structurally related cyclic peptides that are produced naturally by the soil bacterium 
Br. parabrevis [3]. They are produced in conjunction with linear gramicidins and together they 
form the tyrothricin complex which was the first clinically used antibiotic [3–5]. On the other 
hand, the linear and cyclic RW-hexapeptides are synthetic peptides that are derivatives of a 
hexapeptide that was identified through screening of a synthetic combinatorial library [6].  
Both groups of peptides have previously been shown to exhibit excellent antimicrobial activity. 
Their activities against bacterial pathogens, as well as selected fungal phytopathogens are well 
documented in literature [5,7–15]. On the contrary, research regarding antifungal activity against 
human fungal pathogens has been limited to a few studies. To date, the antifungal activity of 
tyrocidines against a human fungal pathogen has only been investigated by our group [16,17]. As 
for the RW-hexapeptides in our library, data pertaining to their activity towards human fungal 
pathogens are lacking. 
Before the biological activity of any peptide can be ascertained, it is of utmost importance that the 
peptide be in a high state of purity. This is because a peptide’s biological effect can only be deemed 
accurate if the peptide is of acceptable purity. The standard practice in our research group is that 
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a peptide needs to be at least 90% pure by peptide composition, as determined by a stringent 
quality control (QC) regime. Two techniques that are indispensable to the purification and 
characterisation of peptides are high performance liquid chromatography (HPLC) and mass 
spectrometry, specifically electrospray ionisation mass spectrometry (ESMS). In this study, an 
optimised semi-preparative reversed phase HPLC methodology was employed to purify individual 
tyrocidines and analogues from crude peptide mixtures that were extracted from cultures of Br. 
parabrevis.  Our stringent QC entailed ultra-performance liquid chromatography (UPLC) linked 
to high resolution electrospray mass spectrometry (ESMS) (denoted as UPLC-MS) and was used 
to determine the success of the purification protocol and confirm identity and purity of all the 
peptides in this study.  
Table 2.1: Summary of the small antimicrobial peptides rich in aromatic residues selected for this 
study. 
Peptide Sequence Structure Monoisotopic Mr 
Tyrocidines and analogues   
Tyrocidine A (YA) fPFfNQYVOL Cyclic 1269.6546 
Tyrocidine B (YB) fPWfNQYVOL Cyclic 1308.6655 
Tyrocidine C (YC) fPWwNQYVOL Cyclic 1347.6764 
Tryptocidine C (WC) fPWwNQWVOL Cyclic 1370.6924 
Synthetic RW-hexapeptides   
cKRK KRKWFW Cyclic 931.5181 
cRKK RKKWFW Cyclic 931.5181 
cWFW RRRWFW Cyclic 987.5304 
cWRW RWRWRW Cyclic 1026.5413 
cWWW RRRWWW Cyclic 1026.5413 
cWYW RRRWYW Cyclic 1003.5253 
Ac-KRK Ac-KRKWFW-NH2 Linear 990.5552 
Ac-RKK Ac-RKKWFW-NH2 Linear 990.5552 
Ac-WFW Ac-RRRWFW-NH2 Linear 1046.5675 
Ac-WRW Ac-RWRWRW-NH2 Linear 1085.5775 
Ac-WWW Ac-RRRWWW-NH2 Linear 1085.5775 
Ac-WYW Ac-RRRWYW-NH2 Linear 1062.5624 
Amino acids in the peptide sequences are denoted by their conventional one letter abbreviations except for 
Ornithine which is denoted as O. Lower case letters are indicative of D-amino acids while uppercase letters 
indicate L-amino acids, Ac denotes N-acetyl or acetylated N-terminal and NH2 denotes amidated or acid amide 
C-terminal 
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2.2 Materials 
Peptide production  
Br. parabrevis 5618-DSM strain was obtained from Leibniz Institute DSMZ – German Collection 
of Microorganisms and Cell Cultures. Merck (Darmstadt, Germany) supplied tryptone soy broth 
(TSB), agar and the following components of the TGS (tryptone glucose salt) medium: tryptone, 
glucose, potassium dihydrogen orthophosphate (KH2PO4), magnesium sulphate heptahydrate 
(MgSO4.7H2O), ferrous (II) sulphate (FeSO4), manganese sulphate (MnSO4) and calcium chloride 
(CaCl2). Potassium chloride for the TGS medium as well as L-tryptophan and L- phenylalanine 
were supplied by Sigma (St. Louis, USA). Petri dishes were purchased from Greiner Bio-one 
(Frickenhausen, Germany) whilst Falcon® tubes were provided by Becton Dickson Labware 
(Lincoln Park, USA). Lasec (Cape Town, South Africa) provided 0.22 µm cellulose acetate 
syringe filters. 
Extraction, purification and analysis of peptides  
All solvent preparation was done using analytical grade water that had undergone reverse osmosis 
followed by filtration through a Millipore Milli-Q water purification system (Milford, USA). 
Acetonitrile (HPLC-grade, far UV cut-off of 190 nm) was supplied by Romil Limited (Cambridge, 
UK). Merck (Darmstadt, Germany) supplied ethanol (EtOH), hydrochloric acid and sodium 
chloride (NaCl). Activated carbon was supplied by Lurgi (Frankfurt, Germany). Trifluoroacetic 
acid (TFA >98%), diethyl ether, acetone, methanol (>99.9%) and commercial tyrothricin were 
obtained from Sigma (St. Louis, USA). Waters-Millipore (Milford, USA) supplied the following 
chromatography columns: Nova-Pak C18 semi-preparative reversed phase HPLC column ((6 µm 
particle size, 60 Å pore size, 7.8 mm x 300 mm and an ACQUITY UPLC® bridged ethyl hybrid 
(BEH) C18 column (1.7 µm particle size, 2.1 mm × 100 mm). HVLP membrane filters (0.45µm) 
were also obtained from Waters-Millipore (Milford, USA). Electrospray mass spectrometry was 
performed using a Waters Synapt G2 mass spectrometer. The synthetic cyclic peptides, except 
cWWW2, cWRW2 and cWYW were sourced from Leibniz, Germany. GL Biochem Limited 
(Shanghai, China) supplied the synthetic linear hexapeptides and the cyclic peptides, cWWW2, 
cWRW2 and cWYW. 
2.3 Methods 
Pre-culturing of the producer organism 
Br. parabrevis 5618-DSM from freezer stocks was streaked onto TSB agar plates (3% w/v TSB, 
1.5% w/v agar) using sterile culturing techniques. The plates were incubated at 37 °C for 48 hours. 
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Single colonies were selected and used to inoculate 20 mL of TSB broth. The inoculated broth 
was incubated at 37 °C with shaking at 150 rpm until an optical density (OD) reading between 0.6 
and 0.9 at 595 nm was reached (approximately 16 hours). Fresh TSB was used to dilute the 
inoculated broth until the OD reading was at 0.20. This dilution was then used as the starter culture 
for tyrocidine production. 
Production and extraction of peptides from cultures of Br. parabrevis 
Three TGS media solutions were prepared and sterilised by autoclaving. Two of the autoclaved 
media solutions were then supplemented with either 16.5 mM Trp or 22 mM Phe. The amino acids 
were filter sterilised. The third TGS medium solution was not supplemented with any amino acid. 
Peptide production cultures were started by inoculating all TGS media solutions with a 1% (v/v; 
relative to final volume of production culture) starter culture of Br. parabrevis. After inoculation, 
the cultures were incubated at 37 °C for ten days.  
An optimised extraction method [3,18] was used to isolate the produced peptides. This optimised 
method is currently protected by a non-disclosure agreement with BIOPEP™, University of 
Stellenbosch. Therefore, a detailed description of the methodology cannot be provided. The 
biomass was extracted by employing a stepwise methodology relying on the solubility of the 
tyrothricin peptides. The dry extract of tyrothricin contained both tyrocidine and linear gramicidin 
fractions. To separate the two fractions, the extract was washed with a combination of diethyl 
ether and acetone. Tyrocidines are precipitated out of solution while gramicidins remained in 
solution. The precipitate was dried under nitrogen gas, resuspended in acetonitrile solution and 
lyophilised. 
Semi-preparative RP-HPLC of tyrocidines and analogues 
Purification of the crude extracts obtained from the non-supplemented and Phe-supplemented 
cultures was achieved by semi-preparative reversed-phase high performance liquid 
chromatography (RP-HPLC). The chromatography system, which was controlled by MAXIMA 
software, consisted of two Waters 510 pumps, a Waters 440 ultraviolet (UV) detector set at 254 
nm and a Nova-Pak C18 semi-preparative RP-HPLC column (6 µm particle size, 60 Å pore size, 
300 mm × 7.8 mm). A similar chromatography system which was under the control of Millenium 
software and was connected to a Waters 717 Autosampler was used to purify the crude extracts 
obtained from the Trp-supplemented culture. Samples to be purified were dissolved in 50% (v/v) 
acetonitrile (ACN) and centrifuged for 10 minutes at 10 000×g before 100 µL aliquots at 10 
mg/mL were injected onto the semi-preparative RP-HPLC column. A non-linear gradient elution 
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method with two solvents, solvent A (0.001% (v/v) TFA) and solvent B (90% (v/v) ACN, 10% 
(v/v) Solvent A), was employed for the separation of peptides (Table 2.2). The solvent flow rate 
was set at 3 mL/minute and the column temperature was set to 35 °C.  
Fractions whose purity was found to be unsatisfactory had to undergo a second round of 
purification which was performed on the chromatography system controlled by Millenium 
software. All parameters of the protocol were kept constant except the concentration of the 
samples injected was adjusted to 4 mg/mL. 
Table 2.2: Gradient elution method used for semi-preparative RP-HPLC 
Time (min) % Solvent A % Solvent B Gradient curve type* 
0.0 50 50 - 
0.5 50 50 - 
23 20 80 Concave 
24 0 100 Linear 
26 0 100 - 
30 50 50 Linear 
35 50 50 - 
*HPLC gradient programme from Waters™.  
ESMS and UPLC-MS analysis of peptides 
Prior to RP-HPLC purification, crude extracts were analysed using ESMS and UPLC-MS to 
confirm peptide production and establish the profile of the produced peptides. After purification, 
ESMS and UPLC-MS analyses were used to establish the success of the purification procedure. 
Samples to be analysed were prepared in 5% (v/v) ACN in analytical grade water to concentrations 
of 1.0 mg/mL (crude extracts) and 0.20 mg/mL (purified extracts).  
For ESMS, the analysis was carried out in a Waters Quadrupole Time-of-flight (Q-TOF) Synapt 
G2 mass spectrometer by injecting 2-5 µL samples directly onto a Z-spray electrospray ionisation 
source with a set temperature of 120 °C. The cone and capillary voltages were set to 15 V and 
3 kV respectively. Desolvation was done at 275 °C using nitrogen gas. Data was acquired by 
scanning through a mass to charge (m/z) range of 300-2000 in positive ion mode. 
UPLC-MS analyses were carried using a Waters Acquity UPLC™ chromatography system 
coupled to the Waters Quadrupole Time-of-flight (Q-TOF) Synapt G2 mass spectrometer. 
Separation was achieved by running samples through an Acquity UPLC® BEH C18 column for 18 
minutes. The column temperature was set to 60 °C. A linear gradient elution method (Table 2.3) 
was employed in which the mobile phase, comprising 1% (v/v) formic acid in analytical grade 
water (eluant A) and ACN (eluant B), with flow through the column at a rate of 0.3 mL/min.  
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Table 2.3: Gradient programme used for analysis of peptides by UPLC 
Time (min) % eluant A % eluant B Gradient curve type* 
0.0 100 0 - 
0.5 100 0 linear 
1.0 70 30 linear 
10.0 40 60 linear 
15.0 20 80 linear 
15.1 100 0 linear 
18.0 100 0 - 
*HPLC gradient programme from Waters™.  
Data Analysis 
GraphPad Prism® 6.0 (GraphPad software, San Diego, USA) was used to graphically represent 
purification data obtained from semi-preparative RP-HPLC. Analysis of ESMS and UPLC-MS 
data was done by using MassLynx™ software V4.1.   
2.4 Results and Discussion 
Part 1: Production, purification and characterisation of tyrocidines and analogues 
Analysis of crude extracts 
Extraction of peptide biomass from cultures of Br. parabrevis yielded crude mixtures composed 
of various tyrocidines and analogues as well as linear gramicidin A. The exact composition of 
these crude extracts was determined by UPLC-MS and is shown in Figure 2.1 and Table 2.4.  
The bacterial culture that received no amino acid supplementation produced a wide range of 
tyrocidines and analogues across all three of the A, B and C peptide subfamilies. In contrast, amino 
acid supplementation caused an apparent shift in the production profile of the tyrocidines and 
analogues. Supplementation with 22.5 mM Phe resulted in the predominant production of 
tyrocidine A analogues with extremely low quantities of the tyrocidine B analogues. On the other 
hand, supplementation with 16.5 mM Trp favoured the production of tyrocidine C analogues. 
Supplementation with the two amino acids also influenced the production of linear VGA. In 
comparison to the non-supplemented culture, supplementation with phenylalanine inhibited the 
production of VGA while supplementation with tryptophan increased the production. These 
results are consistent with the findings of Vosloo et al. [19]. 
As highlighted in Table 2.4, the peptide profile of the extract from the non-supplemented culture 
is comparable to that of the extract from the study conducted by Tang et al. [4]. The differences 
in the relative abundances could be attributed to different culturing conditions such as different 
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bacterial strains for peptide production, different nutrient media and different incubation 




Figure 2.1: UPLC-MS chromatograms showing the composition of the crude peptide mixtures 
extracted from cultures of Br. parabrevis.  
A) Tyrocidine mixture (Tmix) purified from commercial tyrothricin complex.  
B) Crude extracts from the non-supplemented cultures.  
C) Crude extracts from the cultures supplemented with 22 mM phenylalanine.  
D) Crude extracts from the cultures supplemented with 16.5 mM tryptophan.  
The letters Y, W and F denote the tyrocidine, tryptocidine and phenyicidine analogues respectively, which 
differ in the aromatic amino acid residue at position 7. The letters A, B and C denote the A, B and C 
analogues respectively which differ in their content of aromatic residues at the 3rd and 4th positions. The 
subscript 1 is used to denote the Lys containing analogues. 
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Table 2.4: Comparative analysis of the peptide content of crude culture extracts, commercial 






22 mM Phe 
supplemented 








Tyrocidine C1 4.0   11.0 4.8 
Tyrocidine C 11.3  6.2 14.5 16.0 
Tryptocidine C1 <1  13.2 <1 <1 
Tryptocidine C 2.4  66.4 1.1 3.7 
Tyrocidine B1 7.4 1.0  15.2 7.0 
Tyrocidine B 19.3 1.8  15.2 17.4 
Tyrocidine B’ 5.4   3.6 2.2 
Tryptocidine B1 1.2   <1 2.1 
Tryptocidine B 5.8  9.9 1.5 4.1 
Tyrocidine A1 7.8 22.0  16.1 6.2 
Tyrocidine A 26.0 51.0  16.1 14.0 
Tryptocidine A1 1.0   <1  
Tryptocidine A 6.0   <1 2.4 
Phenycidine A1  6.7    
Phenycidine A  17.5   <1 
Val-Gramicidin A <1  1.7  7.0 
  % Relative abundance was determined by expressing the peak area of each peptide as a percentage of the sum of the peak 
areas of all peptides present in the extract. It was assumed that the response factors of all peptides are similar due to their 
analogous structures. 
b The commercial tyrocidine mixture consists of only the tyrocidine containing fraction of the commercial tyrothricin 
complex. 
 
Purification of single peptides by semi-preparative RP-HPLC 
The goal was to purify the major tyrocidines (A, B and C) from the crude extract obtained from 
the non-supplemented culture. From the first round of semi-preparative HPLC purification, ten 
fractions were collected (Figure 2.2) and analysed by UPLC-MS to determine identity and purity. 
Only those fractions with a purity of 60% and/or greater in respect of the targeted single peptides 
were selected for a second round of purification. The selected fractions were fraction 3 (tyrocidine 
C), 5 and 6 (tyrocidine B) and 8 and 9 (tyrocidine A) (summarised in Table 2.5). 
The first round of semi-preparative RP-HPLC purification of the crude extract from the Phe-
supplemented culture yielded ten fractions (Figure 2.3). From these, only fractions 7 to 9 had 
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purities greater than 70% according to UPLC-MS analyses with respect to tyrocidine A and 
phenycidine A, and were subjected to a second round of purification. Fractions 7 and 8 contained 
tyrocidine A and A1 while fraction 9 contained tyrocidine A and phenycidine A (Table 2.5). 
However, the phenycidine-containing fraction was not taken into the second round of purification 
because of low yield. 
Seven fractions were collected from the semi-preparative RP-HPLC purification of the crude 
extract from the Trp-supplemented cultures (Figure 2.4). The peptides of interest from this extract 
were tryptocidine C and tyrocidine C. Tryptocidine C was present in fractions 5 and 6 at purities 
of greater than 90% according to UPLC-MS analyses (Table 2.5). As such, there was no need for 
an additional round of purification. The tyrocidine C containing fraction (fraction 3) was subjected 




Figure 2.2: Chromatogram showing the semi-preparative RP-HPLC purification of individual 
peptides from the crude mixture extracted from the non-supplemented cultures of 
Br. parabrevis. The numbers 1-10 denote the fractions that were collected during purification. 
 








































Figure 2.3: Chromatogram showing the semi-preparative RP-HPLC purification of individual 
peptides from the crude mixture extracted from the cultures of Br. parabrevis supplemented 
with 22 mM phenylalanine. The numbers 1-10 denote the fractions that were collected during 
purification. 
0 5 1 0 1 5 2 0 2 5
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Figure 2.4: Chromatogram showing the semi-preparative RP-HPLC purification of individual 
peptides from the crude mixture extracted from the cultures of Br. parabrevis supplemented 
with 16.5 mM tryptophan. The numbers 1-7 denote the fractions that were collected in this 
round of purification. 
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Table 2.5: Summary of the peptide composition of each of the fractions collected during semi-
preparative HPLC purification of the three culture extracts. 
Origin of crude extract RP-HPLC fraction Peptide compositiona 
Non-supplemented culture 
1 13 YC, 32 YC1 
2 48 YC, 52 YC1 
3 63 YC, 25 YC1 
4 40 YB, 31 YB1, 26 YB1’ 
5 63 YB, 20 YB’, 18 YB1 
6 66 YB, 21 WC, 6 WC1 
7 56 YA, 39 YA1 
8 75 YA, 22 YA1, 2 WB 
9 76 YA, 3 YA1, 18 WB 
10 NDb 




4* YA, YA1 
5 64 YA, 30 YA1 
6 58 YA, 40 YA1 
7 85 YA, 15 YA1 
8 83 YA, 2 YA1, 10 FA 
9 18 YA, 78 FA 
10* FA, WA 
16.5 mM Trp-supplemented 
1 68 YC, 14 YC1, 4 WC1 
2* YC, VGA 
3* WC, WC1 
4 73 WC, 27 WC1 
5 92 WC, 8 WC1 
6 90 WC, 6 WC1, 2 WB 
7* WB 
a Peptide composition is expressed as a percentage contribution (number before peptide abbreviation) and was determined via 
UPLC-MS analysis. The letters Y, W and F denote the tyrocidine, tryptocidine and phenyicidine analogues respectively, which 
differ in the aromatic amino acid residue at position 7. The letters A, B and C denote the A, B and C analogues respectively 
which differ in their content of aromatic residues at the 3rd and 4th positions. The subscript 1 is used to denote the Lys containing 
analogues. 
b ND – not determined. Fractions were not analysed due to low yields obtained during purification. 
* These fractions were analysed by ESMS alone and not subjected to UPLC-MS due to their low peptide content, therefore the 
percentage peptide composition was not ascertained. 
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UPLC-MS analysis of purified single peptides 
Following one or two rounds of semi-preparative HPLC purification, UPLC-MS analyses were 
carried out to determine the success of the purification steps. The final UPLC-MS analyses of the 







Figure 2.5: UPLC-MS analysis of the purified tyrocidine A (YA).  
A) UPLC chromatogram of the purified tyrocidine A (200 µg/mL; 5 µL injection volume) 
indicating an elution time of 10.98 minutes.  
B) ESMS positive ion spectrum of the elution peak of tyrocidine A indicating the singly 
charged molecular ions [M+H]+, doubly charged molecular ions [M+2H]2+ and triply charged 
molecular ions [M+K+2H]3+.   
C) The MaxEnt 3 generated ESMS mass spectrum of tyrocidine A depicting the experimental 
monoisotopic molecular mass.  
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Figure 2.6: UPLC-MS analysis of the purified tyrocidine B (YB).  
A) UPLC chromatogram of the purified tyrocidine B (200 µg/mL; 5 µL injection volume) 
indicating an elution time of 9.83 minutes.  
B) ESMS positive ion spectrum of the elution peaks of tyrocidine B, B1 and B’ indicating the 
singly charged molecular ions [M+H]+, doubly charged molecular ions [M+2H]2+ and triply 
charged molecular ions [M+K+2H]3+.   
C) The MaxEnt 3 generated ESMS mass spectrum of tyrocidine B/B1 complex depicting the 






























































Figure 2.7: UPLC-MS analysis of the purified tyrocidine C (YC).  
A) UPLC chromatogram of the purified tyrocidine C (200 µg/mL; 5 µL injection volume) 
indicating an elution time of 9.07 minutes.  
B) ESMS positive ion spectrum of the elution peak of tyrocidine C indicating the singly charged 
molecular ions [M+H]+, doubly charged molecular ions [M+2H]2+ and triply charged molecular 
ions [M+K+2H]3+.   
C) The MaxEnt 3 generated ESMS mass spectrum of tyrocidine A depicting the experimental 
monoisotopic molecular mass.  
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Figure 2.8: UPLC-MS analysis of the purified tryptocidine C (WC).  
A) UPLC chromatogram of the purified tryptocidine C (200 µg/mL; 5 µL injection volume) 
indicating an elution time of 9.61 minutes.  
B) ESMS positive ion spectrum of the elution peak of tryptocidine C indicating the singly 
charged molecular ions [M+H]+, doubly charged molecular ions [M+2H]2+ and triply charged 
molecular ions [M+K+2H]3+.  
 C) The MaxEnt 3 generated ESMS mass spectrum of tryptocidine C depicting the experimental 
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Overall, purification of the tyrocidines and analogues from crude culture extracts was successful. 
Three out of the four purified peptides attained purities greater than 90% with respect to the single 
peptide. Only tyrocidine B could not be purified to over 90% due to the presence of the tyrocidine 
B1. The two peptides are highly similar in their amino acid sequences differing only by a single 
amino acid substitution of Orn to Lys in tyrocidine B1. Ultimately, a single methylene (CH2) group 
differentiates the two peptides. This renders their separation on a semi-preparative column difficult 
often necessitating the use of an analytical HPLC column and reduction in the loading 
concentrations [16,20,21]. 
Based on the observed retention times, order of retention of the four peptides on the UPLC column 
was consistent with literature [16,17,20–22]. Tyrocidine A was retained the longest followed by 
tyrocidine B, tryptocidine C and tyrocidine C, respectively. These differences in the retention 
times are indicative of the different hydrophobic properties of the tyrocidines and analogues 
imposed by the variable positions in the amino acid sequence. The three tyrocidines (YA, YB and 
YC) differ from each other at positions three and four which comprise the aromatic dipeptide 
moiety. YA contains only Phe residues (Ff), while YC contains only Trp residues (Ww). YB 
contains both Trp and Phe (Wf). The hydrophobicities of the three aromatic amino acids follows 
the trend F>W>Y on the hydrophobic scale [23].  Based on this, YC is relatively polar in 
comparison to the other two analogues hence a shorter retention time. YA is relatively more 
hydrophobic and is thus retained the longest on the UPLC column. Tryptocidine C (WC) differs 
from YC at position seven where it contains a Trp residue in place of Tyr. Because Trp is relatively 
more hydrophobic than Tyr [23], the retention time of WC is greater than that of WC. 
Mass spectrometric analyses revealed that all four peptides form singly, doubly and triply charged 
ion species. The ions carrying the single and double charges are derived from the single and double 
protonation of the peptide. On the other hand, the ionic species carrying the triple charge contain 
two protons and a potassium ion. The relative abundances of the three ionic species on the mass 
spectra highlights the differential ionisation pattern amongst the four peptides. All peptides 
exhibited relatively low tendencies to carry triple charges. However, YA appears to carry a single 
charge more readily than it does a double charge while WC readily carries a double charge over a 
single charge. The abundances of the singly and doubly charged ionic species on the mass spectra 
of YB and YC appeared to be relatively equal. The MaxEnt 3 mathematic algorithm in the 
Masslynx Software was used to calculate the monoisotopic masses of the peptides thereby 
confirming the identity of the peptides. This mass was then compared to the theoretical 
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monoisotopic masses of the peptides to determine mass accuracy (Table 2.6). The mass error for 
all peptides was generally found to be less 15 ppm which indicated that the correct peptides were 
isolated and that they were chemically intact. It is specifically important to determine the chemical 
integrity of the peptides as our research group found that the tyrocidines tend to get deaminated at 
the Asn and/or Gln residues and, in some instances, are oxidised at the aromatic residues 







































2.3 9.07 97 
Tryptocidine C 
(WC) 




7.1 9.61 90 
aExperimental monoisotopic mass was determined by ESMS whereas theoretical monoisotopic mass was calculated by 
summing the monoisotopic masses of the constituent amino acids of each peptide. 
b % Purity was calculated by expressing the peak area of the peptide’s elution peak as a percentage of total of the peak areas of 
all the peaks integrated on the chromatogram. 
 
 
Part two: Chemical characterisation of the synthetic hexapeptides 
Because the RW-synthetic hexapeptides were sourced from elsewhere, it was necessary to confirm 
their identity and state of purity as well as determine their chemical characteristics. This was done 




































Figure 2.9: UPLC-MS analysis of cWFW.  
A) UPLC chromatogram of cWFW (200 µg/mL; 5 µL injection volume) indicating an elution 
time of 2.58 minutes.  
B) ESMS positive ion spectrum of the elution peak of cWFW indicating the doubly charged 
molecular ions [M+2H]2+ and triply charged molecular ions [M+3H]3+.   
C) The MaxEnt 3 generated ESMS mass spectrum of cWFW depicting the experimental 
monoisotopic molecular mass. 
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Figure 2.10: UPLC-MS analysis of cWWW1, a preparation from the Dathe group.  
A) UPLC chromatogram of cWWW (200 µg/mL; 5 µL injection volume) indicating an elution 
time of 2.55 minutes.  
B) ESMS positive ion spectrum of the elution peak of cWWW indicating the doubly charged 
molecular ions [M+2H]2+ and triply charged molecular ions [M+3H]3+.   
C) The MaxEnt3 generated ESMS mass spectrum of cWWW depicting the experimental 
monoisotopic molecular mass. 
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Figure 2.11: ESMS analysis of cWWW2, a preparation  from GL Biochem.  
A) ESMS positive ion spectrum of the elution peak of cWWW indicating the doubly charged 
molecular ions [M+2H]2+, the triply charged molecular ions [M+3H]3+ and contaminating ions.   
B) The MaxEnt3 generated ESMS mass spectrum of cWWW depicting the experimental 
monoisotopic molecular mass as well as the monoisotopic molecular masses of contaminants. 
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Figure 2.12: ESMS analysis of cWWW3, a preparation  from GL Biochem.  
A) ESMS positive ion spectrum of the elution peak of cWWW indicating the doubly charged 
molecular ions [M+2H]2+, triply charged molecular ions [M+3H]3+ and contaminating ions.  
B) The MaxEnt 3 generated ESMS mass spectrum of cWWW depicting the experimental 











































Figure 2.13: UPLC-MS analysis of cWRW1, a preparation from the Dathe group.  
A) UPLC chromatogram of cWRW (200 µg/mL; 5 µL injection volume) indicating an elution 
time of 2.47 minutes.  
B) ESMS positive ion spectrum of the elution peak of cWRW indicating the doubly charged 
molecular ions [M+2H]2+ and triply charged molecular ions [M+3H]3+.  
C) The MaxEnt 3 generated ESMS mass spectrum of cWRW depicting the experimental 
monoisotopic molecular mass. 
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Figure 2.14: UPLC-MS analysis of cWRW2, a preparation from  GL Biochem.  
A) UPLC chromatogram of cWRW (200 µg/mL; 5 µL injection volume) indicating an elution 
time of 2.89 minutes.  
B) ESMS positive ion spectrum of the elution peak of cWRW indicating the doubly charged 
molecular ions [M+2H]2+ and triply charged molecular ions [M+3H]3+.  
C) The MaxEnt 3 generated ESMS mass spectrum of cWRW depicting the experimental 
monoisotopic molecular mass. 
 

















































Figure 2.15: UPLC-MS analysis of cWYW.  
A) UPLC chromatogram of cWYW (200 µg/mL; 5 µL injection volume) indicating an elution 
time of 2.54 minutes.  
B) ESMS positive ion spectrum of the elution peak of cWYW indicating the doubly charged 
molecular ions [M+2H]2+ and triply charged molecular ions [M+3H]3+.  
C) The MaxEnt 3 generated ESMS mass spectrum of cWYW depicting the experimental 
monoisotopic molecular mass. 
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Figure 2.16: UPLC-MS analysis of cKRK.  
A) UPLC chromatogram of cKRK (200 µg/mL; 5 µL injection volume) indicating an elution 
time of 2.53 minutes.  
B) ESMS positive ion spectrum of the elution peak of cKRK indicating the doubly charged 
molecular ions [M+2H]2+ and triply charged molecular ions [M+3H]3+.  
C) The MaxEnt 3 generated ESMS mass spectrum of cKRK depicting the experimental 
monoisotopic molecular mass. 
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Figure 2.17: UPLC-MS analysis of cRKK.  
A) UPLC chromatogram of cRKK (200 µg/mL; 5 µL injection volume) indicating an elution 
time of 2.53 minutes.  
B) ESMS positive ion spectrum of the elution peak of cRKK indicating the doubly charged 
molecular ions [M+2H]2+ and triply charged molecular ions [M+3H]3+.    
C) The MaxEnt 3 generated ESMS mass spectrum of cRKK depicting the experimental 
monoisotopic molecular mass. 
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Figure 2.18: UPLC-MS analysis of AcRKK.  
A) UPLC chromatogram of AcRKK (200 µg/mL; 5 µL injection volume) indicating an elution 
time of 2.48 minutes.  
B) ESMS positive ion spectrum of the elution peak of AcRKK indicating the doubly charged 
molecular ions [M+2H]2+ and triply charged molecular ions [M+3H]3+.  
C) The MaxEnt 3 generated ESMS mass spectrum of AcRKK depicting the experimental 
monoisotopic molecular mass. 
 
Retention time (min)

















































Figure 2.19: UPLC-MS analysis of AcKRK.  
A) UPLC chromatogram of AcKRK (200 µg/mL; 5 µL injection volume) indicating an elution 
time of 2.47 minutes.  
B) ESMS positive ion spectrum of the elution peak of AcKRK indicating the doubly charged 
molecular ions [M+2H]2+ and triply charged molecular ions [M+3H]3+.   
C) The MaxEnt 3 generated ESMS mass spectrum of AcKRK depicting the experimental 
monoisotopic molecular mass. 
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Figure 2.20: UPLC-MS analysis of AcWFW.  
A) UPLC chromatogram of AcWFW (200 µg/mL; 5 µL injection volume) indicating an elution 
time of 2.47 minutes.  
B) ESMS positive ion spectrum of the elution peak of AcWFW indicating the doubly charged 
molecular ions [M+2H]2+ and triply charged molecular ions [M+3H]3+.  
C) The MaxEnt 3 generated ESMS mass spectrum of AcWFW depicting the experimental 
monoisotopic molecular mass. 
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Figure 2.21: UPLC-MS analysis of AcWRW.  
A) UPLC chromatogram of AcWRW (200 µg/mL; 5 µL injection volume) indicating an elution 
time of 2.53 minutes.  
B) ESMS positive ion spectrum of the elution peak of AcWRW indicating the doubly charged 
molecular ions [M+2H]2+ and triply charged molecular ions [M+3H]3+.   
C) The MaxEnt 3 generated ESMS mass spectrum of AcWRW depicting the experimental 
monoisotopic molecular mass. 
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Figure 2.22: UPLC-MS analysis of AcWWW.  
A) UPLC chromatogram of AcWWW (200 µg/mL; 5 µL injection volume) indicating an 
elution time of 2.53 minutes.  
B) ESMS positive ion spectrum of the elution peak of AcWWW indicating the doubly charged 
molecular ions [M+2H]2+ and triply charged molecular ions [M+3H]3+.   
C) The MaxEnt 3 generated ESMS mass spectrum of AcWWW depicting the experimental 
monoisotopic molecular mass. 
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Figure 2.23: UPLC-MS analysis of AcWYW.  
A) UPLC chromatogram of AcWYW (200 µg/mL; 5 µL injection volume) indicating an elution 
time of 2.53 minutes.  
B) ESMS positive ion spectrum of the elution peak of AcWYW indicating the doubly charged 
molecular ions [M+2H]2+ and triply charged molecular ions [M+3H]3+.   
C) The MaxEnt 3 generated ESMS mass spectrum of AcWYW depicting the experimental 
monoisotopic molecular mass. 
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By comparing the experimental Mr derived from ESMS to the theoretical Mr, the identities of all 
the peptides were successfully confirmed (Figures 2.9 – 2.23, Table 2.7). Most of the mass errors 
were below 15 ppm for the peptides which confirmed peptide identity and chemical integrity.  
Table 2.7: Summary of the UPLC-MS characterisation of the synthetic RW-hexapeptides used in 
this study 




































































































14.7 2.54 >99 
a Experimental monoisotopic mass was determined by ESMS whereas theoretical monoisotopic mass was 
calculated by summing the monoisotopic masses of the constituent amino acids of each peptide. 
b % Purity was calculated by expressing the peak area of the peptide’s elution peak as a percentage of total of the 
peak areas of all the peaks integrated on the chromatogram. 
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Because of the three cationic residues in the RW-hexapeptides, they demonstrated a high 
propensity to carry multiple charges as only doubly and triply charged molecular ions were 
detected as shown on their mass spectra. In contrast to the mass spectra of the tyrocidines, no 
singly charged molecular ions or potassium adducts were detected. The UPLC chromatograms 
revealed that the RW-hexapeptides are much more polar in comparison to the tyrocidines. They 
eluted significantly earlier from the UPLC column (Rt < 3 minutes) than the tyrocidines (Rt > 9 
minutes). This could be attributed to the higher proportion of the cationic amino acid residues in 
the sequences of the RW-hexapeptides. The contribution of polar residues to the primary structures 
of RW-hexapeptides is 50% compared to a 30%-40% contribution in the primary structures of the 
tyrocidines and analogues.  
It must be noted that two peptide preparations of the WRW cyclic analogue and three preparations 
of the WWW cyclic analogue were characterised (Figures 2.11-2.15). The first peptide 
preparations (cWWW1 and cWRW1) were obtained from our research collaborators, the Dathe-
group at the Leibniz Institute, Germany whereas the second and third preparations (cWWW2, 
cWWW3 and cWRW2) were supplied by GL Biochem Ltd (Shanghai, China). These peptide 
preparations from the different suppliers exhibited different chemical properties. The cWRW1 
preparation from the Dathe group appeared to be slightly polar than the cWRW2 from from GL-
Biochem as shown by its earlier elution from the UPLC column (Table 2.7). Given that the 
preparation of peptides for the UPLC-MS analyses was done in the same manner and the same 
protocol was utilised during the analyses, the observed anomalies can be linked to differences in 
the UPLC column. Alternatively, the retention difference could be due to shielding of charges by 
contaminants leading to an ion-paring effect and concomitant increase in retention on the C18 
matrix. Even though the two cWRW peptide preparations showed slightly different UPLC-MS 
profiles, their ESMS mass spectra were very similar as were their purities. On the other hand, the 
ESMS mass spectra of the three cWWW peptides were very different. The ESMS mass spectrum 
of cWWW2 (Figure 2.11) displayed various unidentified peaks related to impurities, which are 
absent in the mass spectrum of cWWW1 (Figure 2.10) and cWWW3 (Figure 2.12). However, we 
failed to generate a UPLC chromatogram for either cWWW2 or cWWW3. In both preparations 
the peptide signals were not detected during UPLC-MS at the same concentration as cWWW1. 
From these QC analyses it can be deduced that cWWW2 contained a large amount of impurities, 
resulting in a concentration that was too low for detection with UPLC-MS, therefore this 
preparation was discarded. The failure to generate a UPLC-MS profile for cWWW3 that is quite 
pure according to the direct injection ESMS is unclear. The only observation that could point to 
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non-ionisable impurities is that about a 20-fold lower positive ion signal was obtained for this 
preparation, compared to similar RW preparations at the same concentration. These impurities 
could also have led to ion-paring and retention on the column and a failure to elute during the 
UPLC run. 
With exception of cWRW2, the RW-hexapeptides had very similar retention times regardless of 
their cyclic or linear nature (Table 2.7). In some instances, the same retention times were observed 
for different peptides. It was expected that RW-hexapeptides would have similar amphipathic 
properties due to their highly conserved amino acid composition. The difference in their amino 
acid sequences is a result of either substitution of a single amino acid or just a rearrangement of 
amino acids. In the linear group, the most polar peptides were Ac-RKK and Ac-WFW and the 
least polar peptides were Ac-WWW, Ac-WRW and Ac-WYW. From the cyclic group, cWRW1 
was found to be the most polar while the cWRW2 preparation was found to be the least polar.  
The retention times of peptides containing the same amino acid residues, albeit arranged 
differently were observed to be different (cKRK vs cRKK, cWRW vs cWWW and AcKRK vs 
AcRKK). This indicated that the order of amino acids in the primary structure of peptides 
influences the amphipathic properties. However, for the Ac-WRW and Ac-WWW, rearrangement 
of amino acids had no effect on the amphipathicity as the two peptides had the same retention time 
on the UPLC column. 
Generally, cyclisation increased hydrophobicity as evidenced by a slight increase in retention 
times of the cyclic analogues. A similar phenomenon was reported by other investigators [13,24]. 
Dathe et al. [24] suggested that the increase might related to the clustering of hydrophobic residues 
which in turn enhances the amphipathicity of the molecules. Strangely, for the amino acid 
sequence RWRWRW, a reduction in the retention time was observed upon cyclisation of the linear 
peptide.  
2.4 Conclusion 
The biological production of the natural cyclodecapeptide analogues (YA, YB,YC and WC) using 
cultures of Br. parabrevis was successful. Employing an optimised semi-preparative RP-HPLC 
methodology enabled the successful purification of these peptides to greater than 90% purity by 
peptide composition as determined by ESMS and UPLC-MS analyses. This successful purification 
paved way for structural characterisation and elucidation of the bioactivity which will be discussed 
in Chapters 3 and 4, respectively. Furthermore, the analysis of the synthetic RW-hexapeptides by 
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ESMS and UPLC-MS confirmed their identity and allowed the determination of their level of 
purity. From this study it is also clear that stringent QC is essential to ensure that peptide 
preparations are of high purity and quality, regardless of the supplier’s data on the peptide 
preparation. It was established that the RW-hexapeptides, except cWWW3 had a greater than 90% 
purity, with the majority being greater than 99% pure. The results of the UPLC analysis also gave 
insight into their chemical nature. The members of this family of small peptides possess similar 
amphipathic properties. In addition, they are highly polar relative to the tyrocidines. Chemical 
characterisation as well the structural characterisation (Chapter 3) will be correlated to the 
observed antifungal activity of the peptides that will be presented and discussed in Chapter 4. 
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Structural characterisation of natural cyclodecapeptides and 
synthetic hexapeptides  
3.1 Introduction 
In the development of antimicrobial peptides for therapeutic applications, it is important to have a 
clear understanding of factors that govern the activity of these peptides. It has been shown that 
target cell properties, physicochemical properties of the peptide as well as environmental factors 
all play a role in the interaction between an antimicrobial peptide and its target. Intrinsic properties 
of a peptide that affect bioactivity are related to its conformation and include size, charge 
distribution, hydrophobicity, amphipathicity and secondary structure. Additionally, environmental 
factors such as the hydrophobicity/polarity, ionic strength and pH of a peptide’s environment also 
have an effect on its conformation thereby influencing how it interacts with a target and ultimately, 
its activity [1–4]. Because of the influence of physicochemical parameters of peptides on 
bioactivity, their elucidation is important to better understand structure activity relationships, 
modulation of bioactivity and mode of action [5].  
Circular dichroism (CD), a spectrophotometric character exhibited by chiral compounds, is an 
important technique for studying peptide and protein secondary structure. The spectrophotometric 
properties of the peptide bond, in particular the carbonyl group, are very sensitive to different 
secondary structural motifs and as a result, characteristic CD spectra exist for the various types of 
secondary structures found in proteins and peptides [6,7]. Because conformation dictates the nature 
of the CD spectra, CD can therefore be used to predict the secondary structure of peptides and to 
track any conformational changes induced by the environment [7]. From previous work [5,8,9], it 
has been reported that tyrocidines produce CD spectra that can be misinterpreted as that of α-
helical structures. However, it has been shown through NMR studies [10] and X-ray 
crystallography [11] that they form predominantly β-sheet structures, containing type II β-turns. It 
has been hypothesised that the aberrant CD spectra could possibly be due to the contribution of 
aromatic amino acid residues, their propensity to aggregate in solution and their cyclic nature, as 
well as their two D-amino acids in their structure [5,8,9]. Investigations of the structure of cyclic 
RW-hexapeptides by CD spectroscopy have found that they have rather flexible but ordered 
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conformations consisting of two β-turns in aqueous solution. In lipophilic environments, the 
ordered conformation is maintained but the position of the β-turns is changed [12,13]. On the other 
hand, the structure of the linear analogues has been characterised as random/disordered in aqueous 
solutions. However, it has been shown that in membrane mimicking environments, they transition 
to ordered structures and become structurally similar to their cyclic counterparts as they adopt 
amphipathic conformations [14]. 
In addition to CD, fluorescence spectroscopy (FS) has proved to be a valuable and sensitive 
technique in the study of peptide structure. It relies on the intrinsic fluorescent properties of the 
aromatic amino acids, specifically that of Trp due to it being the dominant fluorophore in peptides 
and proteins [10]. Trp is quite sensitive to its local environment and any change in the local 
environment of Trp causes changes in its fluorescence emission spectra [10]. The spectral changes 
usually observed include shifting of the emission maxima and changes in the fluorescence intensity 
and yield which depicts either quenching or dequenching [15–17]. These changes often reflect 
conformational changes in peptides. Previous work has shown that both tyrocidines and RW-
peptides exhibit blue shifting and fluorescence quenching when their environment changes from 
polar to hydrophobic [9,13]. Furthermore, in the absence of crystal structures and 2D NMR data, 
de novo low energy molecular models can be useful tools in the prediction of peptide structure. 
Using tailored computer software, various physicochemical attributes of molecular models can be 
analysed which can enhance the understanding of peptide structure.    
In this study, CD spectroscopy and FS were employed for the purposes of characterising the 
structure of natural cyclo-decapeptides (tyrocidines and analogues) and synthetic RW-
hexapeptides in different solvent environments. The RW-hexapeptides structures were also 
analysed in silico via modelling and the results of these in silico analyses compared to the in vitro 
analyses. 
3.2 Materials 
Characterisation of peptide structure was performed on two groups of peptides; namely the natural 
cyclo-decapeptides (tyrocidines and analogues) and the synthetic RW-hexapeptides. Three of the 
synthetic cyclic RW-hexapeptides (cKRK, cRKK, and cWFW) were obtained from Liebniz, 
Germany while cWYW, cWRW and cWWW, as well as all the linear RW-hexapeptides were 
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supplied by GL Biochem Limited (Shanghai, China). It should be noted that the cWRW and 
cWWW characterised in this chapter are from the third batch (otherwise referred to as cWRW3 
and cWWW3 in Chapter 2). The tyrothricin-derived cyclodecapeptides were extracted from 
cultures of Brevibacillus parabrevis 5618-DSM and purified by semi-preparative reversed phase 
HPLC (described in Chapter 2). All peptides used in this investigation were at least 90% pure 
according to UPLC-MS analysis, with exception of cWWW from GL Biochem (referred to as 
cWWW3 in Chapter 2) which failed our UPLC-MS analysis although the supplier noted its purity 
as >95% (refer to Chapter 2). Peptide solutions were prepared using the following solvents; 
analytical grade water that had been purified by reverse osmosis followed by filtration through a 
Millipore MilliQ water purification system (Milford, USA), acetonitrile (HPLC-grade, far UV cut-
off of 190 nm) supplied by Romil Limited (Cambridge, UK) and 2,2,2-trifluoroethanol purchased 
from Sigma (St. Louis, USA).  
3.3 Methods 
Molecular modelling of RW-hexapeptide structures 
Using YASARA 11.3.2® software [18], models of RW-hexapeptide structures were generated by 
Prof M. Rautenbach by implementing basic principles of molecular modelling. A template model 
of AcWWW-amide with a -sheet backbone structure was built as the representative starting 
model of the linear hexapeptides. A template model of cWWW, with two -turns in which RW-
and WR are taking part in the β-turn moieties, was built as the representative starting model of the 
cyclo-hexapeptides. These template models were then subjected to exhaustive molecular dynamic 
(MD) simulations at 298K using YASARA 2 force field [18]. Each simulation run was followed 
by an energy minimisation step in vacuo. Simulation runs were performed on the template models 
until successive runs yielded structures with no appreciable difference in energy and backbone 
structure (average RMSD < 1Å for consecutive structures). At this point, it was thus assumed that 
the template models had reached a global energy minimum and could be used as representative 
model structures. Molecular models of the other analogues in each group were derived from these 
low energy template structures by simply mutating the amino acid sequence accordingly and 
performing MD simulation runs to check whether a global energy minimum had been reached. 
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In this study, 15 low energy model structures were selected for each peptide and superposed onto 
each other to validate that similar structures were obtained. The characterisation of the 15 low 
energy structures of each peptide was done using YASARA 11.3.2® software [18]. Secondary 
structures and size-defining parameters (radius, surface area and volume) were determined to 
compare the peptides with each other. 
Circular dichroism spectroscopy 
Dry, analytically weighed aliquots of the cyclodecapeptides were dissolved in 50% (v/v) 
acetonitrile (ACN) in analytical grade water to make 2.000 mM peptide stock solutions. The stock 
solutions were then diluted 10× with analytical grade water so that the concentration of ACN was 
5% (v/v). A final dilution with either analytical grade water or 2,2,2-trifluoroethanol (TFE) was 
carried out to achieve a final peptide concentration of 100.0 µM and ACN concentration of 2.5% 
(v/v). For the RW-peptides, 200.0 µM peptide solutions in analytical grade water were prepared 
prior to further dilution with either 2,2,2-TFE or analytical grade water to achieve a final peptide 
concentration of 100.0 µM. The peptides were analysed for circular dichroism on a Chirascan CD 
spectrometer (Applied Photophysics, UK) at 25 °C using a quartz cuvette with a pathlength of 0.05 
cm. Three scans were performed on each sample and data collection over 185-295 nm was set at 
0.5 seconds per step of 1 nm (average of 4000 data points per nm) and a bandwidth of 1 nm. 
Fluorescence spectroscopy 
Following CD analysis, the same peptide samples were analysed for fluorescence emission on a 
Varioskan® Flash multimode plate reader (Thermo Scientific, USA). Peptide solutions were 
excited at 280 nm with an excitation bandwidth of 5 nm. Acquisition of fluorescence emission data 
was done in the region between 300 nm and 420 nm using a step size of 2 nm. Emission scans 
were done in triplicate for each peptide sample. 
Data analysis 
Data from the peptide models was analysed in YASARA 11.3.2® software. GraphPad Prism® 6.0 
(GraphPad software, San Diego, USA) was used to plot CD spectra and fluorescence emission 
spectra. To determine the content of the various secondary structural elements within the peptides, 
CDPro software package was used to deconvolute CD spectral data (240 - 185 nm). The 
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CONTINLL algorithm and protein reference set 4 (IBasis 4) were utilised in deconvolution 
process.  
3.4 Results and Discussion 
Molecular models of natural cyclodecapeptides 
The structures of YA and YC were previously determined by nuclear magnetic resonance 
spectroscopy (NMR) by Munyuki et al. [10] and by using homology modelling [Rautenbach and 
Leussa, unpublished data] from the structure of YC by Munyuki et al. [10]. All four of the 
cyclodecapeptides displayed the typical -sheet and -turn structures as can be seen in Figure 3.1. 
However, none of the cyclo-decapeptides displayed overt amphipathicity in their monomeric form. 
Munyuki et al. [10] modelled the dimers of YA and YC from NMR data and showed that these 
structures have an amphipathic nature. Similarly, a model of a YA dimer derived from a YA crystal 
structure also displayed amphipathic character [11]. 
A summary of the structural parameters determined from the four cyclodecapeptide models is 
given in Table 3.1. 
Table 3.1: Summary of the structural characteristics of the four cyclodecapeptides derived from 
model structures. Radius, surface area and volume refer to the Van der Waals 
radius/surface/volume.  









Tyrocidine A (YA) fPFfNQYVOL cyclic 12.38 1130.95 1309.3  
Tyrocidine B (YB) fPWfNQYVOL cyclic 12.23 1149.33 1344.6  
Tyrocidine C (YC) fPWwNQYVOL cyclic 12.40 877.84 1377.6  
Tryptocidine C (WC) fPWwNQWVOL cyclic 12.07 1161.31 1399.2  
It is interesting to note that the radii of the peptides are quite similar at 12-13 Å (Table 3.1). A 
typical membrane is 7.5-10 nm thick (75-100 Å) [19]. This means that at least four peptide 
molecules would be needed to span a bilayer membrane to form the ion-conducting pores observed 
by Wenzel et al. [20].  
 
Stellenbosch University  https://scholar.sun.ac.za







Figure 3.1: Low energy structural models of the natural cyclodecapeptides 
A) YA, B) YB, C) YC and D) WC. The images on the left depict ball models, middle images 
depict stick models with the backbone hydrogen bonding highlighted and images on the right 
depict overlays of 10 lowest energy model structures. Carbon atoms are depicted in light blue, 
nitrogen in dark blue, oxygen in red and hydrogen bonds in yellow. For simplicity, hydrogen 
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Molecular modelling of RW-hexapeptide structures 
Peptide structures were modelled exclusively for the RW-hexapeptides as the modelling of the 
cyclodecapeptide structures has been done previously [5,10,21]. Molecular modelling was done 
for the following cyclic and linear RW-hexapeptide analogues: cWFW, cWRW, cWWW, cWYW, 
AcWFW, AcWRW, AcWWW and AcWYW. As expected, the models showed that there, indeed, 
are huge structural differences between the cyclic and linear analogues. Out of the four cyclic 
analogues whose structures were modelled, cWFW, cWYW, cWWW exhibited a highly conserved 
backbone structure comprising a single β-turn and a single γ-turn (Figure 3.2A-C). The two turns 
were stabilised by hydrogen bonds between the amino (NH) and carbonyl (CO) groups of the 
peptide backbone. The β-turn was created by the formation of a hydrogen bond between the amide 
CO-group of Trp1 and the amide NH-group of Arg4. On the other hand, hydrogen bonding between 
the amide NH-group of Arg5 and the amide CO-group of Trp1 gave rise to the γ-turn. A third 
hydrogen bond which was also involved in stabilising the peptide backbone was observed between 
the amide CO-group of Trp3 and the amide NH-group of Arg5. Overall, the three model 
hexapeptides exhibited amphipathic structures; with the aromatics clustered on one side and the 
Arg residues spread out on the opposite side. The observed amphipathic structures show 
consistency with previous structural characterisations of these hexapeptides [12,22]. However, 
there is a slight discrepancy with regards to the types of turns in peptide backbone. While cWFW 
has previously been characterised to also contain two turns, both turns were reported to be β-turns 
[22].  
Although the model structure for cWRW also showed an amphipathic configuration, it did not 
resemble the molecular models of the other cyclic analogues (Figure 3.2D). The hydrophobic 
aromatic residues did not truly cluster together despite being separated from the polar Arg residues. 
In addition, the cWRW backbone consisted of two γ-turns that were stabilised by the following 
hydrogen bonds: Trp3-O:HN-Trp5 and Arg4-O:HN-Arg6. A third hydrogen bond was also observed 
between the terminal NH2 group of Arg
4 and the amide CO-group of the same residue. 
Analysis of secondary structure of these models showed cWRW to consist of solely 
undefined/irregular structural elements whereas the other cyclic analogues were found to have 
66.6% turn structures and 33.3% undefined structures (Table 3.3). The comparative analysis of the 
Stellenbosch University  https://scholar.sun.ac.za




size parameters relating to the Van der Waals surface did not yield any clear trend (Table 3.2). 
Interestingly, the Van der Waals radii of the cyclic hexapeptides were very similar to radii of the 
cyclodecapeptides which can be attributed to the cyclic nature of their peptide backbones.   
Models for the linear analogues also exhibited conservation of backbone structure amongst three 
of the four analogues, namely AcWFW, AcWWW and AcWYW. The structure was characterised 
by a single γ-turn that was stabilised by hydrogen bonding between the CO-group of the acetyl 
moiety and the amide NH-group of Arg2. An additional hydrogen bond was common amongst all 
three analogues and this was between the NH-group on the indole ring of Trp4 and CO-group of 
the acetyl moiety. Other hydrogen bonds stabilised the backbone structures, but their number and 
location varied amongst the three analogues (Table 3.2). For instance, both AcWFW and AcWWW 
had three additional hydrogen bonds but different residues were involved in the bonding. 
AcWYW, on the other hand, only had one extra hydrogen bond. Similar to what was observed for 
the cyclic analogues, the structure of the model for AcWRW was vastly different from the other 
linear analogues. The molecular model displayed a total of six internal hydrogen bonds (Table 
3.2). Two of these, which were also present in the models of the other linear analogues, were 
Acetyl-O:H(NE1)-Trp4 and Acetyl-O:HN-Arg2; with the latter stabilising the γ-turn. In addition 
to the γ-turn that was common to the other three analogues, the model depicted two other γ-turns. 
These γ-turns were a result of the following hydrogens bonds: Trp2-O:HN-Trp4 and Trp4-O:HN-
Trp6. The models for the linear RW-hexapeptides illustrated an amphipathic conformation, albeit 
not as strong and defined as for the cyclic analogues. This was because at least one of the polar 
residues tended to associate with aromatics in the hydrophobic cluster (Figure 3.3). The 
amphipathic nature of the linear RW-hexapeptides has also been previously reported [23,24]. 
Interestingly, the secondary structures of the molecular models of all the linear analogues were 
found to be entirely undefined/irregular even though the models depicted clear structural 
distinctions between AcWRW and the other three analogues (Table 3.3). However, comparative 
analysis of the size parameters relating to the Van der Waals surface highlighted how different 
AcWRW is from its counterparts. While the radii and surface areas of AcWWW, AcWFW and 
AcWYW were comparable, the radius of AcWRW was considerably smaller and its surface area 
substantially greater. However, all four peptides had similar volumes (Table 3.2).  
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Figure 3.2: Low energy structural models of linear RW-hexapeptides 
A) cWFW, B) cWYW, C) cWWW and D) cWRW. The images, from left to right, depict ball 
models, stick models with the backbone hydrogen bonding highlighted and overlays of 15 
lowest energy model structures. Carbon atoms are depicted in light blue, nitrogen in dark blue, 
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Figure 3.3: Low energy structural models of linear RW-hexapeptides 
A) AcWFW, B) AcWYW, C) AcWWW and D) AcWRW. The images on the left depict ball 
models, middle images depict stick models with the backbone hydrogen bonding highlighted 
and images on the right depict overlays of 15 lowest energy model structures. Carbon atoms 
are depicted in light blue, nitrogen in dark blue, oxygen in red and hydrogen bonds in yellow. 
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Table 3.2: Summary of the structural characteristics of the RW-hexapeptides derived from model structures  







Observed hydrogen bonding patternb 
 
Ac-KRK Ac-KRKWFW-NH2 linear n.dc n.d n.d n.d  
Ac-RKK Ac-RKKWFW-NH2 linear n.d n.d n.d n.d  




Ac-WRW Ac-RWRWRW-NH2 linear 12.77 993.13 1118.89 Ac-O:H(N1)-Trp4, Ac-O:HN-Arg2, 
Trp2-O:HN-Trp4, Trp2-O:H(NE1)-Trp6,  
Trp4-O:HN-Trp6, Trp6-O:H2N-Arg5 
 








cKRK KRKWFW cyclic n.d n.d n.d n.d  
cRKK RKKWFW cyclic n.d n.d n.d n.d  
cWFW RRRWFW cyclic 12.66 848.32 1017.31 Arg5-O:HN-Trp1, Trp1-O:HN-Arg4,  
Trp3-O:H2N-Arg5 
 
cWRW RWRWRW cyclic 12.98 919.61 1045.96 Arg4-O:H2N-Arg4, Arg4-O:HN-Arg6,  
Trp3-O:HN-Trp5 
 
cWWW RRRWWW cyclic 12.40 871.58 1046.87 Arg5-O:HN-Trp1, Trp1-O:HN-Arg4,  
Trp3-O:H2N-Arg5 
 
cWYW RRRWYW cyclic 12.04 845.79 1020.23 Arg5-O:HN-Trp1, Trp1-O:HN-Arg4,  
Trp3-O:H2N-Arg5 
 
a Radius, surface area and volume refer to the Van der Waals radius/surface/volume 
b (NE1) refers to the amino group in the indole ring of Trp, NH refers to the amino group of the peptide backbone, NH1 and NH2 refer to the terminal amino groups on the Arg residues 
c n.d refers to not determined 
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Analysis of peptide structure by Circular Dichroism  
Natural cyclodecapeptides 
The far UV CD spectra of the cyclodecapeptides highlighted two negative minima in the regions 
208±2 nm and 216±2 nm, resembling spectra that are typical of α-helical structures and not β sheet 
structures (Figure 3.4). However, this was not an unexpected result as similar findings have been 
reported in literature [5,8,9]. The deviation of the CD spectra of the cyclodecapeptides from 
characteristic β-sheet CD spectra could be attributed to a combination of factors that interfere with 
CD of the peptide backbone. The aromatic amino acids present in the structures of the 
cyclodecapeptides possibly contribute to the atypical spectra. Aromatic amino acids are known 
for their optical absorption in the 210-240 nm region and several CD studies for proteins have 
highlighted the influence of aromatics on CD spectra in the far UV region [25–27]. For this reason, 
it is believed that the minima observed at the 216±2 nm region could be strongly influenced by 
aromatic amino acids [5,9]. In addition to aromatic residues, the structures of the 
cyclodecapeptides consist of D-amino acid residues which most likely contribute to anomalous 
appearance of their CD spectra. The cyclic structures of the cyclodecapeptides are stabilised by 
type Ⅱ β-turns which are also thought to have a contributory role towards distorting the shape of 
the CD spectra [28,29]. Furthermore, the cyclodecapeptides are well known for their tendency to 
self-assemble and form higher order structures in solution. It is thus believed that the aggregation 
state of the cyclodecapeptides potentially interferes with their CD spectra resulting in spectra that 
are unusual for β-sheet structures [8].  
The two minima observed at 208±2 nm and 216±2 nm (Figure 3.4) are attributed to the presence 
of β-turns and β sheet structural elements respectively [26,28]. These two minima were of 
comparable negative ellipticity. In 50% TFE, a membrane mimicking solvent, the minima 
attributed to the β-turns were slightly blue shifted to 208 ± 2 nm and their negative ellipticities 
were greatly enhanced for all analogues. On the other hand, the intensity of the ellipticities at the 
216±2 nm minima were slightly enhanced for YA and YB while it was reduced for YC and WC. 
This is indicative of the higher proportion of sheet structures in the Phe-containing 
cyclodecapeptides relative to the analogues that lack Phe residues. The increased negative 
ellipticity at the 208±2 nm minima indicate stabilisation of the β-turn structural elements. This 
conforms to the widely known secondary structure stabilising effect of TFE [28]. TFE promotes 
intramolecular hydrogen bonding by reducing the competitive effect of water for the peptide 
hydrogen bonds [4]. 
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An additional spectral feature (maximum) was observed in water for two of the Trp4-containing 
cyclodecapeptides, YC and WC which is absent in the Phe-containing peptides, YA and YB. This 
maximum was observed at approximately 230 nm and was well defined for WC while it appeared 
as a shoulder in YC. This spectral feature has previously been attributed to the contributory effect 














Y A  in  T FE
Y A  in  w a te r















































Y B  in  T F E
Y B  in  w a te r















































Y C  in  T F E
Y C  in  w a te r
















































W C  in  T F E
W C  in  w a te r


































Figure 3.4: Far UV CD spectra of the cyclodecapeptide analogues [100 µM] in an aqueous 
environment (water) and membrane mimicking environment (50% TFE).  
A) Tyrocidine A (YA) with Phe3, Phe4 and Tyr7, B) Tyrocidine B (YB) with Phe3, Trp4 and 
Tyr7, C) Tyrocidine C (YC) with Trp3, Trp4 and Tyr7, D) Tryptocidine C (WC) with Trp3, Trp4, 
and Trp7. Blue curves represent CD spectra of peptides in water while red curves represent CD 
spectra of peptides in 50% TFE. Each CD spectra is an average of triplicate determinations.   
A B 
C D 
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of Trp residues because of the strong absorption of the indole ring in this spectral region. 
Moreover, the absence of this maximum in YA that contains no Trp-residues further strengthens 
the notion that this spectral feature is due to Trp residues [8]. Inversion of the 230 nm maximum 
to a negative minimum was observed in 50% TFE. This change in the appearance of the bands 
could also be indicative of changes in the orientation of the Trp side chains with respect to the 
peptide backbone[9]. 
All four cyclodecapeptides exhibited positive maxima in the lower wavelength regions of the CD 
spectra. For YB and YC, the maxima fell outside the CD spectral region (<185 nm) for both water 
and 50% TFE. For YA and WC in aqueous environment, the positive maxima were at 194 nm and 
187 nm, respectively. These maxima were slightly blue shifted to 193 nm and 185 nm respectively 
in the TFE membrane mimicking environment. A positive maximum in the 180 nm – 190 nm 
region is representative of π-π* transitions of the peptide bond [6,30].  
The ellipticity ratio θ208/θ216 can provide important information about structural changes. The 
ellipticity ratios of all analogues in TFE were >1 and followed the order WC>YC>YB>YA, which 
is also related to the Trp content illustrating the influence of aromatic residues (Figure 3.5). 
Unfortunately, due to the varying contributions of the different aromatic residues towards the 
ellipticity at 216 nm, it is not feasible to compare the ellipticity ratios of the different 
cyclodecapeptides. However, comparisons can be made between the ellipticity ratios of a single 
peptide when in water and in 50% TFE. Changes in the ellipticity ratios can indicate alterations in 
the backbone structure and/or formation of higher order structures [5,9,10]. The ellipticity ratios 
of all the cyclodecapeptide analogues were enhanced in the TFE membrane mimicking 
environment implying a decreased proportion of β-sheet structures relative to β-turn structures 
(Figure 3.5). It is possible that TFE-induced changes in the conformation led to the formation of 
intermolecular hydrogen bonds and as a result the formation of higher order sheet structures. 
Intramolecular hydrogen bonding seems to have been promoted by TFE as indicated by the 
enhancement of β-turn minima at 208 nm. This change in the ellipticity ratios could be attributed 
to new hydrogen bonded networks that are not only -structures, since TFE is known to promote 
the formation of ordered structures and hydrogen bonding [4]. YA was least influenced by solvent 
change which suggests that the more hydrophobic YA already had a more ordered conformation 
in water than the Trp-containing analogues. 
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It was not possible to determine the content of the different secondary structure fractions in the 
cyclodecapeptides from the CD spectra. This is because CDPro, a software that analyses CD 
spectra to estimate the content of structural elements, is not suitable to analyse 
oligopeptides/polypeptides consisting of unnatural and/or D-amino acids because they are not 
represented within its databases.  
The CD of aromatic amino acids in the near UV spectral region (250 nm – 320 nm) can be utilised 
as a fingerprint for tertiary structure [6]. Changes in the tertiary structure often cause changes in 
the local environment of these aromatics which in turn leads to changes in their CD spectra [31]. 
It should be noted that near UV CD has the potential to detect major changes in the tertiary 
structure of peptides even though there may be no apparent change in the secondary structure 
[31,32]. This is because the tertiary structure is influenced by the orientation of side chains 
whereas the backbone orientation determines the secondary structure.  
Although it seems as if the backbone conformations of the four cyclodecapeptides are quite stable 
and rigid, as expected for cyclic peptides (refer to Figure 3.1), the self-assembly structures (i.e. 
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Figure 3.5: Changes in the ellipticity ratios (θ208/θ216) of the cyclodecapeptides induced by a 
membrane-mimicking environment.  
Ellipticity ratios of the peptides in an aqueous environment and membrane mimicking 
environment are depicted in blue and red respectively. Each ratio is a mean value calculated from 
three spectra with error bar depicting the standard error of the mean (SEM).  
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dimers and higher oligomers) formed by the oligomerisation of peptide monomers are dynamic 
and their formation relies on both backbone interactions and interactions between the amino acid 
side chains. It has been shown through ESMS that the cyclodecapeptides have a high propensity 
to form dimers in aqueous solution, with the dimers being more dominant in the more hydrophobic 
analogues (YA and YB) than the polar analogues (YC and WC) [9,10]. It has been proposed that 
these dimers may be the active structures responsible for the antimicrobial activity of the 
cyclodecapeptides [10,11]. X-ray crystallography studies and NMR studies showed that the 
dimers are stabilised by hydrogen bonds and hydrophobic interactions between their monomeric 
units [10,11]. Moreover, aromatic residues play a key role in stabilising the dimer structures as 
they are involved in both intramolecular (residue 3) and intermolecular hydrogen bonding 
(residues 1 and 7) [10,11]. As such, near UV CD spectroscopy can be employed to monitor the 
character of aromatic amino acids in self-assembly structures such as dimers and higher order 
oligomers in different environments (Figure 3.5).  
For YA, the shift to a membrane mimicking environment resulted in a loss of resolution of the 
near UV peaks observed in the aqueous environment. Moreover, the shape of the spectrum in the 
260-290 nm was inverted indicating reorientation of the Tyr side-chain which could potentially 
indicate changes in the Tyr-dependent self-assembly structures of YA.  
The spectra of YB were comparable in both solvent environments except for a slight blue shift 
and reduced intensity of the ellipticity between 250-260 nm in the TFE environment. This 
difference alludes to an altered orientation of the Phe residues. The similar near UV spectra in 
both solvent environments implies that the environment has little influence on the self-assembly 
structures of YB whose formation involves the participation of aromatic amino acid residues. 
The near UV CD spectra for YC and WC showed increased ellipticity in the wavelength region 
between 270-290 nm (Figure 3.6). As Trp and Tyr residues are known to produce peaks in this  
spectral region [6], the observed enhanced ellipticities could be attributed to altered orientations 
of these aromatic residues. In addition, for both peptides, the shape of the peak at about 260 nm 
was inverted and the ellipticity decreased which is suggestive of changes in the local environment 
of the Phe residues. Just like YA and YB, this could potentially indicate changes in the aromatic 
residue-dependent self-assembly structures of YC and WC.  
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Figure 3.6: Near UV CD spectra of the cyclodecapeptide analogues [100 µM] in an aqueous 
environment (water) and membrane mimicking environment (50% TFE).  
A) Tyrocidine A (YA) with Phe3, Phe4 and Tyr7, B) Tyrocidine B (YB) with Phe3, Trp4 and 
Tyr7, C) Tyrocidine C (YC) with Trp3, Trp4 and Tyr7, D) Tryptocidine C (WC) with Trp3, 
Trp4, and Trp7. Blue curves represent CD spectra of peptides in water while red curves 
represent CD spectra of peptides in 50% TFE. Each CD spectra is an average of triplicate 
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RW-hexapeptides 
As with the tyrothricin-derived cyclodecapeptides, the CD spectra of the RW-hexapeptides are 
also anomalous. None show any clear conformity to the spectra that characterise regular structural 
elements such as β-sheets and α-helices. Like the cyclodecapeptides, the RW-hexapeptides are 
rich in aromatic side chains which can interfere with the amide CD of the peptide backbone thereby 
distorting the shape of the CD spectra. Moreover, according to the molecular modelling that was 
done for these hexapeptides, their structures consist of γ-turns. These γ-turns possibly contribute 
to the unusual appearance of the CD spectra of these peptides since there currently is no reference 
spectra for the characterisation of γ-turns.   
The far UV CD spectra of the cyclic analogues in aqueous environment show minima at 203±1nm 
which is characteristic of β-turns (Figure 3.7). This result is consistent with previous observations 
[13,14,33] and can be correlated to the β-turns depicted in the molecular models discussed above. 
A second minimum was observed at approximately 214 nm for cWRW (Figure 3.7D), as well as 
for the Phe- and Lys-containing analogues (Figure 3.7 A, B and C). The minimum was observed 
at 225 nm and 221 nm for cWWW and cWYW respectively (Figure 3.7E and F). This second 
minimum can be attributed to β-sheet structures in the peptide backbone. The combination of the 
two minima denotes a β-turn/ β-sheet motif [4,28,29]. The second minimum can also be attributed 
to the contributions from the aromatic residues. This is because the CD within the 210-240 nm 
region can be influenced by the contribution of aromatic residues, especially Tyr and Trp, which 
are known to have profound absorption in this region [25]. Therefore, contributions from Tyr and 
Trp residues in the middle position of the aromatic tripeptide moieties of cWYW and cWWW 
respectively would account for the red shift, as well as the increased negative ellipticity observed 
at this second minimum relative to the other analogues. The analogues with Phe in this position 
have a reduced negative ellipticity because the absorption of Phe is not as strong as that of the 
other two aromatic amino acids. The intensity of this second minimum is also reduced on the 
cWRW spectrum because the residue in the fifth position is Arg. In 50% TFE, the negative 
ellipticity of both minima were enhanced. This indicates increased backbone constraints leading 
to stabilisation of the turn structures and β-sheet structures which is consistent with the reported 
stabilising effect of TFE-containing solutions on β-hairpin and β-turn structures [28,34]. For the 
second minimum, the enhanced ellipticity as well as the subtle red/ blue shifts could also point to 
changes in the orientation of the aromatic side chains. 
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The spectra of the Phe-containing hexapeptides appeared sufficiently similar in both water and 
50% TFE alluding to a conserved structure amongst these analogues. The spectra of cWYW were 
also quite comparable to the spectra of the Phe-containing analogues. The only difference was the 
enhanced ellipticity of the second minimum which could be attributed to the contribution of its 
Tyr residue. This also shows how structurally similar cWYW is to the Phe-containing analogues. 
The molecular models also depict a conserved structure between cWFW and cWYW thereby 
corroborating the findings from CD. 
The general shape of the CD spectra of cWWW appears considerably different from that of the 
Tyr and Phe-containing analogues. This difference in shape suggests a different backbone 
configuration for the cWWW analogue. However, based on the model structures which depict a 
conserved backbone structure for cWWW, cWFW and cWYW, it is expected that the CD spectra 
of cWWW would resemble that of the other two analogues. Interestingly, the CD spectra of the 
analysed cWWW preparation appear to resemble those of the linear analogue, AcWWW 
(discussed below). From this, it can be concluded that the cyclisation process during peptide 
synthesis may not have been successful and as such some of the peptide in the preparation might 
still be in its linear form. Additionally, the ellipticity of the cWWW preparation was observed to 
be substantially weaker than the ellipticities of the other cyclic analogues (Figure 3.7E). The 
reason for this could be the purity of this cWWW preparation (referred to as cWWW3 in Chapter 
2).   
From the ESMS analysis (Chapter 2), it was established that the peptide preparation showed a 
signal 20-fold below the signals of the other peptides. As we were unable to obtain a UPLC-MS 
analysis, it could mean that the preparation contained only about 5% peptide, which is well below 
acceptable standard of purity (must be ≥ 90% peptide composition as determined by UPLC-MS). 
It, therefore, means that the concentration of the correct peptide was considerably less than what 
was calculated which resulted in the weak MS and CD signals. This is unfortunate, as the initial 
cWWW peptide batch (referred to as cWWW1 in Chapter 2) from Dr Margitta Dathe showed a 
high purity, but we had a limited amount of this peptide and it was used as one of our model 
peptides in Chapter 4. It is unclear which components are contributing to the mass that was 
weighed out for this cWWW3 peptide preparation, but it is quite possible that the supplier’s 
synthesis procedure led to a modified peptide product with the same molecular mass as cWWW, 
with some residual linear peptide.  
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Figure 3.7: Far UV CD spectra of the cyclic RW-hexapeptide analogues at [100 µM] in an 
aqueous environment (water) and membrane mimicking environment (50% TFE).  
A) cKRK, B) cRKK, C) cWFW, D) cWRW, E) cWWW and F) cWYW. Blue lines represent 
CD spectra of peptides in water while red lines represent CD spectra of peptides in 50% TFE. 
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cWRW was the only cyclic analogue whose spectra showed a pronounced positive maximum band 
at 230 nm in water and 228 nm in 50% TFE (Figure 3.7F). This maximum can also be attributed 
to contribution of Trp residues [32] due to the observed blue shift in the membrane mimicking 
environment. The exclusivity of this maximum to the spectra of cWRW highlights how 
structurally different this peptide is from the other analogues, which correlates well the structures 
of the molecular models discussed above.  
The CD spectra of the linear analogues were significantly different from those of the cyclic 
analogues (Figure 3.8). For the Phe-containing analogues (Figure 3.8A-C) and the Tyr-containing 
analogues (Figure 3.8F), the CD spectra in water had three visible bands; one negative minimum 
at 196±1 nm, a shoulder with negative ellipticity at 213 ± 1 nm and a positive maximum at 228±1 
nm. The combination of a negative minimum at 196±1 nm and a positive maximum at 228±1 nm 
is typical of irregular/undefined structural elements [14]. The positive maximum as well as the 
shoulder at 213±1 nm could also represent the contributions from aromatic residues. The shoulder 
at 213±1 nm cannot possibly be attributed to β-sheet structural elements because the analysis of 
secondary structure of the molecular models did not yield any β-sheet elements. Moreover, 
previous research has shown that structures of linear RW-hexapeptides in solution are undefined 
[13,14]. In a hydrophobic environment, the shapes of the CD spectra changed drastically and 
appeared to resemble the CD spectra of the cyclic analogues. The intensity of the negative minima 
at 196±1 nm was reduced and red shifted to approximately 200 nm, the shoulders at 213±1 nm 
were converted to defined minima and red shifted to 217 nm and the positive maxima at 228±1 
nm disappeared. These changes indicate changes in the peptide backbone structure and possible 
changes in the orientation of aromatic side chains [13,14]. Thus, it can be deduced that 
hydrophobic nature of 50% TFE induced a disordered to more ordered conformational transition 
in the linear RW-hexapeptides. Interestingly, the spectra of AcWWW were found to be quite 
comparable to that of its cyclic analogue, with minor variations (Compare Figure 3.8E with Figure 
3.7E). In water, the CD spectrum of AcWWW exhibited two minima at 197 nm and 225 nm while 
in 50% TFE the first minimum was red shifted to 200 nm and the second was blue shifted to 223 
nm. In comparison with the CD spectra of cWWW, which highlighted its minima at 202 nm and 
225 nm in water and at 201 nm and 221 nm in 50% TFE, an apparent similarity is evident. This 
further corroborates the earlier assumption that the cWWW from the second batch was, in fact, 
not a cyclic peptide. 
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Figure 3.8: Far UV CD spectra of the linear RW-hexapeptide analogues at [100 µM] in an 
aqueous environment (water) and membrane mimicking environment (50% TFE).  
A) AcKRK, B) AcRKK, C) AcWFW, D) AcWRW, E) AcWWW and F) AcWYW. Blue curves 
represent CD spectra of peptides in water while red curves represent CD spectra of peptides in 
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For AcWRW, the shape of the spectra is virtually the same as that of the cyclic analogue (compare 
Figure 3.8D with Figure 3.7D). Based on this and the molecular models, it is plausible to conclude 
that the structures of the linear and cyclic analogues of WRW are undefined in both aqueous and 
membrane mimicking environments.  
The CD spectra were analysed using CDPro software package to estimate the composition of 
various secondary structure fractions. The analysis did not yield any clear correlation with the 
analysis of secondary structure of the molecular models, except that both did not identify helical 
structures. The reason for this could be that the databases used by this software do not include 
structures for cyclic peptides and oligopeptides with a high content of aromatic residues thus, the 
software fails to accurately interpret the spectra data of such peptides. Moreover, proteins and 
peptides with secondary structures such as γ-turns are not well represented in the software’s 
databases. This means that the software is unable to recognise these structural elements and may 
interpret them as undefined structures. On the other hand, the molecular models were constructed 
from basic principles using the YASARA 2 algorithm that has also been built from a protein 
database. The molecular models only considered intramolecular bonds, even though 
intermolecular bonds could also take place in solution leading to hydrogen-bonded networks and 
sheet structures. Because of these shortcomings, the absolute contribution of the secondary 
structures predicted by the CDPro and YASARA software packages must be considered with 
caution. The results from these calculations and prediction of secondary structures are given in 
Table 3.3. 
Table 3.3: Analysis of secondary structure of RW-hexapeptides (H – α-helix, S – β-sheet, T – turns, U 
– undefined/irregular structures. The calculated/predicted content of these secondary structural elements is expressed 
in percentages.)  
Peptide 
Identity 
Secondary structural elements 
        CD (Water)      CD (50% TFE)    YA SARA 
Structure H S T U H S T U H   S T U 
Ac-KRK 0.1 61.7 2.2 36.1 0 27.1 7.6 65.4 n.d 
cKRK 0 61.5 16.9 21.6 0 56.1 33.8 10 n.d 
Ac-RKK 0.1 74.1 2.7 23.1 0 28.2 7.6 64.1 n.d 
cRKK 0.1 42.2 13.4 44.3 0 41.4 58.5 0 n.d 
Ac-WFW 0 42.4 3.7 53.8 0 27.6 16.9 55.5 0 0 0 100 
cWFW 0 20.5 26 53.5 0 4.7 27 68.2 0 66.7 33.3 0 
Ac-WRW 0.1 96.6 3.3 0 0 84.5 0.9 14.6 0 0 0 100 
cWRW 0.1 85.3 1 13.6 0 83.9 12.9 3.3 0 0 0 100 
Ac-WWW 0 9.1 3.8 87.1 0.1 14.1 7.6 78.1 0 0 0 100 
cWWW 0 27.0 7.2 65.8 0 11.6 15.9 72.4   0 66.7 33.3 0 
Ac-WYW 0 47.4 0 52.6 0.1 13.7 17.6 68.5 0 0 0 100 
cWYW 0 32.5 3.9 63.6 0.2 32.5 19.5 47.9 0 66.7 33.3 0 
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If we assume that the undefined structures are actually γ-turns or new hydrogen bonded networks 
in TFE, then the increase in these structures, as calculated by CDPro, for most of the peptides is 
explained. YASARA predicted sheet and turn structures for the cyclic peptides cWYW, cWWW 
and cWFW. This correlated with the CDPro analysis if we only consider the results of cWYW and 
cWFW (as cWWW is impure), which indicated -sheets and -turn structures in water and/or TFE 
correlating with the model prediction. YASARA failed to predict the -sheets in the linear peptides 
and cWRW, which could indicate that these structures are intermolecular structures in solution, as 
calculated with CDPro from the CD spectra. 
Characterisation of the Trp environment using fluorescence spectroscopy 
Natural cyclodecapeptides 
In addition to CD spectroscopy, fluorescence spectroscopy was employed to gain more insight 
into the structural characteristics of the cyclodecapeptides in environments with different 
polarities. Trp fluorescence was used due to the sensitivity of the indole ring to changes in its local 
environment [15]. Trp experiences a fluorescence emission maximum at approximately 350 nm 
in water, but this maximum is blue shifted when exposed to a more hydrophobic environment 
[15,16]. Therefore, changes in the spectral properties of tryptophan can be used to report its 
location within a peptide. In turn, changes in the location of Trp residues are indicative of 
conformational changes within the peptide (or protein) [15].  
A decrease in the total fluorescence intensity (quenching) was noted for all cyclodecapeptides 
when transferred from water to the TFE membrane mimicking environment relative to the aqueous 
environment (Figures 3.9 and 3.10). Fluorescence quenching occurs through a host of molecular 
interactions which include collisional quenching, energy transfer, ground state complex formation 
and excited state reactions [15]. The occurrence of fluorescence quenching concomitantly with a 
blue shift is usually associated with stacking of aromatic rings [15]. Aromatic stacking could have 
been facilitated by the enhanced β-turns and -sheet structures in the TFE environment which 
might have caused aromatic residues to be close enough to allow stacking. Furthermore, the Trp 
residues could possibly be in the proximity of other chemical groups that can possibly quench 
their fluorescence via excited state reactions [17,35]. However, caution ought to be applied when 
interpreting data relating to the quenching of Trp fluorescence in TFE containing solvents as TFE 
has been shown to quench indole fluorescence by excited state proton transfer reactions [34]. 
Therefore, the observed fluorescence quenching might not necessarily be due to changes in peptide 
conformation but rather the quenching effect of TFE.  
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The three Trp-containing cyclodecapeptides showed very similar fluorescence maxima in water 
(Table 3.4 & Figure 3.10). All of them displayed emission maxima at 340 nm. The fact that the 
emission maxima of these Trp residues are blue shifted from the expected 350-353 nm when in 
water shows that the Trp residues are not completely exposed to water but are partially in a 
hydrophobic environment [16]. In 50% TFE, the maxima were blue shifted to 334 nm for YB and 
YC, and to 338 nm for WC. The blue shifts indicated that local environment of the Trp residues 
changed to a more hydrophobic one implying a change in their orientation. YA does not contain 
any Trp residues, therefore the fluorescence observed after excitation at 280 nm was due to its 
single Tyr residue. The fluorescence emission maximum of Tyr residues exposed to water is 
usually observed at 303 nm [15]. In this instance, the maximum was blue shifted to below 300 nm 
indicating that in the native conformation of the peptide, the Tyr is only partially exposed to the 
aqueous environment (Figure 3.9A). Because the fluorescence emission maximum fell outside the 
spectral range, the effect of the membrane mimicking environment on the emission could not be 
determined. 
Table 3.4: Effect of changing the local environment of Trp residues on the fluorescence emission 
of the cyclodecapeptides 
Peptide 𝝀em max (nm) 𝚫 𝝀em max (nm) 
 In water In 50% TFE 
YA <300 <300 0 
YB 340 334 6 
YC 340 334 6 
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Figure 3.8: Total fluorescence yields of the cyclodecapeptide analogues with excitation at 280 nm 
Fluorescence yields were obtained from emission spectra by calculating area under the curve. Blue 
bars are representative of the fluorescence yield produced by peptides in an aqueous environment 
(water) while red bars are representative of the fluorescence yield produced by peptides in a 
membrane-mimicking environment (50% TFE). 
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The observed changes in the fluorescence emission properties of the Trp side chains of YC and 
WC correlate well with the observed changes in their near UV CD spectra (refer to Figure 3.6). 
The CD spectra of both peptides in TFE highlighted enhanced ellipticities in the 280-290 nm 
region indicating changes in the orientation of the Trp residues which were substantiated by the 
observed blue shifts and reduced fluorescence yields in TFE. On the other hand, while similar 
changes were observed in the fluorescence emission properties of the Trp residues of YB, the near 
UV CD spectra of the peptide in the two solvent environments do not depict any appreciable 
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Figure 3.10: Fluorescence emission spectra of cyclodecapeptides for excitation at 280 nm  
A) Tyrocidine A (YA) with Phe3, Phe4 and Tyr7, B) Tyrocidine B (YB) with Phe3, Trp4 and 
Tyr7, C) Tyrocidine C (YC) with Trp3, Trp4 and Tyr7, D) Tryptocidine C (WC) with Trp3, Trp4, 
and Trp7. Blue lines represent emission spectra of peptides in water while red lines represent 
emission spectra of peptides in 50% TFE.  Fluorescence intensity is indicated in relative 
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RW-hexapeptides 
In general, all peptides displayed maximum fluorescence emission between 348-346 nm and 346-
342 nm regions in water and 50% TFE respectively (Figure 3.11, Table 3.5). The blue shift denotes 
a change in the environment within which Trp residues reside. This correlates well with data from 
CD analyses which show enhanced ellipticity of the minima localised in the 210-230 nm region 
when the peptides are in 50% TFE. Both observations allude to changes in the orientation of 
aromatic side chains and ultimately altered peptide conformations.  





𝝀em max (nm) 
𝚫 𝝀em max 
(nm) 
Linear 
𝝀em max (nm) 
𝚫 𝝀em max 
(nm) 
In water In 50% 
TFE 
In water In 50% 
TFE 
KRKWFW 346 342 4 348 342 6 
RKKWFW 348 344 4 348 342 6 
RRRWFW 346 342 4 348 344 4 
RWRWRW 346 342 4 346 342 4 
RRRWWW 348 342 6 348 346 2 
RRRWYW 346 342 4 348 346 2 
 
The fluorescence intensities and total fluorescence yields of the linear analogues in an aqueous 
environment versus a membrane mimicking environment were generally comparable except for 
AcWRW whose fluorescence intensity and yield were enhanced by the membrane mimicking 
environment (Figures 3.11 & 3.12B). On the other hand, the 50% TFE led to quenching of the 
fluorescence intensities and decreased the total fluorescence yields of most of the cyclic analogues 
(Figures 3.11& 3.11B). The molecular models of the cyclic analogues showed that the aromatic 
residues are clustered together in an amphipathic configuration (Refer to Figure 3.6). This 
proximity of aromatic residues may be responsible for the quenching effect, possibly as a 
consequence of aromatic ring stacking. 
The fluorescence intensity and the total fluorescence yield of the cWWW analogue was 
appreciably reduced in comparison to the rest of the RW-hexapeptides. This confirms that the 
concentration of the Trp fluorophore was very low in solution which is attributable to the low 
purity of the peptide preparation.  
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Figure 3.10: Fluorescence emission spectra of the RW-hexapeptides for excitation at 280 nm  
A)-F) are fluorescence emission spectra of the cyclic and linear analogues of the same peptide. 
A) KRKWFW, B) RKKWFW, C) RRRWFW, D) RWRWRW, E) RRRWWW and F) 
RRRWYW. Blue lines represent emission spectra of peptides in water while red lines represent 
emission spectra of peptides in 50% TFE. Fluorescence intensity is indicated in relative 
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Figure 3.11: Total fluorescence yields of RW-hexapeptides for excitation at 280 nm  
A) Fluorescence yields of the cyclic analogues, B) Fluorescence yields of the linear analogues. 
Fluorescence yields were obtained from emission spectra by calculating area under the curve. 
Blue bars are representative of the fluorescence yield produced by peptides in an aqueous 
environment (water) while red bars are representative of the fluorescence yield produced by 
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The fluorescence yields of the cyclic analogues, with the exception of the impure cWWW 
(cWWW3 preparation, refer to chapter 2), were generally higher than those of the linear analogues 
in the aqueous environment. This observation could be attributed to the more pronounced 
amphipathic configuration of the cyclic analogues brought about by the clustering of their aromatic 
residues. By clustering together, the exposure of the aromatic residues to water molecules is 
reduced hence the enhanced fluorescence yields. In TFE, however, it is not clear which group of 
analogues had the greatest fluorescence yields. The reason for this could be the adoption of similar 
structural conformations by analogues from both groups as indicated by CD spectroscopy.   
3.5 Conclusion 
Characterisation of the secondary structure of cyclo-decapeptides by CD spectroscopy confirmed 
their β-sheet structure even though their CD spectra are anomalous. The spectra exhibited two 
negative minima at 208±2 nm and 216±2 nm corresponding to β-turn and β-sheet structural 
elements. It is believed that the distorted β-sheet spectra are a result of the combined contribution 
of the aromatic sidechains, β-turns, D-amino acid residues and the aggregation of peptides in 
solution, all of which interfere with the CD of the peptide backbone. It was shown that in a 
hydrophobic environment as represented by 50% TFE, the β-turn elements of the cyclo-
decapeptides are stabilised. Furthermore, the increased ellipticity ratio θ208/θ216 indicates increased 
proportions of β-turn structures relative to β-sheet structures. The near UV CD spectra of the 
cyclo-decapeptides clearly depicted the changes in the orientation of the aromatic residues induced 
by changes in the environment. Changes in the orientation of aromatic side chains are indicative 
of changes in tertiary structure [15], and in the case of the cyclodecapeptides this could point to 
increased self-assembly into oligomers placing the aromatic residues in a different environment. 
For the Trp-containing cyclodecapeptides, further evidence of changes in the solution structure in 
a hydrophobic environment was obtained via fluorescence spectroscopy. Emission maxima were 
blue-shifted and quenching of fluorescence was observed in the membrane mimicking 
environment clearly indicating changes in the local environment of the Trp residues and hence an 
altered tertiary conformation.  
The structural differences between the cyclic and linear analogues of the RW-hexapeptides were 
highlighted. In aqueous solution, cyclic analogues were found to consist of sheet and turn elements 
whereas the linear analogues had an undefined structure. In TFE, the cyclic analogues maintained 
their structure indicating a stable backbone structure while the structure of the linear analogues 
changed and appeared to resemble that of the cyclic analogues. This shows that a membrane 
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mimicking environment induces a transition from irregular to ordered structures. The exceptions 
to this were both WRW analogues whose structures were undefined, possibly containing a number 
of -turns in both aqueous and membrane mimicking environments. This highlights the influence 
of the amino acid sequence on structure. The amino acid sequence of WRW analogues is 
characterised by alternating Arg and Trp residues whereas the amino acid sequences of the other 
analogues consist of two domains; the polar and hydrophobic domains. TFE also induced changes 
in the orientation of aromatic side chains. This was highlighted by the changes in the intensity of 
the ellipticity in the 210-230 nm region on the CD spectra. Furthermore, fluorescence spectroscopy 
also showed that the emission maxima of the RW-hexapeptides were blue shifted in 50% TFE 
indicating an altered orientation of Trp side-chains. Differences in structure between the linear 
and cyclic analogues were also highlighted by the fact that the fluorescence emission of the cyclic 
analogues was quenched in the TFE environment whereas the emission of the linear analogues 
was not affected.  
The structural properties of the cyclodecapeptides and RW-hexapeptides will be correlated to their 
biological activity in Chapter 4. 
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Chapter 4 
Characterisation of biological activity and mode of action of 
natural cyclodecapeptides and synthetic RW-hexapeptides 
4.1 Introduction 
The recent years have seen an unprecedented rise in the population of immunocompromised 
individuals [1]. Concomitantly, there has been a surge in the incidence of fungal infections. Of 
great  concern are the invasive fungal infections due to their extremely high mortality rates [2]. 
An example of such infections is invasive aspergillosis which is caused by the human fungal 
pathogen, A. fumigatus. Invasive aspergillosis poses the greatest challenge in cancer and transplant 
patients. More than 50% of individuals that are diagnosed with this infection succumb to it, even 
when they receive treatment. However, in the absence of treatment, the case fatalities can be 100% 
[2,3]. The fact that the mortality rates are still very high despite treatment highlights the limitations 
of the existing antifungal therapeutic arsenal. Because of this, novel therapeutic options with 
alternative mechanisms of action are urgently required for the effective management of invasive 
fungal infections. 
Antimicrobial peptides (AMPs) can potentially be the armament required in the fight against 
invasive fungal infections. AMPs are rendered attractive for therapeutic development by their high 
antimicrobial potency, rapid killing kinetics, which involve the utilisation of multiple modes of 
action and limited potential for the development of resistance [4,5]. Furthermore,  AMPs can 
possibly improve the activity of conventional therapeutics thus making them attractive for use in 
combination therapy [6]. A plethora of natural and synthetic AMPs with antifungal activity have 
been discovered, but the focus of this investigation are the tyrocidines and analogues (natural 
cyclodecapeptides) and the synthetic RW-hexapeptides.   
The tyrocidines and analogues are a group of structurally related cyclodecapeptides that were 
discovered as part of the tyrothricin complex that was  isolated from cultures of a soil bacterium, 
Bacillus brevis [7], later reclassified as Brevibacillus parabrevis [8]. Since their discovery over 
seven decades ago, these cyclodecapeptides have illustrated broad spectrum antimicrobial activity 
[7,9–14].  Nonetheless, there is very little literature on the antifungal activity of the natural 
cyclodecapeptides. Most of the work on the characterisation of their antifungal activity has been 
done by our group [12–14].   
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The synthetic RW-hexapeptides are a relatively new group of AMPs that are derivatives of a linear 
hexapeptide (Ac-RRWWRF-NH2) that was identified in the screening of a synthetic combinatorial 
library [15]. Their amino acid sequences closely resemble a motif that is recurrent in some natural 
AMPs such as lactoferricin, indolicidin and tritrypticin and to which their antimicrobial activity 
has been attributed. The RW-hexapeptides have exhibited tremendous antibacterial activity 
against Gram-positive and Gram-negative bacteria [11,16–18]. A few of the linear RW-
hexapeptide analogues were found to have antifungal activity [19–21], but the antifungal activity 
of the cyclic RW-hexapeptides remains uncharacterised.  
The need for the development of new antifungal agents coupled with the largely unexplored 
antifungal potential of the cyclodecapeptides and the RW-hexapeptides was the motivation for 
this investigation. In this chapter, the characterisation of the biological activity of the 
aforementioned peptides, as well as a partial characterisation of their mode of action are presented.  
4.2 Materials 
Peptides utilised in this study were purified and characterised as described in Chapter 2. These 
included two tyrocidine analogues (YA, YB) and tryptocidine C (WC), as well as the twelve 
synthetic RW-hexapeptides. Five of the six cyclic RW-hexapeptide preparations were donated by 
Dr Margitta Dathe (Leipzig Institute, Germany), while cWYW and the six linear peptide 
preparations were from GL-Biochem (Shanghai, China). Gramicidin S (GS) was purchased from 
Sigma Aldrich (Steinheim, Germany). Aspergillus fumigatus ATCC 204305 was obtained from 
the American Type culture Collection (ATCC) (Manassas, VA, USA). Sterile water was prepared 
by reverse osmosis followed by filtration through a Millipore MilliQ® water purification system 
(Milford, USA). Potato dextrose broth (PDB), agar, and Tween-20 were supplied by Fluka (Buchs, 
Switzerland). Polypropylene 96-well microtiter black plates were purchased form Nunc (Roskilde, 
Denmark) while polystyrene 96-well microtiter clear plates were obtained from Corning 
Incorporated (Corning, USA). Sterile petri dishes were obtained from Lasec (South Africa) and 
Falcon tubes were supplied by Becton Dickson Labware (Lincoln Park, USA). Sigma Aldrich (St 
Louis, USA) supplied gentamycin, RPMI 1640 medium, resazurin sodium salt and 2′,7′-
dichlorofluorescein diacetate (H2DCFDA). SYTOX Green was from Lonza (Walkersville, USA) 
while ascorbic acid was obtained from Roth (Karlsruhe, Germany). Components of phosphate 
buffered saline (KH2PO4, Na2HPO4, NaCl and KCl) as well as ethanol (>99.8%) were supplied by 
Merck (Darmstadt, Germany). A+ packed erythrocytes from anonymous donors (containing 300 
mL erythrocytes, 100 mL saline-adenine-glucose-mannitol red blood cell preservation solution 
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and 63.0 mL citrate phosphate dextrose anticoagulant) were obtained from the Western Cape 
Blood Services in South Africa. 
4.3 Methods 
Peptide preparation 
Dry, analytically weighed aliquots of peptides were used to make up peptide solutions. Preparation 
of 4.00 mM stock solutions of the natural cyclodecapeptides was done by dissolving dry peptide 
aliquots in 60% (v/v) EtOH in water.  This was followed by a 4× dilution step to achieve a final 
peptide concentration of 1.00 mM in 15% (v/v) EtOH in water.  Stock solutions (1.00 mM) of the 
synthetic peptides were prepared by dissolving dry aliquots of peptide into water.  Gramicidin S 
was prepared either like the cyclodecapeptides or the hexapeptides. All peptide preparations were 
done in pyrolyzed glassware to limit contamination with detergents and pyrogens. All the prepared 
peptide solutions (1.00 mM) were subjected to serial doubling dilution steps in 96-well microtiter 
plates so that the peptide concentration ranged between 1.00 mM – 0.0078 mM. Dilutions were 
carried using the same solvent in which the peptides had been dissolved.  
For the studies that were performed using peptide combinations, 1.00 mM stock solutions of 
tryptocidine C (WC) and each of the selected RW-hexapeptides (cWWW, cWRW, AcWWW and 
AcWRW) were mixed together in a 1:1 ratio so that the concentration of each peptide in the 
mixture was 0.5 mM.  Serial doubling dilutions of these peptide combinations were then prepared 
so that the final peptide concentration range in the dilution plate was 0.5 mM – 0.0039 mM.  
Culturing of fungi and spore harvesting 
Aspergillus fumigatus was cultured from dormant spores. Cultures were grown at 25 °C on potato 
dextrose agar (PDA) plates containing gentamycin for 10 days until sporulation. Spores were 
harvested using 5 ml of sterile Tween-20 water (0.1%, v/v). They were left to hydrate overnight at 
4 °C prior to counting using a haemocytometer. A spore concentration of 2.0 × 104 spores/mL was 
used in all the assays. 
Microdilution broth assays to investigate inhibition of the germination and growth of A. 
fumigatus spores  
Spore suspensions containing 2.0 × 104 spores/mL were prepared in half-strength potato dextrose 
broth (50% PDB in water; v/v) solutions. Subsequently, 90 µL of spore suspensions were pipetted 
into the wells of microtiter plates followed by the addition of 10 µL of peptide solutions. The 
growth control wells contained spore suspensions but received no peptide. Instead, they received 
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10 µL of 15% EtOH or sterile water for the assays involving cyclodecapeptides and hexapeptides 
respectively. To control for sterility, 10 µL of either 15% EtOH or sterile water were added to 90 
µL of spore free 50% PDB. These wells represented the background. Microtiter plates were then 
covered with aluminium foil and incubated at 25 °C for 48 hours after which light dispersion was 
spectrophotometrically determined at 595 nm using a Spark™ 10M multimode microplate reader. 
Growth inhibition was determined according to the following equation: 
% 𝑔𝑟𝑜𝑤𝑡ℎ 𝑖𝑛ℎ𝑖𝑏𝑖𝑡𝑖𝑜𝑛 = 100 −
100×(𝐴595 𝑜𝑓 𝑤𝑒𝑙𝑙−𝑚𝑒𝑎𝑛 𝐴595 𝑜𝑓 𝑏𝑎𝑐𝑘𝑔𝑟𝑜𝑢𝑛𝑑)
(𝑚𝑒𝑎𝑛 𝐴595 𝑜𝑓 𝑔𝑟𝑜𝑤𝑡ℎ 𝑤𝑒𝑙𝑙𝑠−𝑚𝑒𝑎𝑛 𝐴595 𝑜𝑓 𝑏𝑎𝑐𝑘𝑔𝑟𝑜𝑢𝑛𝑑)
  
Microdilution broth assays to determine metabolic inhibition of A. fumigatus hyphae 
The activity of selected peptides (wC, cWWW, cWRW, AcWRW and AcWWW) against A. 
fumigatus hyphae was determined by measuring the effect of peptide treatment on fungal 
metabolic activity. This was achieved by using resazurin as a metabolic indicator. Spores of A. 
fumigatus (2.0 × 104 spores/mL) were incubated in 96-well black microtiter plates containing 50% 
PDB solution (90 µL/well) at 25 °C for 30 h to get hyphae growing. To control for sterility, four 
wells on the microtiter plate received 50% PDB media without spores. Hyphae were then treated 
for two hours with either 10 µL of peptide solutions in 15% EtOH or 10 µL of 15% EtOH. 
Gramicidin S was the activity control for metabolic inhibition. Subsequently, hyphae were washed 
three times with phosphate-buffered saline (PBS). This was followed by the addition of resazurin 
solution (10 µL of 1.0 mg resazurin sodium salt in 1.00 mL water) to 90 µL of PBS- hyphae 
suspension. Following a 3-hour incubation at 37 °C in the dark, fluorescence readings were taken 
using the Spark™ 10M multimode microplate reader with excitation and emission wavelengths 
set at 540 nm and 590 nm respectively. Inhibition of metabolic activity was calculated as follows: 
% 𝑚𝑒𝑡𝑎𝑏𝑜𝑙𝑖𝑐 𝑖𝑛ℎ𝑖𝑏𝑖𝑡𝑖𝑜𝑛 = 100 −
100×(𝐸𝑚590 𝑜𝑓 𝑤𝑒𝑙𝑙−𝑚𝑒𝑎𝑛 𝐸𝑚590 𝑜𝑓 𝑏𝑎𝑐𝑘𝑔𝑟𝑜𝑢𝑛𝑑)
(𝑚𝑒𝑎𝑛 𝐸𝑚590 𝑜𝑓 𝑚𝑒𝑡𝑎𝑏𝑜𝑙𝑖𝑐𝑎𝑙𝑙𝑦 𝑎𝑐𝑡𝑖𝑣𝑒−𝑚𝑒𝑎𝑛 𝐸𝑚590 𝑜𝑓 𝑏𝑎𝑐𝑘𝑔𝑟𝑜𝑢𝑛𝑑)
  
with the background being represented by the wells that contained no hyphae and the 
metabolically active wells represented by wells that contained hyphae but received no peptide 
treatment. 
Haemolysis assay 
Preparation of human erythrocytes was done according to a previously described methodology 
[22]. Briefly, with strict adherence to ethical regulations, A+ packed erythrocytes were obtained 
from the Western Cape Blood Services in South Africa. The erythrocytes were washed twice with 
RPMI media and the remaining cells were resuspended in the RPMI media. Prior to the assay, the 
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erythrocyte suspension was briefly centrifuged at 1200×g for 3 minutes. Subsequently, a 2% 
haematocrit suspension was prepared by adding erythrocytes to PBS solution in a falcon tube. Into 
the wells of 96-well microtiter plates was pipetted 90 µL of the haematocrit suspension followed 
by 10 µL of peptide solutions. Preparation of peptide solutions was exactly as for the antifungal 
assays. The controls for haemolysis activity were gramicidin S (100% haemolysis) and sterile 
water (0% haemolysis). The erythrocyte-containing microtiter plates were incubated at 37 °C for 
2 hours after which they were centrifuged at 900×g for 10 minutes. From them, 10 µL of 
supernatant was extracted and added to 90 uL of fresh PBS in microtiter plates. Subsequently, 
optical absorbance at 415 nm was spectrophotometrically determined using a Spark™ 10M 
multimode microplate reader. Haemolytic activity was determined as follows: 
% ℎ𝑎𝑒𝑚𝑜𝑙𝑦𝑠𝑖𝑠 = 100 ×
(𝐴415 𝑜𝑓 𝑤𝑒𝑙𝑙 − 𝑚𝑒𝑎𝑛 𝐴415 𝑜𝑓 𝑏𝑎𝑐𝑘𝑔𝑟𝑜𝑢𝑛𝑑)
(𝑚𝑒𝑎𝑛 𝐴415 𝑜𝑓 𝑐𝑜𝑚𝑝𝑙𝑒𝑡𝑒 𝑙𝑦𝑠𝑖𝑠 − 𝑚𝑒𝑎𝑛 𝐴415 𝑜𝑓 𝑏𝑎𝑐𝑘𝑔𝑟𝑜𝑢𝑛𝑑)
 
Time course kinetic study to investigate membrane permeabilisation 
Spores of A. fumigatus in 5% PDB solution (2 × 104 spores/mL) were left to grow at 25 °C for 30 
hours. Hyphae were then treated with 10× stock solutions of peptide (0.25 mM) prepared as 
described above. Simultaneously, SYTOX Green dye was added to the hyphae at a final 
concentration of 0.5 µM. Measurement of fluorescence emission was immediately commenced 
using a Spark™ multimode microplate reader with 485 nm and 538 nm set as the excitation and 
emission wavelengths respectively. Fluorescence readings were taken over a 60-minute period 
with 2-minute intervals. Sterile water was used as the no lysis control while WC was the control 
for total lysis. 
Spectrofluorometric determination of ROS production 
Spores of A. fumigatus (2.0 × 104 spores/mL) were incubated for 30 hours at 25 °C in 96-well 
microtiter plates containing 90 µL of 50% PDB. Hyphae were then treated with 10 µL of 10× 
stock solutions of peptides resulting in final concentrations ranging from 100.0 µM to 0.78 µM. 
Hyphae that served as the negative controls for peptide treatment were treated with the same 
volume of 15% EtOH. Treated hyphae were incubated at 25 °C for 3 hours after which the hyphae 
were washed three times with phosphate-buffered saline (PBS). Ten microlitres of 2′,7′-
dichlorofluorescein diacetate (H2DCFDA) were then added to 90 µL of a PBS-hyphae suspension 
and incubated for a further 1 hour at 37 °C. Accumulation of reactive oxygen species (ROS) was 
determined by measuring fluorescence emission using the Spark™ 10M multimode microplate 
reader with excitation and emission wavelengths set at 485 nm and 540 nm respectively. To 
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determine whether the observed fluorescence was due to accumulation of ROS induced by 
peptides, hyphae were pre-treated with peptide in the presence of ascorbic acid (10 mM) before 
incubation with H2DCFDA.  
Data Analysis 
GraphPad Prism® 6.0 (GraphPad software, San Diego, USA) was used to plot data from dose 
response assays. Data from growth inhibition, metabolic inhibition and haemolysis assays were 
fitted onto sigmoidal curve using non-linear regression. The curves were defined by the equation: 
𝑌 =
𝑏𝑜𝑡𝑡𝑜𝑚 + (𝑡𝑜𝑝 − 𝑏𝑜𝑡𝑡𝑜𝑚)
1 + 10𝑙𝑜𝑔𝐼𝐶50×𝐴𝑐𝑡𝑖𝑣𝑖𝑡𝑦 𝑠𝑙𝑜𝑝𝑒
 
All curves had a slope set to <7. The midpoint between top and bottom plateaus represents the 
IC50 or HC50, which are activity parameters representing the concentrations necessary to cause 
50% growth and metabolic inhibition or 50% haemolysis.  
The IC50 values calculated from data of the dose response assays involving peptide combinations 
were used to calculate fractional inhibitory concentrations (FIC) and fractional inhibitory indices 
(FICI). FICI values are used to classify the type of interactions between the peptides in 
combination mixture as synergistic, antagonistic or additive. The interactions are indicated as 
follows: FICI ≤0.5 indicates absolute synergism, 1>FICI>0.5 indicates slight synergism, FICI =1 
indicates additive or no interactions, 1<FICI<4 indicates slight antagonism and FICI ≥4 indicates 
absolute antagonism [11,23]. The equations below represent how the FIC and FICI are calculated; 
𝐹𝐼𝐶 (𝐴) =




𝐼𝐶50 (𝐵 𝑖𝑛 𝐴 + 𝐵 𝑐𝑜𝑚𝑏𝑖𝑛𝑎𝑡𝑖𝑜𝑛)
𝐼𝐶50 𝑜𝑓 𝐵 𝑎𝑙𝑜𝑛𝑒
 
𝐹𝐼𝐶𝐼 = 𝐹𝐼𝐶 (𝐴) + 𝐹𝐼𝐶 (𝐵) 
Data from the membrane permeability kinetic assay was plotted onto a one phase association curve 
according to the equation:  
𝑌 = 𝑌𝑚𝑎𝑥 × (1 − 𝑒
(−𝐾.𝑋)) 
Statistical data analysis was also done using GraphPad Prism® 6.0. The analyses included 
standard error of the mean (SEM), one-way ANOVA and multiple t-tests.  
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4.4 Results and Discussion 
Part 1: Characterisation of biological activity 
 Growth inhibition of A. fumigatus spores 
The growth inhibitory activity of three cyclodecapeptides (YA, YB and WC) and twelve RW-
hexapeptides against A. fumigatus spores was characterised. Due to the low yield obtained from 
semi-preparative RP-HPLC, YC was depleted during structural characterisation (described in 
Chapter 3) hence its biological activity could not be assessed. Gramicidin S (GS), an analogous 
cyclodecapeptide with 50% sequence identity to the Trcs, was utilised as the positive control for 
antifungal activity in all experiments. Antifungal activity was determined by considering the two 
activity parameters, IC50 and ICmax which define the concentrations causing 50% and 100% growth 
inhibition respectively. ICmax is calculated from the dose response curve and represents a calculated 
MIC (minimum inhibitory concentration). 
Cyclodecapeptides 
All the cyclodecapeptides potently inhibited the growth of A. fumigatus spores (Table 4.1). Their 
growth inhibitory activity was characterised by IC50 and ICmax values in the low micromolar range 
(<10 µM). The potency of the cyclodecapeptides followed the trend YB>YA>WC. In a study 
conducted by Vosloo [24], a similar trend was observed, albeit slightly lower IC50 and ICmax values 
were reported for the growth inhibition of A. fumigatus spores. Antifungal activity of all 
cyclodecapeptides was comparable and there were no statistically significant differences in their 
IC50 values (P>0.05; refer to Table 4.6 in addendum for statistical analysis).  This can be attributed 
to the high similarity in amino acid sequence as well the conserved β-sheet structure among the 
cyclodecapeptide analogues [24–26]. Furthermore, antifungal activity seems to be modulated by 
amphipathicity. Comparison of the UPLC retention times (Chapter 2) of the three 
cyclodecapeptide analogues shows YB to be the intermediate analogue in terms of hydrophobicity 
and hydrophilicity suggesting a higher degree of amphipathicity.  
RW-hexapeptides 
For peptides designed to target bacterial pathogens [11], the cyclohexapeptides displayed 
profound growth inhibitory activity towards A. fumigatus, as summarised in Table 4.1. For all but 
cRKK, the IC50 and ICmax values were <10 µM and ≤20 µM respectively, indicating a close 
similarity in their activity. The two most active analogues were cWWW and cWRW, unlike with 
antibacterial activity where cWFW was found to be the most active analogue (Table 4.1). 
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Nevertheless, the antifungal activity of cWFW was not significantly different from that of cWWW 
and cWRW (P>0.05; refer to Table 4.7 in addendum for statistical analysis).  
The two most active peptides, cWRW and cWWW, contain the same amino acid residues, which 
are Arg and Trp, but differ in the order of arrangement of these residues. Based on the potent 
activity displayed by these two RW-hexapeptide analogues, it can therefore be hypothesised that 
Arg and Trp are the two most important residues for antifungal activity. The importance of Arg is 
further underscored by the fact that the two Lys-containing analogues exhibit the least potency in 
inhibiting the germination and growth of A. fumigatus from spores. Additionally, the statistical 
similarity between the IC50 and ICmax values of cWRW and cWWW suggests that the order of the 
residues may not be important for antifungal activity given that the residue content is identical. It 
must be noted that the cWRW and cWWW that were tested for activity were from the batch that 
was provided by Dr Margitha Dathe (referred to as cWWW1 and cWRW1 in Chapter 2). 
The slight differences noted in the growth inhibitory activity of the three analogues with a mutation 
in the middle aromatic residue of the aromatic tripeptide moiety (cWFW, cWWW and cWYW) 
show that the identity of aromatic residue in this position may be influential in the modulation of 
activity.  The results indicated that Trp is the most preferred residue in this position, followed by 
Phe and lastly Tyr (Table 4.1, refer to Table 4.7 in addendum for statistical analysis). 
The activity of some of the cyclohexapeptides was quite comparable to that of the 
cyclodecapeptides. According to the one-way ANOVA statistical analysis performed on the IC50 
values, the activity of the three most active cyclohexapeptides (cWWW, cWRW and cWFW) was 
similar to that of the cyclodecapeptides (Table 4.1, refer to Table 4.8 in addendum for statistical 
analysis). 
On the other hand, the activity of linear RW-hexapeptides was found to be significantly lower than 
that of the cyclodecapeptides. Furthermore, they demonstrated reduced antifungal potency 
characterised by IC50 values that were 2- to 4-fold higher than those of the corresponding cyclic 
analogues (Table 4.1). This highlights the activity enhancing effect of cyclisation on the RW-
hexapeptides. Dathe et al. [17] also reported improved antibacterial activity of the RW-
hexapeptides upon cyclisation.  
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Table 4.1: Summary of the germination and growth inhibitory activity of the cyclodecapeptides 
and RW-hexapeptides towards A. fumigatus spores. The values of the activity parameters, IC50 
and ICmax, are expressed in µM and represent the mean ± SEM of n biological repeats, each with 











3.9 ± 1.1 
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5.4 ± 0.4 
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4.5 ± 0.5 
(3) 
WC 
5.3 ± 1.0 
(3) 





4.6 ± 1.1 
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9.8 ± 0.8 
(3) 
20.4 ± 1.5 
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12.1 ± 1.3 
(3) 
26.0 ± 3.9 
(3) 
cWFW 
7.8 ± 0.6 
(3) 
17.2 ± 2.9 
(3) 
cWRW 
7.0 ± 0.6 
(4) 
13.2 ± 1.6 
(4) 
cWWW 
5.9 ± 0.6 
(4) 
9.3 ± 1.0 
(4) 
cWYW 
9.3 ± 0.2 
(3) 






28.3 ± 2.3 
(3) 
54.6 ± 5.0 
(3) 
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48.2 ± 3.2 
(3) 
68.6 ± 5.5 
(3) 
AcWFW 
21.4 ± 2.4 
(3) 
59.3 ± 12 
(3) 
AcWRW 
12.6 ± 0.9 
(3) 
26.0 ± 0.7 
(3) 
AcWWW 
13.0 ± 1.0 
(3) 
26.6 ± 1.2 
(3) 
AcWYW 
27.1 ± 2.9 
(3) 
71.4 ± 11 
(3) 
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Based on the structural models of the RW-hexapeptides (Chapter 3), the higher activity of the 
cyclic analogues can possibly be attributed to their more pronounced amphipathic conformation. 
Nonetheless, the same trend of activity was observed for the linear RW-hexapeptides as was for 
the cyclic RW-hexapeptides, with AcWWW and AcWRW exhibiting the greatest antifungal 
activity. It was interesting to note that AcRKK exhibited the least potency against A. fumigatus 
spores. AcRKK is the L-form analogue of the D-amino acid peptide PAF26, a synthetic peptide 
that was discovered by screening a synthetic combinatorial library for antifungal peptides. It has 
shown potent to moderate activity against various filamentous fungal pathogens [20].  
Antifungal activity against A. fumigatus hyphae 
The effect of WC and selected RW-hexapeptide analogues (WRW and WWW) on the hyphae of 
A. fumigatus was investigated using the resazurin assay [27]. In this assay, the metabolic reduction 
of resazurin (blue) to resorufin (pink, fluorescent) is used as measure of the cells’ metabolic 
activity (redox potential) and in turn their viability [27,28]. The only peptides that effectively 
arrested the metabolic activity of the fungal hyphae within the range of peptide concentrations 
tested were cWWW and WC (Table 4.2 and Figure 4.1). However, their activities were 
significantly different (P<0.05; refer to Table 4.12 in addendum for statistical analysis). The 
activity of WC against A. fumigatus hyphae was more than four-fold greater than that of cWWW 
(Table 4.2). Moreover, WC exhibited greater activity than the control (GS), while cWWW was 
less active. The other three RW-hexapeptide analogues had minimal to no activity towards A. 
fumigatus hyphae.  
In this study all the peptides exhibited lower IC50 values for germination and growth inhibition of 
A. fumigatus spores, compared to the inhibition of hyphal metabolic activity (Table 4.2). The 
hyphal growth forms of fungi are normally more resistant to antifungal treatments [29,30]. 
However, an encouraging result is that for WC, this difference is not statistically significant 
(P>0.05; refer to Table 4.13 in addendum for statistical analysis). This illustrates that WC is 
equally as effective at inhibiting the growth of spores, as it is at abolishing metabolic activity in 
hyphae. A non-discriminatory membranolytic mode of action of WC may account for the observed 
similarity in the activity towards spores and hyphae.  
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Table 4.2: Comparison of the activity of peptides against A. fumigatus spores and hyphae. All 
IC50 values are in µM units and represent the mean ± SEM of n biological repeats, each repeat 
consisting of 3-6 technical repeats.  
Peptides 
Metabolic inhibition of 
hyphae 
IC50 ± SEM (n) 
Germination and growth 
inhibition of spores 
IC50 ± SEM (n) 
WC 
6.2 ± 1.1 
(3) 





7.0 ± 0.6 
(4) 
cWWW 
28.3 ± 1.1 
(3) 










26.6 ± 1.2 
(3) 
GS 
15.7 ± 1.1 
(3) 
4.6 ± 1.1 
(6) 
 
Conversely, the RW-hexapeptide analogues are not as effective at inhibiting the metabolic activity 
of hyphae, as they are at inhibiting the growth of spores (Table 4.2, Figure 4.1). This loss of 
antifungal activity towards fungal hyphae by the RW-hexapeptides may be an indication that the 
target upon which they act in spores may be absent, present in lower concentration, shielded or 
modified in hyphae. 
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Figure 4.1: Inhibition of the metabolic activity of A. fumigatus hyphae.  
Thirty-hour old A. fumigatus hyphae were treated for 2 hours with selected peptides followed 
by a 2-hour incubation with resazurin solution to evaluate metabolic activity. Peptide 
concentrations ranged between 100.0-0.79 µM. Each data point is representative of the mean 
± SEM of triplicate biological assays with triplicate technical repeats per assay. 
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Evaluation of the toxicity of the cyclodecapeptides and the RW-hexapeptides 
Evaluation of peptide toxicity was achieved by assessing the haemolytic activity elicited by the 
peptide groups towards human erythrocytes. The haemolytic activity of the cyclodecapeptides has 
been well characterised previously [22,31,32] and has been shown to compare well with that of 
GS, which was used as the positive control for haemolysis in this investigation. As expected, the 
cyclodecapeptides displayed haemolytic activity that was quite prominent and highly comparable 
to the activity of GS (Table 4.3). The HC50 values of all the analogues were below 20 µM and 
were confined within a narrow concentration range. However, according to one-way ANOVA, a 
significant difference exists between the activities of YB and WC (P<0.05; refer to Table 4.14 in 
addendum for statistical analysis). The activity of the cyclodecapeptides followed the same trend 
that was depicted for the growth inhibition of A. fumigatus spores, with YB>YA>WC. On this 
premise, it can be inferred that both the antifungal and haemolytic activities are governed by the 
same factors. Additionally, the pronounced haemolytic activity of the tyrocidines can be ascribed 
to their previously characterised membranolytic mode of action [10,13]. 
Conversely, the RW-hexapeptides exhibited very little haemolytic activity, maintaining 
consistency with the findings of other investigators [17,18] (Table 4.3). Because of their low 
haemolytic activity, it was not possible to fit the data obtained from dose response assays onto 
sigmoidal curves and in turn, determine HC50. In order to assess the unique haemolytic properties 
of each hexapeptide analogue, % haemolysis induced at 100 µM was taken into consideration.  In 
general, the linear analogues exhibited less haemolytic activity in comparison to their cyclic 
counterparts. This indicates that while cyclisation enhances antimicrobial activity, it also enhances 
their toxicity thereby compromising some of their selectivity. However, the difference in activity 
between the cyclic and linear RW-hexapeptides is not statistically significant (P>0.05), except for 
the RKK and WWW analogues (Table 4.3, refer to Table 4.15 in addendum for statistical 
analysis).  It was also established that the Lys-containing analogues induced greater haemolysis 
over the Arg-containing analogues. Based on this and the antifungal data, it can thus be concluded 
the roles of the two basic amino acid residues in peptides are juxtaposed. While Arg appears to 
promote antimicrobial activity, Lys promotes peptide toxicity against human erythrocytes. 
It appears that aromatic residues have an influential role in the haemolytic activity of the RW-
hexapeptides, as they do in their antifungal activity. As shown in Table 4.3, the haemolytic activity 
of the WWW analogues was approximately four-fold higher than that of WFW and WYW 
analogues indicating that the nature of the aromatic residue in the middle position of the aromatic  
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Table 4.3: Summary of the haemolytic activity of the cyclodecapeptides and RW-hexapeptides 
towards human erythrocytes. The values of the activity parameter, HC50, are expressed in µM and 
haemolysis activity at 100 µM is given in percentages. All values represent the mean ± SEM of n 
biological repeats, each with between 3-6 technical repeats.  
Description Peptide 
HC50 ± SEM 
(n) 
%Haemolysis 
at 100 µM ± 
SEM (n) 





11.6 ± 1.2 
(3) 
103 ± 1.8 
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8.3 ± 1.1 
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97.6 ± 2.7 
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15.8 ± 1.3 
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tripeptide moiety influences the haemolytic activity of these peptides. From this and the antifungal 
activity data, it can be concluded that while Trp may be the best aromatic residue for antifungal 
activity, its presence in this position compromises selectivity. 
Determination of peptide selectivity 
For future therapeutic development, it is of utmost importance that antimicrobial peptides display 
higher selectivity for the microbial target. In vitro selectivity can be determined by comparing a 
peptide’s (or compound’s) antimicrobial activity to its toxicity against a selected host/human cell 
type. For the cyclodecapeptides, the in vitro selectivity parameter was determined by using the 
antifungal activity parameter, IC50 to the haemolytic toxicity parameter, HC50 (Figure 4.2, Table 
4.4). All three natural cyclodecapeptides exhibited similar levels of low selectivity for the fungal 
target as indicated by their selectivity indices of values of approximately 3 (Table 4.4). This low 
selectivity can be attributed to a non-discriminatory membranolytic mode of action.  
On the other hand, the RW-hexapeptides demonstrated a high degree of selectivity for the fungal 
target. Because the HC50 could not be determined, the selectivity of the RW-hexapeptides was 
established by considering the growth inhibitory activity and haemolytic activity at 100 µM (the 
highest concentration tested in the dose response assays) (Table 4.4).  











YA 3.01 cKRK 9.23 AcKRK 14.6 
YB 2.83 cRKK 4.20 AcRKK 14.9 
WC 3.01 cWFW 20.4 AcWFW 80.1 
GS 2.81 cWRW 94.2 AcWRW 56.7 
* Antifungal activity at 100 µM
Haemolysis at 100 µM
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Figure 4.2: Comparison of the antifungal and haemolytic activities to establish peptide 
selectivity. 
A) Selectivity of the cyclodecapeptides depicted as a comparison between the activity 
parameters IC50 (antifungal) and HC50 (haemolysis).   
B) Selectivity of cyclic RW-hexapeptides depicted as comparison between the antifungal and 
haemolytic activities at 100 µM.  
C) Selectivity of cyclic RW-hexapeptides depicted as comparison between the antifungal and 






Stellenbosch University  https://scholar.sun.ac.za
4-16 
In Figure 4.2 it is quite clear that at the same peptide concentration antifungal activity was 
significantly greater than the haemolytic activity, for all the peptides.  However, the RW 
hexapeptides exhibited much better selectivity than the cyclodecapeptides (Figure 4.2, Table 4.4). 
This selectivity is an indication that the target of the RW-hexapeptides in A. fumigatus is absent 
in human erythrocytes. The differences in the selectivity exhibited by the two peptide groups 
(cyclodecapeptides vs RW-hexapeptides) could possibly allude to distinctly different mechanisms 
of action. 
Antifungal activity of peptide combinations 
Having established the activity of single peptides in each of the three groups, it was decided to 
investigate the activity of selected peptides when used in combination. This was motivated by the 
fact that combination therapy can potentially boost activity and minimise the development of 
antimicrobial resistance, concomitantly. In addition, postulations regarding the modes of action of 
each of the peptides in a combination pair can be made based on the nature of interactions between 
two peptides. Synergistic interactions often indicate distinct modes of action, while additive 
interactions may suggest similar modes of action or a shared target. Antagonistic interactions 
suggest a shared target but different or opposing modes of action. 
From the cyclodecapeptides, WC was selected as the representative analogue. This decision was 
based on the fact that all three cyclodecapeptides displayed similar growth inhibitory activity 
against A. fumigatus spores and WC was the most selective analogue. From the RW-hexapeptide 
library cWWW and cWRW and their linear analogues were selected, as they were the most active 
analogues in their respective categories.  
Based on the FIC indices (FICIs) and isobologram shapes of the peptide combinations, the 
interactions turned out to be slightly antagonistic (1<FICI<4)[11,23] (Table 4.5). The antagonism 
seemed to increase with an increasing WC concentration.  Since cyclodecapeptides are known to 
have a membranolytic mode of action [10,13], it is possible that this lytic action of WC prevented 
the RW-hexapeptides from accessing their target; a target which could potentially be located 
within the membrane or  inside the fungal cell. The higher the concentration of WC, the greater 
its lytic action and the more the RW-hexapeptide analogues are impeded from accessing their 
target resulting in an increase in their FICs and ultimately a greater FICI. 
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Table 4.5: Summary of the characterisation of the nature of interactions between WC and selected 
RW-hexapeptide analogues. FIC values and FIC indices were calculated from three biological 
repeats (each with four technical replicates) of growth inhibition assays towards A. fumigatus 
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In all combinations, the best FICI was found to be at 1:3 where it was shown to be an additive 
interaction (Table 4.5). The addition of 25% WC to, for example, 75% cWRW in a formulation 
would ensure that such a combination will be effective against both spores and hyphae. Such a 
combination would also hypothetically lower the toxicity, although this must still be determined. 
Part 2: Mode of action studies 
Investigation of the membranolytic action of RW-hexapeptides  
After establishing that the RW-hexapeptides had profound growth inhibitory activity against A. 
fumigatus spores, it was befitting that an investigation be carried out to gain more insight on how 
this inhibitory action is exerted. Given their low haemolytic activity, and low permeabilising effect 
on lipid model membranes, RW-hexapeptides are believed to act via a non-membrane 
permeabilisation mode of action. However, it was necessary to establish whether this assumption 
holds true when it comes to their activity against fungal pathogens. 
SYTOX Green, a membrane impermeable dye, was employed in the investigation of the 
membrane integrity of peptide treated A. fumigatus hyphae. In this instance, WC was utilised as 
the lysis positive control due to its known permeabilising effect on the cell membrane [6]. As 
shown in Figures 4.3 and 4.4A, some of the RW-hexapeptide analogues induced membrane 
permeation to a certain extent. In comparison to WC, this membrane permeation was negligible 
as depicted by the low fluorescence intensity of SG. Statistical analysis using one-way ANOVA 
revealed a significant difference in the uptake of SG by WC and the RW-hexapeptide analogues 
(P<0.001; refer to Table 4.16 in addendum for statistical analysis). Figure 4.3B shows the rate of 
permeabilisation that was calculated by analysing data obtained within the first 10 minutes of the 
time course study using first order kinetics. As expected, WC exhibited a much higher 
permeabilisation rate than the RW-hexapeptides. This result therefore confirms the hypothesis that 
membrane lysis is not the dominant mode of action of the RW-hexapeptides. 
It is important to note that these results do not indicate the absence of membrane permeabilisation. 
Rather, they portray a much slower induction of membrane permeabilisation by the RW-
hexapeptide analogues. This means that even though membrane permeabilisation may not be 
considered as the primary means by which the RW-hexapeptides act, it should not be completely 
ruled out as it could potentially be an additional mechanism of action. Alternatively, membrane 
permeabilisation could be a secondary effect of their primary mode of action.  
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Amongst the RW-hexapeptides, the Lys-containing analogues induced a higher uptake of the dye 
as indicated by the observed maximum fluorescence intensity of SG hyphae treated with these 
analogues. They also permeabilised the hyphal membrane at a much faster rate than the other RW-
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Figure 4.3: Time course kinetics of SYTOX Green (SG) uptake by peptide treated A. fumigatus 
hyphae.  
A) SG uptake by linear RW-hexapeptides B) SG uptake by cyclic RW-hexapeptides.  
A. fumigatus hyphae (30 hours old) were simultaneously treated with 25 µM peptide and 0.5 
µM SG. Monitoring of SG uptake commenced immediately and lasted for 60 minutes, with 
fluorescence readings being recorded at 2-minute intervals. Tryptocidine C (WC) served as the 
positive control for lysis.  
B 
A 
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The linear and cyclic analogues of the Lys-containing peptides exhibited statistically similar 
membrane permeabilising effects. However, the cyclic analogues cWFW, cWYW, and cWWW 
induced a significantly greater total uptake of SG than their linear counterparts, correlating with 
their higher haemolytic activity. In contrast , the membrane permeabilising activity of cWRW was 
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Figure 4.4: Permeabilisation of A. fumigatus membrane by RW-hexapeptides.  
A) Maximum fluorescence intensity of SG dye observed in A. fumigatus hyphae after one hour 
of treatment with 25 µM peptide and 0.5 µM SG. 
B) Rate of SG uptake by A. fumigatus hyphae treated with 25 µM peptide, depicted as rate of 
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Peptide induced accumulation of ROS in A. fumigatus hyphae  
Apoptosis or programmed cell death is a carefully controlled process that can be triggered by the 
intracellular accumulation of toxins such as reactive oxygen species (ROS) [33]. Several 
antifungal agents have been shown to induce the accumulation of reactive oxygen species in the 
cells of susceptible fungi [12,34–37]. On account of this, the two most active RW-hexapeptides 
from each of the two RW-hexapeptide categories, together with WC were tested for their ability 
to induce the accumulation of reactive oxygen species in the hyphae of A. fumigatus. Figure 4.5 
shows a significantly enhanced accumulation of ROS species in the hyphae treated with cWWW 
and WC relative to the untreated control (refer to Table 4.18 in addendum for statistical analysis).  
The quantities of ROS were severely reduced upon addition of a known antioxidant, Vitamin C 














In a study conducted by Troskie et al. [12], the antifungal activity of cyclodecapeptides towards 
C. albicans cells was found to be independent of their induction of ROS. The investigators thus 
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Figure 4.5: Induction of ROS in peptide treated A. fumigatus hyphae.  
A. fumigatus hyphae (30 hours old) were treated with 25 µM of peptide (WC, cWRW, cWWW, 
AcWRW and AcWWW) in the presence or absence of the antioxidant ascorbic acid (Vit C) 
prior to staining with 10 mM H2DCFDA. Orange and black bars are representative of the 
%ROS produced in the absence and presence of antioxidant, respectively. Each data point 
represents the mean of three biological repeats (with four technical repeats) ± SEM.  
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concluded that the induction of ROS may be a secondary effect of cyclodecapeptides, such as WC. 
Because of this, it was necessary to determine whether the observed increase in ROS accumulation 
that was induced by cWWW and WC was linked to their antifungal activity. Unfortunately, we 
were unable to obtain another cWWW preparation with reproducible activity. Two attempts to 
obtain another viable batch of this expensive peptide were fruitless. Consequently, the role of ROS 
in the antifungal activity of these two peptides will only be evaluated in a future study when we 
have obtained good quality cWWW preparation and produced and purified more WC .  
4.5 Conclusion 
The natural cyclodecapeptides exhibited excellent and highly comparable antifungal activity 
against A. fumigatus. The results correlated well with previous studies on the antifungal activity 
of these natural peptides [12–14]. All the cyclodecapeptide analogues potently inhibited the 
growth of A. fumigatus spores as indicated by their extremely low IC50 and ICmax values. In 
addition to inhibiting the growth of spores, WC demonstrated equally potent activity towards A. 
fumigatus hyphae, as well as the highest selectivity of the group of cyclodecapeptides tested. 
Because of this potent antifungal activity, this natural cyclodecapeptide has the potential for 
further development as an antifungal agent. However, its high haemolytic activity continues to 
derail its development as an agent for systemic application. Nonetheless, there are ongoing efforts 
in our group aimed at eliminating undesirable toxicity by selective formulation.  
The RW-hexapeptides also exhibited profound growth inhibitory activity against A. fumigatus 
spores. In fact, the activity of three of the cyclic analogues was comparable to that of the natural 
cyclodecapeptides. The cyclic analogues demonstrated superior activity to the linear analogues, 
which highlighted the activity enhancing effect of cyclisation that has been reported previously 
[17]. The importance of Trp residues in antifungal activity was highlighted by the superior activity 
of the WRW and WWW analogues over the WFW and WYW analogues. Moreover, the greater 
antifungal activity exhibited by the WWW analogues over the WFW and WYW analogues also 
highlighted that Trp is the most preferred aromatic residue in the middle position of the aromatic 
tripeptide moiety for antifungal activity. However, it was shown that Trp compromises selectivity 
as it increases the toxicity of the RW-hexapeptides. Arg residues were also   shown to be important 
for antifungal activity as the Arg-containing analogues demonstrated better activity in comparison 
to the Lys-containing analogues.  
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Unfortunately, the antifungal activity of the RW-hexapeptide analogues was drastically 
diminished against A. fumigatus hyphae. Apart from cWWW, none of the lead RW-hexapeptide 
analogues could effectively inhibit the metabolism of A. fumigatus hyphae. Even for cWWW, the 
activity decreased four-fold. Based on these observations, it is believed that the target of RW-
hexapeptide analogues is either altered, shielded, present at a lower concentration or absent in 
fungal hyphae hence the reduction in their activity. Unlike the natural cyclodecapeptides, RW-
hexapeptides displayed little to no haemolytic activity. This low haemolytic activity coupled with 
their excellent fungal growth inhibitory activity makes them very attractive for further 
development as antifungal agents for systemic use. Their high selectivity confers them an 
advantage over the natural cyclodecapeptides when it comes to potential systemic use.   
The RW-hexapeptides also induced minimal uptake of SG indicating that they are not as effective 
as the cyclodecapeptides at permeabilising the membrane. Taken together, the low haemolytic 
activity and the low permeabilisation of fungal membrane illustrate that membrane 
permeabilisation is not the primary mode of action of the RW-hexapeptides. Interestingly, the 
natural cyclodecapeptides and the RW-hexapeptides could potentially have a common mechanism 
of action. WC and the lead RW-hexapeptide analogues induced the accumulation of ROS in A. 
fumigatus hyphae. However, more experiments are needed to establish if the observed ROS 
induction is linked to the antifungal activity of these peptides. 
The interactions between WC and the RW-hexapeptide analogues were found to be slightly 
antagonistic, in general. The antagonism can be attributed to the high membranolytic activity of 
WC. It is postulated that by lysing the highly sensitive membrane of the fungal hyphal apex 
(growth point), WC hindered the RW-hexapeptide analogues from reaching their target. However, 
it was noted that FICIs of the peptide combinations in the 1:3 ratio had FICIs that were very close 
to 1; an indication that the interactions were additive. Based on the selectivity of the RW-
hexapeptides and the antifungal activity of the combinations with WC, a good lead formulation 
for further development would be cWRW and WC. Given the additivity of activity at the 1:3 
peptide ratio, it can be hypothesised that the WC:cWRW combination has the potential to reduce 
the toxicity of WC while still maintaining antifungal activity against both hyphae and spores.  
4.6 References 
[1] M.A. Pfaller, D.J. Diekema, Epidemiology of invasive mycoses in North America, Critical 
Reviews in Microbiology, 36 (2010) 1–53. 
[2] G.D. Brown, D.W. Denning, N.A.R. Gow, S.M. Levitz, M.G. Netea, T.C. White, Hidden 
Stellenbosch University  https://scholar.sun.ac.za
4-24 
killers: Human fungal infections, Science Translational Medicine, 4 (2012). 
[3] D.W. Denning, Therapeutic outcome in invasive aspergillosis, Clinical Infectious Diseases, 
23 (1996) 608–615. 
[4] K.A. Brogden, Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria?, 
Nature Reviews Microbiology, 3 (2005) 238–250. 
[5] R.E. Hancock, Peptide antibiotics, Lancet, 349 (1997) 418–422. 
[6] A.M. Troskie, Tyrocidines, cyclic decapeptides produced by soil bacilli, as potent inhibitors 
of fungal pathogens, PhD Thesis, Department of Biochemistry, University of Stellenbosch, 
(2013), http://hdl.handle.net/10019.1/86162 
[7] R.J. Dubos, Studies on bactericidal agent extracted from a soil Bacillus: 1 Preparation of 
the agent. Its activity in vitro, The Journal of Experimental Medicine, 70 (1939) 1–10. 
[8] O. Shida, H. Takagi, K. Kadowaki, K. Komagata, Proposal for two new genera, 
Brevibacillus gen nov and Aneurinibacillus gen nov, International Journal of Systematic 
Bacteriology, 46 (1996) 939–946. 
[9] R.J. Dubos, R.D. Hotchkiss, A.F. Coburn, The effect of gramicidin and tyrocidine on 
bacterial metabolism, Journal of Biological Chemistry, 146 (1942) 421–426. 
[10] B.M. Spathelf, M. Rautenbach, Anti-listerial activity and structure-activity relationships of 
the six major tyrocidines, cyclic decapeptides from Bacillus aneurinolyticus, Bioorganic 
and Medicinal Chemistry, 17 (2009) 5541–5548. 
[11] A.N.-N. Leussa, Characterisation of small cyclic peptides with antimalarial and antilisterial 
activity PhD Thesis, Department of Biochemistry, University of Stellenbosch, (2014), 
http://hdl.handle.net/100191/86161.  
[12] A.M. Troskie, M. Rautenbach, N. Delattin, J.A. Vosloo, M. Dathe, B.P.A. Cammue, K. 
Thevissen, Synergistic activity of the tyrocidines, antimicrobial cyclodecapeptides from 
Bacillus aneurinolyticus, with amphotericin B and caspofungin against Candida albicans 
biofilms, Antimicrobial Agents and Chemotherapy, 58 (2014) 3697–3707. 
[13] A.M. Troskie, A. de Beer, J.A. Vosloo, K. Jacobs, M. Rautenbach, Inhibition of 
agronomically relevant fungal phytopathogens by tyrocidines, cyclic antimicrobial peptides 
isolated from Bacillus aneurinolyticus, Microbiology, 160 (2014) 2089–2101. 
[14] M. Rautenbach, A.M. Troskie, J.A. Vosloo, M.E. Dathe, Antifungal membranolytic activity 
of the tyrocidines against filamentous plant fungi, Biochimie, 130 (2016) 122–131. 
[15] S.E. Blondelle, R.A. Houghten, Novel antimicrobial compounds identified using synthetic 
combinatorial library technology, Trends in Biotechnology, 14 (1996) 60–65. 
[16] A. Wessolowski, M. Bienert, M. Dathe, Antimicrobial activity of arginine- and tryptophan-
rich hexapeptides: The effects of aromatic clusters, D-amino acid substitution and 
cyclization, Journal of Peptide Research, 64 (2004) 159–169. 
[17] M. Dathe, H. Nikolenko, J. Klose, M. Bienert, Cyclization increases the antimicrobial 
activity and selectivity of arginine- and tryptophan-containing hexapeptides, Biochemistry, 
43 (2004) 9140–9150. 
[18] K. Scheinpflug, H. Nikolenko, I. V. Komarov, M. Rautenbach, M. Dathe, What goes around 
comes around: a comparative study of the influence of chemical modifications on the 
antimicrobial properties of small cyclic peptides, Pharmaceuticals, 6 (2013) 1130–1144. 
[19] A. Muñoz, B. López-García, J.F. Marcos, Studies on the mode of action of the antifungal 
Stellenbosch University  https://scholar.sun.ac.za
4-25 
hexapeptide PAF26, Antimicrobial Agents and Chemotherapy, 50 (2006) 3847–3855. 
[20] B. López-García, E. Pérez-Payá, J.F. Marcos, Identification of Novel Hexapeptides 
Bioactive against Phytopathogenic Fungi through Screening of a Synthetic Peptide 
Combinatorial Library, Applied and Environmental Microbiology, 68 (2002) 2453–2460. 
[21] A. Muñoz, J.F. Marcos, N.D. Read, Concentration-dependent mechanisms of cell 
penetration and killing by the de novo designed antifungal hexapeptide PAF26, Molecular 
Microbiology, 85 (2012) 89–106. 
[22] M. Rautenbach, N.M. Vlok, M. Stander, H.C. Hoppe, Inhibition of malaria parasite blood 
stages by tyrocidines, membrane-active cyclic peptide antibiotics from Bacillus brevis, 
Biochimica et Biophysica Acta - Biomembranes, 1768 (2007) 1488–1497. 
[23] F.C. Odds, Synergy, antagonism, and what the chequerboard puts between them, Journal 
of Antimicrobial Chemotherapy, 52 (2003) 1–1. 
[24] J.A. Vosloo, Optimised bacterial production and characterisation of natural antimicrobial 
peptides with potential application in agriculture, PhD Thesis, Department of Biochemistry, 
University of Stellenbosch, (2016), http://hdl.handle.net/10019.1/98411 
[25] S. Laiken, M. Printz, L.C. Craig, Circular dichroism of the tyrocidines and gramicidin S-A, 
Journal of Biological Chemistry, 244 (1969) 4454–4457. 
[26] G. Munyuki, G.E. Jackson, G.A. Venter, K.E. Kövér, L. Szilágyi, M. Rautenbach, B.M. 
Spathelf, B. Bhattacharya, D. Van Der Spoel, β-sheet structures and dimer models of the 
two major tyrocidines, antimicrobial peptides from Bacillus aneurinolyticus, Biochemistry, 
52 (2013) 7798–7806. 
[27] T.L. Riss, R.A. Moravec, A.L. Niles, S. Duellman, H.A. Benink, T.J. Worzella, L. Minor, 
Cell viability assays, Eli Lilly & Company and the National Center for Advancing 
Translational Sciences, 2004. 
[28] J. O’Brien, I. Wilson, T. Orton, F. Pognan, Investigation of the Alamar Blue (resazurin) 
fluorescent dye for the assessment of mammalian cell cytotoxicity, European Journal of 
Biochemistry, 267 (2000) 5421–5426. 
[29] C. Lass-Florl, M. Nagl, E. Gunsilius, C. Speth, H. Ulmer, R. Wurzner, In vitro studies on 
the activity of amphotericin B and lipid-based amphotericin B formulations against 
Aspergillus conidia and hyphae  In vitro-Empfindlichkeit von Aspergillus-Konidien und -
Hyphen gegenuber Amphotericin B und Amphotericin B-Lipidpraparationen, Mycoses, 45 
(2002) 166–169. 
[30] J. Guarro, C. Llop, C. Aguilar, I. Pujol, Comparison of in vitro antifungal susceptibilities 
of conidia and hyphae of filamentous fungi, Antimicrobial Agents and Chemotherapy, 41 
(1997) 2760–2. 
[31] C.H. Rammelkamp, L. Weinstein, Toxic effects of tyrothricin, gramicidin and tyrocidine, 
Journal of Infectious Diseases, 71 (1942) 166–173. 
[32] B. Spathelf, Qualitative structure-activity relationships of the major tyrocidines , cyclic 
decapeptides from Bacillus aneurinolyticus, PhD Thesis, Department of Biochemistry, 
University of Stellenbosch, (2013), http://hdl.handle.net/10019.1/4001 
[33] É. Leiter, H. Szappanos, C. Oberparleiter, L. Kaiserer, L. Csernoch, T. Pusztahelyi, T. Emri, 
I. Pócsi, W. Salvenmoser, F. Marx, Antifungal protein PAF severely affects the integrity of 
the plasma membrane of Aspergillus nidulans and induces an apoptosis-like phenotype, 
Antimicrobial Agents and Chemotherapy, 49 (2005) 2445–2453. 
Stellenbosch University  https://scholar.sun.ac.za
4-26 
[34] A.J. Phillips, I. Sudbery, M. Ramsdale, Apoptosis induced by environmental stresses and 
amphotericin B in Candida albicans, Proceedings of the National Academy of Sciences, 
100 (2003) 14327–14332. 
[35] I. Francois, B. Cammue, M. Borgers, J. Ausma, G. Dispersyn, K. Thevissen, Azoles: mode 
of antifungal action and resistance development. Effect of miconazole on endogenous 
reactive oxygen species production in Candida albicans, Anti-Infective Agents in 
Medicinal Chemistry, 5 (2006) 3–13. 
[36] K. De Brucker, B.P.A. Cammue, K. Thevissen, Apoptosis-inducing antifungal peptides and 
proteins, Biochemical Society Transactions, 39 (2011) 1527–1532. 
[37] A.M. Aerts, I.E.J.A. François, E.M.K. Meert, Q.T. Li, B.P.A. Cammue, K. Thevissen, The 
antifungal activity of RsAFP2, a plant defensin from Raphanus sativus, involves the 
induction of reactive oxygen species in Candida albicans, Journal of Molecular 















Stellenbosch University  https://scholar.sun.ac.za
4-27 
4.7 Addendum 
Table 4.6: Summary of the P-values obtained from the statistical analysis of the germination and 
growth inhibitory activity of the cyclodecapeptides against A. fumigatus spores. Statistical 
significance was determined by performing one-way ANOVA (using the Bonferroni’s multiple 
comparisons test) on the IC50 values. “ns” denotes a P-value > 0.05.  
 YB WC GS 
YA ns ns ns 
YB  ns ns 
WC   ns 
 
Table 4.7: Summary of the P-values obtained from the statistical analysis of the germination and 
growth inhibitory activity of the cyclic RW-hexapeptides against A. fumigatus spores. Statistical 
significance was determined by performing one-way ANOVA (using the Bonferroni’s multiple 
comparisons test) on the IC50 values.  “ns” denotes a P-value > 0.05.  
 cRKK cWFW cWRW cWWW cWYW 
cKRK ns ns ns 0.03 ns 
cRKK  0.02 0.003 0.0004 ns 
cWFW   ns ns ns 
cWRW    ns ns 
cWWW     ns 
 
Table 4.8: Summary of the P-values obtained from the statistical comparison of the activities of 
the cyclic RW-hexapeptides and cyclodecapeptides in inhibiting the germination and growth A. 
fumigatus spores. Statistical significance was determined by performing one-way ANOVA (using 
the Bonferroni’s multiple comparisons test) on the IC50 values. “ns” denotes a P-value > 0.05.  
 YA YB WC GS 
cKRK 0.02 0.003 ns 0.02 
cRKK 0.0003 <0.0001 0.003 0.0001 
cWFW ns ns ns ns 
cWRW ns ns ns ns 
cWWW ns ns ns ns 
cWYW 0.04 0.008 ns 0.04 
 
Table 4.9: Summary of the P-values obtained from the statistical analysis of the germination and 
growth inhibitory activity of the linear RW-hexapeptides against A. fumigatus spores. Statistical 
significance was determined by performing one-way ANOVA (using the Bonferroni’s multiple 
comparisons test) on the IC50 values. “ns” denotes a P-value > 0.05.  
 AcRKK AcWFW AcWRW AcWWW AcWYW 
AcKRK 0.0006 ns 0.004 0.006 ns 
AcRKK  <0.0001 <0.0001 <0.0001 0.0003 
AcWFW   ns ns ns 
AcWRW    ns 0.008 
AcWWW     0.009 
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Table 4.10: Summary of the P-values obtained from the statistical comparison of the activities of 
the linear RW-hexapeptides and cyclodecapeptides in inhibiting the germination and growth A. 
fumigatus spores. Statistical significance was determined by performing One-way ANOVA (using 
the Bonferroni’s multiple comparisons test) on the IC50 values. “ns” denotes a P-value > 0.05.  
 YA YB WC GS 
AcKRK <0.0001 <0.0001 <0.0001 <0.0001 
AcRKK <0.0001 <0.0001 <0.0001 <0.0001 
AcWFW <0.0001 <0.0001 0.0001 <0.0001 
AcWRW ns 0.04 ns ns 
AcWWW ns 0.03 ns 0.04 
AcWYW <0.0001 <0.0001 <0.0001 <0.0001 
 
Table 4.11: Summary of the P-values obtained from the statistical comparison of the activities of 
the linear  and cyclic RW-hexapeptides at inhibiting the germination and growth A. fumigatus 
spores. Statistical significance was determined by performing multiple t-tests (using the Sidak-
Bonferroni method) on the IC50 values. “ns” denotes a P-value > 0.05.  
Peptides Significant P-value 
cKRK vs AcKRK Yes 0.002 
cRKK vs AcRKK Yes 0.0005 
cWFW vs AcWFW Yes 0.006 
cWRW vs AcWRW Yes 0.003 
cWWW vs AcWWW Yes 0.0009 
cWYW vs AcWYW Yes 0.004 
 
Table 4.12: Summary of the P-values obtained from the statistical analysis of the inhibition of the 
metabolic activity of  A. fumigatus hyphae by selected peptides. Statistical significance was 
determined by performing one-way ANOVA (using the Bonferroni’s multiple comparisons test) 
on the IC50 values. “ns” denotes a P-value > 0.05.  
 cWWW cWRW AcWWW AcWRW GS 
WC <0.0001 <0.0001 <0.0001 <0.0001 0.0001 
cWWW  <0.0001 <0.0001 <0.0001 <0.0001 
cWRW   <0.0001 <0.0001 <0.0001 
AcWWW    <0.0001 <0.0001 
AcWRW     <0.0001 
 
Table 4.13: Summary of the P-values obtained from the statistical comparison of the inhibitory 
activities of the selected peptides against A. fumigatus spores and hyphae. Statistical significance 
was determined by performing multiple t-tests (using the Sidak-Bonferroni method) on the IC50 
values. “ns” denotes a P-value > 0.05.  
Peptides Significant? P-value 
cWWW Yes <0.0001 
cWRW Yes <0.0001 
AcWWW Yes <0.0001 
AcWWW Yes <0.0001 
WC No 0.5 
GS Yes 0.0003 
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Table 4.14: Summary of the P-values obtained from the statistical analysis of the haemolytic 
activity of the cyclodecapeptides against towards human erythrocytes. Statistical significance was 
determined by performing one-way ANOVA (using the Bonferroni’s multiple comparisons test) 
on the HC50 values. “ns” denotes a P-value > 0.05.  
 YB WC GS 
YA ns ns ns 
YB  0.0001 0.04 
WC   ns 
 
Table 4.15: Summary of the P-values obtained from the statistical comparison of the haemolytic 
activities of the linear  and cyclic RW-hexapeptides towards human erythrocytes. Statistical 
significance was determined by performing multiple t-tests (using the Sidak-Bonferroni method) 
on the percentage haemolysis induced at 100 µM. “ns” denotes a P-value > 0.05.  
Peptides Significant? P-value 
cKRK vs AcKRK No 0.1 
cRKK vs AcRKK Yes <0.0001 
cWFW vs AcWFW No 0.01 
cWRW vs AcWRW No 0.5 
cWWW vs AcWWW Yes 0.0003 
cWYW vs AcWYW No 0.07 
 
Table 4.16: Summary of the P-values obtained from the statistical comparison of the membrane 
permeabilising activity of the RW-hexapeptides with that of WC.  Statistical significance was 
determined by performing one-way ANOVA (using the Bonferroni’s multiple comparisons test) 
on the total fluorescence intensity of SYTOX Green. “ns” denotes a P-value > 0.05.  
Peptide compared to WC Significant? P-value 
AcKRK Yes <0.0001 
AcRKK Yes <0.0001 
AcWFW Yes <0.0001 
AcWRW Yes <0.0001 
AcWWW Yes <0.0001 
AcWYW Yes <0.0001 
cKRK Yes <0.0001 
cRKK Yes <0.0001 
cWFW Yes <0.0001 
cWRW Yes <0.0001 
cWWW Yes <0.0001 
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Table 4.17: Summary of the P-values obtained from the statistical comparison of the membrane 
permeabilising activities of the linear  and cyclic RW-hexapeptides. Statistical significance was 
determined by performing multiple t-tests (using the Sidak-Bonferroni method) on the total 
fluorescence intensity of SYTOX Green. “ns” denotes a P-value > 0.05.  
Peptides Significant? P-value 
cKRK vs AcKRK No 0.7 
cRKK vs AcRKK No 0.07 
cWFW vs AcWFW Yes <0.0001 
cWRW vs AcWRW Yes <0.0001 
cWWW vs AcWWW Yes <0.0001 
cWYW vs AcWYW Yes <0.0001 
 
Table 4.18: Summary of the P-values obtained from the statistical comparison of the accumulation 
of ROS species in peptide treated hyphae versus untreated hyphae. Statistical significance was 
determined by performing one-way ANOVA (using the Bonferroni’s multiple comparisons test) 
on the percentage ROS accumulated. “ns” denotes a P-value > 0.05.  
Peptide compared to 
untreated control 
Significant? P-value 
AcWRW No >0.05 
AcWWW No >0.05 
cWRW No >0.05 
cWWW Yes <0.0001 
WC Yes <0.0001 
 
Table 4.19: Summary of the P-values obtained from the statistical comparison of the accumulation 
of ROS species in peptide treated hyphae in the presence versus absence of  the antioxidant, 
Vitamin C. Statistical significance was determined by performing multiple t-tests (using the Sidak-
Bonferroni method) on the total fluorescence intensity of SYTOX Green. “ns” denotes a P-value 
> 0.05.  
Peptide Significant P-value 
AcWRW No >0.05 
AcWWW No >0.05 
cWRW No >0.05 
cWWW Yes <0.0001 
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Chapter 5 
Conclusions and recommendations for future studies 
5.1 Introduction 
An unprecedented global increase in the incidence of systemic fungal infections which has 
occurred in concurrence with a rising population of immunocompromised individuals has 
necessitated the search for  novel agents of antifungal therapy [1–3]. Currently available 
therapeutic options have failed to effectively manage systemic fungal infections which are 
associated with high mortality rates due to modest activity against fungal pathogens and/or 
significant host toxicity [2]. Antimicrobial peptides (AMPs), regarded as Nature’s very own 
antibiotics, are thus believed to be a potential solution to the threat of pathogenic fungi due to their 
highlighted potent and broad-spectrum antimicrobial activity [4–6].  On this premise, we set out 
to investigate the potential of small AMPs (natural cyclodecapeptides and RW-hexapeptides)  for 
development as antifungal agents by characterising their antifungal activity against Aspergillus 
fumigatus. A. fumigatus is implicated in the pathogenesis of invasive aspergillosis, a deadly 
systemic fungal infection [7,8]. 
The investigation of the antifungal activity of the peptides was preceded by their chemical and 
structural characterisation. Chemical characterisation is essential to ascertain purity and chemical 
integrity as these properties influence the biological activity of peptides. The RW-hexapeptides 
only needed chemical characterisation as they were acquired elsewhere. The cyclodecapeptides 
had to be produced and extracted from cultures of Brevibacillus parabrevis first before they were 
purified and characterised chemically. Following successful chemical characterisation, the 
peptides were characterised structurally using biophysical methods in order to investigate the role 
of structure in peptide activity. Finally, an investigation into their antifungal activity against A. 
fumigatus spores and hyphae was carried out. Subsequently, a partial characterisation of the mode 
of action was done to gain insight into how antifungal activity is exerted. 
5.2 Experimental conclusions 
Production, purification and chemical characterisation of natural cyclodecapeptides  
The tailored production of natural cyclodecapeptide analogues from amino acid supplemented 
cultures of Br. parabrevis was successful. From the analysis of the three culture extracts, it was 
evident that amino acid supplementation shifted the production profile of the cyclodecapeptides 
in fashion that is similar to what was reported by Vosloo et al. [9]. Supplementation with 16.5 
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mM Trp favoured the production of YC analogues, specifically WC while an increased production 
of YA analogues was observed in the extract obtained from cultures supplemented with 22 mM 
Phe. Purification of individual peptides using semi-preparative reversed phase HPLC was 
successful for most of the analogues as their UPLC-MS analyses confirmed their purities to be 
greater than 90% (specific peptide in composition). YB is the only analogue whose purity was 
below 90% as its complete separation from the closely related tyrocidine B1 could not be achieved 
even after two rounds of purification. Thus, it would be ideal to optimise the HPLC purification 
methodology to ensure complete resolution between tyrocidine B and tyrocidine B1 in future.  The 
yield of tyrocidine C was low in production which prevented the investigation of its antifungal 
activity. This analogue is difficult to obtain in sufficient quantities via microbial culture 
production. Future studies could utilise different Trp:Phe ratios that would favour the production 
of YC by the producer cultures, as suggested by Vosloo et al. [9]. 
Chemical characterisation of RW-hexapeptides 
Most of the RW-hexapeptide preparations  passed our stringent quality control (QC) assessment 
as they were found to have purities of greater than 90%,  according to UPLC-MS analysis. 
However, the two peptide preparations of the cWWW analogue that were obtained from GL 
Biochem failed our stringent QC tests. ESMS analysis of cWWW2  revealed the presence of 
various unidentified impurities in the peptide preparation. While the ESMS spectrum of cWWW3 
appeared similar to that of the pure cWWW1, the positive ion signal was approximately 20-fold 
lower than expected, which could be an indication of the presence of non-ionisable impurities in 
the peptide preparation. The low positive ion signal and the failure to generate a UPLC-MS profile 
for cWWW3 are indications that the correct peptide was present only in very low quantities in the 
preparation which translated to a low purity.  
In Chapter 4, cWWW was found to be the most active RW-hexapeptide analogue against A. 
fumigatus spores and hyphae making it a lead peptide for further development as an antifungal 
therapeutic agent.  Because of this, it is quite important to obtain a pure preparation of this 
analogue as it would allow further characterisation of its activity and mode of action. In future, it 
would be ideal to  synthesise the peptide in the BIOPEP facility as GL-Biochem are clearly 
struggling to synthesise cWWW correctly, and Dr Margitta Dathe’s group in Leibniz have 
terminated their projects on the RW-hexapeptides. 
UPLC-MS analysis showed the RW-hexapeptides to be highly polar as indicated by their early 
elution from the UPLC column (Rt<3 minutes). The comparable retention times of the RW-
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hexapeptide analogues was an indication of their similar amphipathic properties. However, the 
cyclic analogues exhibited slightly greater hydrophobicity in comparison to the linear analogues 
as indicated by their longer retention on the C18 matrix during UPLC analysis. Dathe et al. [10] 
postulated that this increase in hydrophobicity could be attributed to the clustering of aromatic 
residues and could result in a slight enhancement of the amphipathicity of the cyclic analogues.  
The results from our molecular modelling experiments (Chapter 3) confirmed this hypothesis as 
the models of the cyclic hexapeptides exhibited a more defined amphipathic conformation than 
models of the linear analogues. 
Structural characterisation of cyclodecapeptides 
The results of the structural characterisation of the cyclodecapeptides showed consistency with 
previous findings [11–13]. The secondary structure of the cyclodecapeptides was found to be 
conserved and to consist of  β-turn and β-sheet elements. In TFE, increased negative ellipticity at 
the 208 nm minima was observed which indicated an increase in β-turns and hydrogen bonded 
networks. TFE also promoted the formation of higher order sheet structures among the 
cyclodecapeptide analogues as indicated by the increased ellipticity ratios (θ208/θ216). Formation 
of higher order sheet structures was consistent with the propensity of the cyclodecapeptides to 
self-assemble in solution [14]. It was established from near UV CD spectroscopy and FS that self-
assembly of the cyclodecapeptides is influenced by the nature of their solvent environment. 
Changes were observed in the shapes of the near UV CD spectra and fluorescence emission spectra 
of the cyclodecapeptides when their solvent environment changed. These changes pointed to the 
reorientation of aromatic side chains which would occur if there is an  increased formation of self-
assembly structures and/or alteration in the tertiary structure.  
Structural characterisation of RW-hexapeptides 
Characterisation of the structures of the RW-hexapeptides highlighted fundamental differences 
between the linear and cyclic analogues. From the in silico molecular modelling, the secondary 
structure of the molecular models of the cyclic analogues depicted a β-turn and γ-turn while the 
models of the  linear analogues depicted only γ-turns. Analysis of secondary structure using the 
modelling software YASARA, indicated the secondary structure of the cyclic analogues to be 
composed of turn and β-sheet structures. A β-turn β-sheet motif was also represented on their CD 
spectra in water [15,16]. In silico analysis of the secondary structural composition of the linear 
analogues indicated only undefined elements which could be the γ turns. The shapes of their CD 
spectra in water were reminiscent of  undefined/irregular structures [17,18]. However, a huge 
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change in spectral shape was observed when the solvent environment of the linear analogues 
changed to TFE indicating that their structures had changed significantly. This is in stark contrast 
to the cyclic analogues whose CD spectra did not change much in TFE indicating the stability of 
the backbone structure which could be attributed to the two turns in their backbone and 
confinement in a cyclic structure. FS also highlighted structural differences between the linear  
and cyclic RW-hexapeptides. While the fluorescence emission maximum of  all the analogues 
were blue-shifted in TFE, only the cyclic analogues experienced quenching of their total 
fluorescence intensity.  
In future, the use of model membranes is recommended when characterising the structure of 
peptides with CD and FS as opposed to a membrane-mimicking solvent such as TFE as they better 
represent the architecture of a true membrane and would give a more accurate representation of 
the structures adopted by peptides in a membrane environment.  Advanced 2D-NMR spectroscopy 
of the peptides in different solvents would also be beneficial to refine the in silico models of the 
peptides. 
Biological activity of peptides 
In general, the cyclodecapeptides and the RW-hexapeptides displayed excellent antifungal activity 
against A. fumigatus. The cyclodecapeptides were, however, the most active followed by the cyclic 
RW-hexapeptides and lastly, the linear RW-hexapeptides. The activity of the most active cyclic 
RW-hexapeptides (cWRW, cWWW and cWFW) compared well with that of the 
cyclodecapeptides as indicated by the similarity of the IC50 values for germination and growth 
inhibition of A. fumigatus spores. The superior activity of the cyclic analogues over the linear 
analogues was attributed to their more pronounced amphipathicity.  Amongst the RW-
hexapeptides, the WRW and WWW cyclic and linear analogues exhibited the most profound 
germination and growth inhibitory activity against A. fumigatus spores highlighting the important 
role of Arg and Trp residues in antifungal activity. Superior activity was observed for the Arg- 
containing analogues over the analogues containing Lys residues. In addition, the analogues that 
had only Trp  as their aromatic residue had better activity than analogues with Phe and Tyr. Taken 
together, these two observations suggest that the antifungal activity of the RW-hexapeptides is not 
determined by amphipathicity alone but by specific residues.  
Consistent with the findings from previous investigations [19,20], the natural cyclodecapeptides 
were found to be toxic as they exhibited haemolytic activity.  This toxicity continues to derail their 
potential development as antifungal agents for the treatment of systemic infections. Conversely, 
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the RW-hexapeptides demonstrated limited haemolytic activity which is also consistent with 
previous findings [10,21]. Their low propensity to lyse human erythrocytes renders them more 
attractive for development as therapeutic agents for systemic use.  
Investigation of the antifungal activity of  peptide combinations showed the peptide interactions 
of the 1:3 peptide combinations of WC and each of the lead RW-hexapeptide analogues to be 
additive. Based on this observation, it is proposed that a combination of WC and cWRW at this  
ratio would be worth considering for further development as an antifungal agent. Hypothetically, 
such a combination would eliminate the high toxicity of WC but maintain the high antifungal 
potency towards spores and hyphae. It would therefore be ideal to develop such a formulation for 
the treatment of systemic infections, as well as topical infections such as foot and mouth ulcers 
caused by fungal infections. Further investigations of this proposed combination towards other 
fungal pathogens (Candida spp. and Cryptococcus spp.) and optimisation of the formulation are 
thus recommended.  
Investigation of membrane permeabilisation as a mode of action showed that for the RW-
hexapeptides, it is not the primary mode of action. The low uptake of SG indicated their inability 
to effectively disrupt the membrane integrity of the A. fumigatus hyphae. On the other hand, WC 
effectively permeabilised the membrane of A. fumigatus hyphae and induced rapid uptake of SG. 
This result was consistent with the previously reported membranolytic mode of action of the 
cyclodecapeptides [6]. The observed lytic action or lack thereof directly correlated to the 
haemolytic activity of all peptides.  
WC and cWWW increased the accumulation of ROS in A. fumigatus hyphae. Moreover, they were 
the only two peptides that exhibited activity against fungal hyphae. Together, these results indicate 
the possible involvement of ROS in the execution of WC and cWWW’s antifungal activity. 
However, further investigations are required to ascertain whether the increased production of ROS 
is linked to the antifungal activity of the peptides as Troskie et al. [22] found that the antifungal 
activity of some cyclodecapeptide analogues was not related to their ROS induction in C. albicans. 
5.3 Last word 
This study has highlighted the potent antifungal activity of the cyclodecapeptides and the RW-
hexapeptides thus confirming our hypothesis that AMPs could potentially be developed as novel 
therapeutic agents to be used in the therapy of the rampant systemic fungal infections. The 
membrane action of the cyclodecapeptides  has also been highlighted. However, the mode action 
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of the RW-hexapeptides still remains a mystery warranting further investigations into their mode 
of action.  
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